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 ABSTRACT 
The tambjamines (1-12) are a subset of the 4-methoxybipyrrolic class of natural products. They 
are structurally related to the tripyrrolic prodigiosins and, like these compounds, show some 
intriguing biological effects such as the inhibition of immunoproliferation in rabbits (for 
example tambjamine 5 aka BE-18591). They also bind to duplex DNA and effect cleavage of it 
in the presence of copper (II) without the aid of an external reductant. Despite exhibiting these 
interesting properties, no total synthesis of the tambjamines had been previously described and 
neither had any comprehensive biological assessment of these compounds been published. 
Accordingly, Chapter One of this thesis reports on the total synthesis of tambjamines 2-6 and 8-
11 and the outcomes of their evaluation as anti-microbial and cytotoxic agents. 
 
Chapter Two introduces a different, but large and growing class of epoxyquinol-type natural 
products, members of which display a wide range of biological effects. Representative 
epoxyquinol-type natural products include (+)-bromoxone (55), (+)-bromoxone acetate (106), 
(+)-epiepoformin (108), (−)-harveynone (148) and (−)-tricholomenyn A (174). 
 
In an effort to address the challenges associated with producing epoxyquinol natural products on 
scales useful for the establishment of detailed structure-activity relationships (SAR), selective 
methods for the elaboration of the versatile epoxyquinol synthons 98-100, 107 and 188 from 
enantiomerically pure cis-dihydrocatechols 88-90 were devised. The former group of 
compounds were then converted, generally by straightforward means, into the natural products 
ent-55, ent-106, ent-108, 148 and 174. 
viii Abstract  
 
 By related means compounds 199 and 244 were prepared and then shown to engage in Diels-
Alder dimerization reactions to give the dimeric epoxyquinol natural products 
(+)-panepophenanthrin (192) and (+)-hexacyclinol (233), respectively. 
 
 GLOSSARY 
The following abbreviations have been used throughout this thesis: 
δ chemical shift (parts per million) 
°C degrees Celsius 
µg microgram(s) 
µL microlitre(s) 
Ac acetyl 
AcOH acetic acid 
aq. aqueous 
Ar (unspecified) aryl group 
atm atmosphere(s) 
Bn benzyl 
br broad 
Bu butyl 
n-Bu n-butyl 
s-Bu sec-butyl 
t-Bu tert-butyl 
c concentration (g/100 mL) 
ca. circa (approximately) 
cat. catalytic/catalyst 
cf. confer (compare) 
cm centimeter(s) 
conc. concentrated 
m-CPBA meta-chloroperbenzoic acid 
CSA (1S)-(+)-10-camphor sulfonic acid 
d doublet 
DA (intermolecular) Diels-Alder 
DDQ 2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
DEAD diethyl azodicarboxylate 
c-DHC cis-1,2-dihydrocatechol 
DIBAL-H diisobutylaluminium hydride 
DMAP 4-(N,N-dimethylamino)pyridine 
DME 1,2-dimethoxyethane 
DMF N,N-dimethylformamide 
x Glossary 
DMP Dess-Martin periodinane 
2,2-DMP 2,2-dimethoxypropane 
DMSO dimethyl sulfoxide 
ee enantiomeric excess 
e.g. exempli gratia (for example) 
EI electron impact 
equiv. equivalents 
ES electrospray (mass spectrometry) 
Et ethyl 
et al. et alia (and others) 
Et3N triethylamine 
Et2O diethyl ether 
EtOAc ethyl acetate 
EtOH ethanol 
eV electron volt(s) 
FGI functional group interconversion 
g gram 
GC gas chromatography 
gem geminal 
gen. generation 
h hour(s) 
HRMS high resolution mass spectrometry 
hν light 
Hz Hertz 
IMDA intramolecular Diels-Alder 
IBX 2-iodoxybenzoic acid 
IR infra-red 
J 
1
H-
1
H coupling constant (in Hz) 
kbar kilobar(s) 
KHMDS potassium bis(trimethylsilyl)amide 
L litre(s) 
LDA lithium diisopropylamide 
LiHMDS lithium hexamethyldisilazide 
lit. literature value 
LiTMP lithium 2,2,6,6-tetramethylpiperidine 
LRMS low resolution mass spectrometry 
 Glossary xi 
m multiplet 
M molar 
M
+•
 molecular ion 
Me methyl 
MeOH methanol 
MHz mega-Hertz 
min minute(s) 
mL millilitre(s) 
mm millimetre(s) 
mmol millimole(s) 
mol mole(s) 
m.p. melting point (°C) 
MS mass spectrometry 
m/z mass-to-charge ratio 
NaHMDS sodium hexamethyldisilazide 
NBS N-bromosuccinimide 
nm nanometre(s) 
NMR nuclear magnetic resonance 
ORTEP Oak Ridge Thermal Ellipsoid Plot 
P unspecified protecting group 
p para 
PCC pyridinium chlorochromate 
PDC pyridinium dichromate 
Ph phenyl 
PMB para-methoxybenzyl 
PPL porcine pancreatic lipase 
ppm parts per million 
PPTS pyridinium para-toluenesulfonate 
q quartet 
qu quintet 
quant. quantitative 
ref. reference 
R (unspecified) alkyl group 
Rf retardation factor (as encountered in TLC) 
r.t. room temperature 
s singlet 
xii Glossary 
t triplet 
t tertiary 
TASF tris(dimethylamino)sulfonium difluorotrimethylsilicate 
TBAF tetra-n-butylammonium fluoride 
TBS tert-butyldimethylsilyl 
temp. temperature (°C) 
TEMPO 2,2,6,6-tetramethyl-piperidine N-oxide 
TES triethylsilyl 
Tf trifluoromethanesulfonyl 
TFA trifluoroacetic acid 
THF tetrahydrofuran 
TIPS triisopropylsilyl 
TLC thin layer chromatography 
TMEDA N,N,N′,N′-tetramethylenediamine 
TMS trimethylsilyl 
TPAP tetrapropylammonium perruthenate 
TsOH para-toluenesulfonic acid 
UV ultra violet (spectroscopy) 
viz. videlicit (that is, namely) 
vs. versus 
v/v unit volume per unit volume (ratio) 
W watt(s) 
w/v unit weight per unit volume (%) 
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 CHAPTER ONE 
1. THE TOTAL SYNTHESIS AND BIOLOGICAL EVALUATION OF THE 
TAMBJAMINES 
1.1 INTRODUCTION 
1.1.1 Isolation and characterisation of the tambjamines 
The tambjamines (1-12, see Figure 1-1),
†
 are a class of some dozen alkaloids that have been 
isolated from various marine sources including bryozoans, nudibranchs and ascidians.
1-6
 In 
addition, the related alkaloids BE-18591 (5)
1
 and 6
2
 have been obtained from cultures of 
Streptomyces sp. BA18591 and the marine bacterium Pseudoalteromonas tunicata, respectively. 
They all incorporate a (1Z)-1-[3-methoxy-5-(1H-pyrrol-2'-yl)-2H-pyrrolylidene]-methanamine 
core and are, therefore, structurally related to various polypyrrolic natural products including the 
prodigiosins (some of which are potent immunosuppressive and/or anti-cancer agents),
3,4
 
tambjamine tetrapyrrole (an inhibitor of cancer cell proliferation)
3,4
 and streptorubin B (an 
immunomodulator).
5
 A discussion of such related natural products follows in Section 1.1.2. 
                                                   
 
† For convenience, and because they each possess the same bipyrrolic core, all of the natural products 1-
12 have been designated as tambjamines even though one of these, 6,  has been assigned the code-name 
BE-18591 while another, 12, has only been identified as a “...new member of the tambjamine class...” and 
remains to be assigned a letter. 
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Figure 1-1: Tambjamines A - J, BE-18591 and a related alkaloid from the marine bacterium Pseudoalteromonas 
tunicata. 
In some instances the tambjamines have been implicated in the chemical defense mechanisms of 
the organisms from which they were first obtained. A number of them have been shown to 
possess intriguing biological properties although the studies revealing these tend to have been 
conducted in conjunction with their isolation and, therefore, carried out in a piecemeal fashion. 
Thus, tambjamines A–D have been shown to act against Escherichia coli, Staphylococcus 
aureus and Vibrio anguillarum
6
 while the last of these compounds displayed cytotoxic activity 
against several tumor cell lines, antimitotic effects in a sea urchin egg development assay, 
antifungal effects against Candida albicans and antibacterial activity against Bacillus subtilis.
7
 
Tambjamine D (the 3'-bromo-analogue of 10) also shows concentration-dependent cytotoxic 
and genotoxic effects in cultured Chinese hamster lung fibroblasts (V79 cells)
8
 while screening 
of tambjamine I (10) against a 60-cell line panel revealed that it had average GI50 and LD50 
values of 1.6 and 18 μM, respectively.9 BE-18591 (5) has been shown to inhibit 
immunoproliferation and gastritis in rabbits.
10
 Certain tambjamines have also been observed to 
bind duplex DNA and can cleave this biomolecule in the presence of Cu(II). It is this last 
property that may be responsible for many of the reported biological effects of the 
tambjamines.
9-14
 While the tambjamines have been manipulated chemically for the purposes of 
securing a library of analogues,
15
 they do not appear to have been the subject of any total 
synthesis studies. Accordingly, the development of total syntheses of these intriguing alkaloids 
was considered a priority. Successful total syntheses would assist in confirming the structural 
assignment of these alkaloids. Furthermore, it was hoped that the production of useful quantities 
of the natural products would allow for a more comprehensive evaluation of their biological 
properties. 
1.1.2 Other pyrrolic natural products closely related to the tambjamines 
The tambjamines and related alkaloids are members of the 4-methoxybipyrrolic subdivision of 
pyrrole-containing natural products as they incorporate the 4-methoxy-2,2′-bipyrrole 
chromophore. These compounds are structurally related to the more well-known prodigiosins, 
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certain members of which have been the subject of total syntheses.
16-21
 The tripyrrolic 
prodigiosins, such as compounds 7 and 8, often exhibit strong coloration and it is believed that 
this property, and their presence in bacterial colonies, has contributed to some events being 
considered miraculous (or “prodigious”).22 
Roseophilin (9) is structurally reminiscent of the prodigiosins and the tambjamines but with the 
4-methoxybipyrrolic unit having been exchanged for a 4-methoxyfuran moiety. Roseophilin 
also incorporates a chiral, ansa-bridged azafulvene core. 
 
Figure 1-2: Prodigiosin (left), the parent member of its class is shown alongside the closely related alkaloids 
streptorubin B (centre) and roseophilin (right). 
1.1.3 Previous studies on the synthesis of compounds related to the 
tambjamines 
No total syntheses of the tambjamines had been described prior to the studies described herein. 
However, a consideration of the syntheses of the following related compounds is instructive. 
Quinn’s syntheses of a library of tambjamine analogues (2001) 
Quinn et al. extracted a mixture of tambjamines C (4), E (2) and F (3) from Australian marine 
ascidian, Sigillina signifera, and hydrolysed this to afford 202 mg of aldehyde 17.
15
 Exposure of 
this aldehyde to a range of primary amines then afforded, via a Schiff-base condensation 
reaction, a combinatorial library of ten tambjamine analogues (Scheme 1-1). This work 
emphasized the utility of aldehyde 17 as a precursor to the tambjamines themselves as well as 
various analogues. The outcomes of the screening of this novel tambjamine library have not 
been published to date. 
 
Scheme 1-1: Reagents (i) KOH, MeOH; (ii) one of sixteen primary amines, acetic acid. 
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Lavallée’s two-step synthesis of 4-methoxy-2,2′-bipyrrole-5-carboxaldehyde (2006) 
Protracted and low-yielding syntheses of aldehyde 17
20,23,24
 have been such that, as is described 
above, Quinn et al. opted to obtain this pivotal compound through the hydrolysis of 
tambjamines obtained from natural sources.
15
 However, in 2006 Lavallée and co-workers 
described a two-step process for the conversion, in 67% overall yield, of the commercially-
available lactam 21 into aldehyde 17.
25
 In order to accomplish this transformation, the starting 
material 21 was reacted with a Vilsmeier complex obtained from the combination of phosphoryl 
tribromide and diethyl formamide. As a result, azafulvene 40 was obtained. Suzuki cross-
coupling of this material with the previously described pyrrole boronic acid 23 proceeded in a 
high yield. Under these conditions, the tert-butoxycarbonyl protecting group was cleaved and 
the enamine residue was hydrolyzed to the desired aldehyde, processes that were likely to have 
occurred during the work-up process. 
 
Scheme 1-2: Reagents (i) POBr3, Et2NC(O)H; (ii) Pd(PPh3)4, Na2CO3. 
This sequence could be performed on a multi-kilogram scale and product 17 has been used to 
prepare compound GX15-070 (41) in sufficient quantities for comprehensive testing of it as a 
potential oncolytic agent.
26
 
 
Figure 1-3: GX15-070 (41)  
Rapoport and Holden’s total synthesis of prodigiosin (1962) 
The total synthesis of prodigiosin carried out by Rapoport and Holden in the early sixties hinged 
on the generation of the pivotal intermediate 4-methoxy-2,2′-bipyrrole-5-carboxaldehyde (17).20 
The means by which this aldehyde was obtained have been exploited in a number of subsequent 
syntheses. The process devised by Rapoport and Holden is shown in Scheme 1-3 and involves 
the application of the Knorr pyrrole synthesis to the known compounds, diethyl 
ethoxymethlenemalonate and ethyl N-ethoxycarbonylglycinate. Methylation of the ensuing 
alcohol, 12, followed by selective and acid-catalyzed ester hydrolysis then afforded the 
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thermally-sensitive pyrrole 13. Heat-induced proto-decarboxylation provided pyrrole 15 and 
this compound was sufficiently reactive to engage the Schiff base obtained from 2-pyrroline 
under acidic conditions to afford a bicyclic enamine intermediate. Catalytic dehydrogenation of 
this enamine was used to aromatize the left-hand azacycle and thereby delivered the requisite 
bipyrrole (16). The McFadyen-Stevens reaction was then used to reduce the ethyl ester to the 
desired aldehyde (17). This last step involved the formation of the corresponding 
acylsulfonylhydrazide from ester 16 and then decomposition of it with base. In the closing 
stages of the total synthesis, aldehyde 17 was condensed with 2-methyl-3-amylpyrrole (18) in 
the presence of a catalytic quantity of acid. In this way, the first total synthesis of prodigiosin 
(7) was achieved. 
 
Scheme 1-3: Reagents (i) Na; (ii) CH2N2; (iii) sulfuric acid, H2O; (iv) 300 °C in a sublimation apparatus; (v) 150 °C 
in a sealed tube; (vi) Pd/C, p-cymene; (vii) hydrazine; (viii) p-toluenesulfonyl chloride, pyridine; (ix) Na2CO3; (x) 
HCl. 
D’Alessio and Rossi’s total synthesis of undecylprodigiosin (1996) 
The emergence of transition metal cross-coupling reactions has led to a new approach to the 
synthesis of the pyrrole-based alkaloids. Unlike earlier syntheses that relied upon the 
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preparation of an intermediate 2,2′-bipyrrole moiety, D’Alessio and Rossi postponed the 
formation of this motif until the last step of the four-step reaction sequence that afforded 
undecylprodigiosin (25) (Scheme 1-4).
16
 Thus, the known 2-undecylpyrrole 19 underwent 
regioselective formylation under Vilsmeier-Haack conditions to afford aldehyde 20. In the 
presence of hydroxide, compound 20 and the previously described α,β-unsaturated γ-lactam 21 
engaged in an aldol-type condensation reaction that afforded the pyrrolomethylene derivative 
22. Exposure of this last compound to trifluoromethanesulfonic anhydride delivered triflate 24 
that engaged the known and readily available boronic acid 23 in a Pd[0]-catalyzed Suzuki 
Miyaura cross-coupling reaction to give target 25. The utility of late-stage coupling of the A-
ring was demonstrated recently in preparing a collection of C-ring functionalized prodigiosin 
analogues.
21
 
 
Scheme 1-4: Reagents (i) DMF, POCl3; (ii) NaOH; (iii) Tf2O; (iv) Pd[0], K2CO3. 
Fürstner’s total synthesis of nonylprodigiosin (1999) 
Having described the first total synthesis of roseophilin (9) in 1997,
27
 Fürstner et al. proceeded 
to develop the first total synthesis of nonylprodigiosin.
17
 The sequence incorporated, as a key 
step, a Pd[0]-catalyzed cross coupling reaction reminiscent of that developed by D’Allesio and 
Rossi.
16
 A ring-closing metathesis reaction was employed in the penultimate step of this 
synthesis in order to establish the requisite nineteen-membered macrocycle. Thus, pyrroles 32 
and 33, differing only in the length of their olefinic side-chains, were prepared in parallel 
sequences from unsaturated carboxylic acids 26 and 27, respectively (Scheme 1-5). The 
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preparation of these intermediates proceeded via the corresponding 2-pyridylthioesters 28 and 
29, respectively. These compounds readily C-acylate pyrrole thus affording ketones 30 and 31. 
Presumably the electron-rich nature of the pyrrole ring facilities the complete reduction of the 
carbonyl functional group in the latter compounds and thereby allows their ready conversion 
into the somewhat-unstable pyrroles 32 and 33, respectively. 
Of pyrroles 32 and 33, the one bearing the shorter side-chain (32) was selected for conversion 
into the boronic acid coupling partner. Under conditions described below, the other pyrrole, 33, 
was converted into the triflate 37 required in the projected palladium-catalyzed cross-coupling 
reaction. Vilsmeier-Haack formylation of pyrrole 33 afforded aldehyde 34 that engaged in a 
dehydrative coupling with lactam 21. Compound 35 so formed was treated with triflic 
anhydride to give triflate 37. 
The desired boronic acid coupling partner (36) was obtained in two steps from pyrrole 32. In 
order to avoid unwanted reaction at nitrogen, as well as to aid in directing subsequent 
metallation, this position was protected with the tert-butoxycarbonyl group. As a result, 
deprotonation took place at the 5-position and the ensuing metallated intermediate was 
quenched with trimethyl borate. Addition of dilute hydrochloric acid facilitated the hydrolysis 
of the resulting boronic ester and thereby furnished the other coupling partner, namely acid 36. 
The boronic acid 36 and triflate 37 were united using Suzuki cross-coupling chemistry and in a 
manner analogous to that applied by D’Alessio and Rossi en route to alkaloid 25. In this 
instance, the reaction proceeded in a moderate yield and delivered RCM-precursor 38. A 
modified ruthenium catalyst derived from bis(triphenylphosphine)ruthenium(II) chloride 
effected the pivotal ring-closing metathesis reaction that produced the anticipated trans-olefinic 
macrocycle. The isolated alkene, present in this intermediate, was removed by hydrogenation in 
the presence of a ruthenium (I) catalyst. As a result, nonyl prodigiosin (39) was obtained in 59% 
combined yield over the final two steps. Fürstner et al. later carried out the total synthesis of 
butylcycloheptylprodigiosin, a related alkaloid, using very similar chemistry.
19
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Scheme 1-5: Reagents (i) Bis(2-pyridyl) disulfide, PPh3; (ii) pyrrolylmagnesium chloride; (iii) NaBH4, i-PrOH; (iv) 
POCl3, DMF; (v) NaOH; (vi) triflic anhydride; (vii) Boc2O, DMAP; (viii) lithium 2,2,6,6-tetramethylpiperidinide; 
B(OMe)3; HCl (aq.); (ix) Pd(PPh3)4, Na2CO3 (aq.) LiCl; (x) indenylidene ruthenium complex
17; (xi) RhCl(PPh3)3, H2. 
1.2 SYNTHETIC STRATEGY ASSOCIATED WITH THE PRESENT SYNTHESIS 
OF THE TAMBJAMINES 
While naturally-derived samples of the tambjamines have been manipulated chemically for the 
purposes of securing a library of analogues,
15
 they have not been subjected to any total synthesis 
 Tambjamine synthesis and testing 9 
studies prior to the work described here.
28
 As noted earlier, to the best of our knowledge the 
outcomes of the screening of the above-mentioned library have not been published. 
The recently reported and very concise synthesis of aldehyde 17 by Lavallée and co-workers 
provided ready access to a pivotal intermediate associated with various syntheses of prodigiosin 
and its analogues.
3,20,23,29-33
 It was anticipated that this same compound would also serve to 
underpin the work reported in the following section and allow for the completion of the first 
total syntheses of the tambjamines.  
1.3 TOTAL SYNTHESES OF CERTAIN NON-BROMINATED TAMBJAMINES 
The non-brominated tambjamines (1-6) were selected as the first targets of total synthesis as it 
was considered that these compounds would be the easiest to obtain. As well, this endeavour 
would present an opportunity to develop methodology that would later be useful in the synthesis 
of brominated congeners 7-12. 
1.3.1 The synthesis of 4-methoxy-2,2'-bipyrrole-5-carboxaldehyde 
As reported by Lavallée and co-workers,
25
 commercially available 4-methoxy-3-pyrrolin-2-one 
(21) was subjected to a Vilsmeier−Haack reaction using POBr3 and DMF, and the ensuing 
azafulvene 40 (49% yield) was engaged in a Suzuki−Miyaura cross-coupling reaction34 with the 
readily available boronic acid 23 to give the required aldehyde 17 in 95% yield. The spectral 
data acquired on this aldehyde (17) were in complete accord with those reported by Lavallée 
and co-workers.
25
 
 
Scheme 1-6: Reagents and conditions (i) POBr3, Et2NC(O)H, CHCl3, 0 °C, 0.5 h; 60 °C, 5 h; (ii) Pd(PPh3)4, Na2CO3, 
H2O/1,4-dioxane, 100 °C, 2 h. 
1.3.2 The synthesis of tambjamines C, E, F and BE-18591 
With the aldehyde 17 in hand, its conversion into various target tambjamines could begin. 
Accordingly, reaction of aldehyde 17, as a solution in 1,2-dichloroethane (DCE), with the 
relevant range of commercially available alkyl amines in the presence of acetic acid at 18−50 °C 
then afforded the acetate salts of tambjamines 2-5 in yields ranging from 69 to 100% (Scheme 
1-7). For example, treatment of aldehyde 17 with 1-aminododecane under the specified 
conditions produced the acetate salt of BE-18591 (5) in 100% yield. The spectral data derived 
from this material were in complete accord with those reported for the natural product (Table 
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1-1).
1
 Thus far, we have been unable to identify conditions under which aldehyde 17 reacts with 
ammonia or a surrogate thereof so as to provide useful quantities of the parent natural product, 
namely tambjamine A (1). 
 
Scheme 1-7: Reagents and conditions (i) RNH2, AcOH, DCE, 50 °C, 2 h. 
The NMR data recorded on synthetically- and naturally- derived tambjamines C, E, F and 
BE-18591 are tabulated in Appendix one. For the purposes of illustration, a comparison of the 
NMR data recorded for synthetically-derived tambjamine BE-18591 with those recorded on the 
naturally-derived material follows in Section 1.3.3. 
1.3.3 Comparison of the NMR data recorded for the naturally- and 
synthetically-derived tambjamine BE-18591 
Synthetically-derived BE-18591 (5), like other tambjamine samples prepared here, was isolated 
as its acetic acid salt. As expected, the acetate counter-anion gave rise to some extra signals in 
the associated 
13
C and 
1
H NMR spectra when compared to the spectra recorded on the naturally-
derived free bases as published by Kojiri and co-workers (see Table 1-1).
1
 The acetate counter-
anion gave rise, as expected, to signals at δ 179.0 and 24.6 in the 13C NMR spectrum, and to a 
singlet at δ 2.06 in the 1H NMR spectrum. All sp2-hybridized carbon nuclei appear in the range 
δ 163.2 and 91.0 and show a good correlation with those recorded on the naturally-derived 
material; the average deviation is 0.60 ppm and the greatest deviation is less than 1.0 ppm. The 
chemical shifts of the methoxy carbon and aminomethylenic carbon are also in close agreement. 
The chemical shift recorded for these moieties was δ 58.0 and 50.9, respectively, and these 
compare favourably with the values listed for the naturally-derived material; the deviation of 
these values from those listed in the literature are 0.4 and 0.1 ppm, respectively. The remaining 
carbon signals arise from the docecyl sidechain. In order to account for every carbon atom 
present in the framework of tambjamine 5, it must be that two carbon signals overlap at around 
δ 29.5 in the spectrum recorded on the synthetic sample, though this is not surprising given the 
congestion of signals at this region. Where direct comparisons are possible, however, the 
chemical shifts recorded for the carbon nuclei constituting the dodecyl sidechain show a very 
close agreement with values obtained from the naturally-derived material; the average deviation 
is 0.10 ppm and the maximum deviation is 0.2 ppm. 
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As is typical for spectra recorded on tambjamines isolated as the acetic acid salts, the resonances 
due to the amino protons are coalesced in the 
1
H NMR spectrum (at δ 11.4); this is likely due to 
an enhanced rate of exchange and equivalence effected by complexation of the molecule with 
acetic acid. Other characteristics of the 
1
H NMR spectrum recorded on synthetically-derived 
BE-18591 (5) are in close accord with those reported by Kojiri et. al.
1
 For instance, all signals 
expected to arise from protons of the dodecyl sidechain are present and integrate for the 
anticipated 25 protons. Where direct comparisons of chemical shifts are possible, the deviation 
between signals in the synthetically- and naturally-derived spectra does not exceed 0.1 ppm. 
Likewise pyrrole-bound protons bound to carbon show good correlations. The distribution of 
these signals is nearly identical in the two spectra, although those signals derived from the 
synthetic sample were consistently shifted slightly upfield, by 0.06 ppm on average. 
A strong absorption band, at 2923 cm
-1
, was observed in the IR spectrum of the synthetic 
sample of tambjamine 5. The same band was also observed in the naturally-derived material (at 
2926 cm
−1
) and it is likely arises from stretching of the imine C=N bond. The ESI mass 
spectrum of tambjamine 5 displays a [M+H]
+
 ion at m/z 358, and accurate mass measurement on 
this species established the molecular formula of the compound is C22H35N3O, as expected. 
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Table 1-1: Comparison of the 13C and 1H NMR data recorded on naturally- and synthetically-derived BE-18591 (5), 
isolated as the free base and acetic acid salt, respectively. 
13C NMR Data 13C NMR Data 1H NMR Data 1H NMR Data 
Natural 5 
(δC) 
(75 MHz, CDCl3)
35 
Synthetic 5 
(δC) 
(75 MHz, CDCl3) 
Natural 5 
(δH) 
(300 MHz, CDCl3)
35 
Synthetic 5 
(δH) 
(300 MHz, CDCl3) 
 179.0 10.8 (broad s, 1H) 11.4 (s, 2H) 
163.6 163.2 9.50 (broad s, 1H)  
142.4 142.6 7.33 (broad d, J = 9.0 Hz, 1H) 7.26 (s, 1H) 
140.0 140.5 7.06 (m, 1H) 7.00 (m, 1H) 
124.1 123.4 6.74 (m, 1H) 6.64 (m, 1H) 
122.3 123.1 6.28 (m, 1H) 6.21 (m, 1H) 
113.2 112.3 5.96 (s, 1H) 5.89 (s, 1H) 
110.6 110.9 3.93 (s, 3H) 3.83 (s, 3H) 
110.6 109.9 3.47 (broad t, J = 7.0 Hz, 2H) 3.37 (t, J = 7.1 Hz, 2H) 
91.9 91.0  2.06 (s, 3H, CH3CO2
−) 
58.4 58.0 1.75 (m, 2H) 1.66 (m, 2H) 
51.0 50.9 1.20-1.45 (m, 18H) 1.22 (m, 18H) 
31.9 31.8 0.88 (t, J = 7.0 Hz, 3H) 0.85 (t, J = 6.8 Hz, 3H) 
30.2 30.3   
29.6    
29.6 29.5   
29.6 29.4   
29.4 29.3   
29.3 29.2   
29.1 29.1   
26.5 26.4   
22.7 24.6   
 22.6   
14.1 14.0   
1.3.4 The synthesis of a tambjamine bearing an unsaturated side-chain 
The unsaturated primary amine required for the preparation of tambjamine 6 has not been 
reported in the literature previously. Scheme 1-8 outlines the process by which cis-alkene 47 
was obtained in four steps from bis-tosylethanolamine 42 and the subsequent condensation of 
the former compound with aldehyde 17 to afford tambjamine 6. 
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Scheme 1-8: Reagents and conditions (i) KOH, H2O; (ii) n-BuLi, THF; (iii) H2, Lindlar’s cat., quinoline, hexane, 
18 °C, 2 h; (iv) C10H8Na, DME, 18 °C, 1 h; (v) AcOH, compound 17, DCE, 18 °C, 2h. 
Thus, following a protocol reported by Bulkowski,
36
 the bis-tosyl derivative, 42, of 
ethanolamine was treated with aqueous KOH to give aziridine 43.
36
 Using a procedure reported 
by Gronquist and Meinwald, this compound was then subjected to nucleophilic ring-opening 
with the anion derived from 1-decyne (44).
37
 Each of the seventeen chemically unique carbons 
present in alkyne 45 was observed in the 
13
C NMR spectrum recorded on this compound. 
Resonances arising from the two alkynyl carbons appeared at δ 83.2 and 75.6. 
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Figure 1-4: 75 MHz 13C NMR spectrum of alkyne 45 (recorded in CDCl3).  
Inset: An expansion of a region from the spectrum. 
Internal alkyne 45 was subjected to hydrogenation using Lindlar’s catalyst in the presence of 
quinoline
38
 so as to afford the Z-alkene 46 in 99% yield. The 
1
H NMR spectrum recorded on 
cis-alkene 46 exhibited multiplets at δ 5.49 and 5.15 that were assigned to the pair of alkenic 
protons introduced in the catalytic hydrogenation reaction. In most other respects, this spectrum 
bore a close resemblance to that of the precursor alkyne. The ESI mass spectrum of alkene 46 
exhibited an [M+H]
+
 ion at m/z 338 and an accurate mass measurement of this species 
established that it possessed the expected molecular formula, viz. C19H31NO2S. The derived 
13
C 
NMR spectrum exhibited fifteen signals, rather than the expected seventeen, and this implied 
that some of the signals overlap. 
 
Figure 1-5: 300 MHz 1H NMR spectrum of cis-alkene 46 (recorded in CDCl3). 
Reductive cleavage of the sulfonamide linkage within cis-alkene 46 using sodium naphthalenide 
in 1,2-dimethoxyethane (DME)
39
 then afforded the required amine 47. Consistent with this 
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transformation, proton resonances in the aromatic region of the 
1
H NMR spectrum of compound 
47 were no longer present indicating that the primary amine had been successfully obtained 
from its N-tosyl precursor. The infrared spectrum of compound 47 showed a broad absorption 
band at 3431 cm
-1
 that is attributed to N−H bond stretching. Associated N−H bending resulted 
in the appearance of an absorption band at 1577 cm
-1
. 
 
Figure 1-6: 300 MHz 1H NMR spectrum of primary amine 47 (recorded in CDCl3). 
Amine 47 was then engaged in the, by now, standard condensation reaction with aldehyde 17 to 
give tambjamine 6. The 
1
H and 
13
C NMR spectra derived from compound 6 match those 
recorded on the natural product.
2
 Furthermore, the infrared and mass spectral data obtained on 
the synthetic material were in full accord with the assigned structure. 
Tambjamine 6, isolated as its acetic acid salt from the condensation of amine 47 with aldehyde 
17, exhibited spectral properties that were in close agreement with those reported for the natural 
product isolated by Kumar and co-workers.
2
 The 
13
C NMR spectrum is shown in Figure 1-7. 
 
Figure 1-7: 300 MHz 1H NMR spectrum of tambjamine 6 (recorded in CDCl3). 
For instance, the pair of multiplets arising from the Z-alkene embedded within the twelve-
carbon side-chain was observed at δ 5.54 and 5.34. In the publication that describes the isolation 
of this compound and the assignment of NMR resonances, these same signals appear (though 
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each as discernable doublets of triplets) at δ 5.55 and 5.35, respectively. (See Table 1-2). The 
ESI mass spectrum of tambjamine 6 exhibited a molecular ion at m/z 356 and an accurate mass 
measurement carried out on this species established that it possessed the molecular formula 
(C22H32N3O) expected for tambjamine 6. 
Table 1-2: Comparison of the 13C and 1H NMR data recorded on naturally- and synthetically-derived tambjamine 6, 
isolated at the free base and acetic acid salt respectively. 
13C NMR Data 13C NMR Data 1H NMR Data 1H NMR Data 
Natural 6 
(δC) 
(75 MHz, CDCl3)
2  
Synthetic 6 
(δC) 
(75 MHz, CDCl3) 
Natural 6 
(δH) 
(300 MHz, CDCl3)
2  
Synthetic 6 
(δH) 
(300 MHz, CDCl3) 
 179.0  11.4 (s, 2H) 
163.9 163.5 7.29 (d, J = 14 Hz, 1H) 7.28 (s, 1H) 
143.4 142.9 7.06 (m, 1H) 7.04 (m, 1H) 
141.1 140.6 6.70 (m, 1H) 6.69 (m, 1H) 
134.5 134.1 6.25 (m, 1H) 6.25 (m, 1H) 
124.1 123.9 5.95 (s, 1H) 5.94 (s, 1H) 
124.0 123.7 5.55 (dt, J = 10.8 Hz, 1H) 5.54 (m, 1H) 
123.5 123.1 5.35 (dt, J = 10.8 Hz, 1H) 5.34 (m, 1H) 
113.0 112.5 3.90 (s, 3H) 3.89 (s, 3H) 
111.3 110.9 3.46 (m, 2H) 3.45 (t, J = 6.9 Hz, 2H) 
110.5 110.1 2.46 (m, 2H) 2.45 (m, 2H) 
91.6 91.2  2.09 (s, 3H, CH3CO2
−) 
58.8 58.2 2.01 (m, 2H) 2.02 (m, 2H) 
51.2 50.8 1.70-1.21 (complex m, 12H) 1.22 (m, 12H) 
28.8 31.8 0.86 (t, 3H) 0.85 (t, J = 6.8 Hz, 3H) 
27.8 29.7   
27.7-26.5 (6C) 29.5   
 29.3   
 29.3   
 28.4   
 27.4   
 24.5   
 22.6   
14.5 14.1   
1.3.5 The synthesis of 4-methoxy-5'-bromo-2,2'-bipyrrole-5-
carboxaldehyde 
Our initial attempts to generate the requisite bromo-analogues of compound 17, for use in the 
preparation tambjamines 7−11, involved treating the aldehyde 17 with various electrophilic 
brominating agents. Unfortunately, under all the conditions investigated thus far only complex 
mixtures of products were obtained. Accordingly, directed syntheses of such compounds were 
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pursued. Eventually, the route shown in Scheme 1-9 was established as a method for obtaining 
the 5′-bromo-analogue, 54, of compound 17. 
 
Scheme 1-9: Reagents and conditions (i) NBS, THF, −78 °C, 2 h; (ii) n-BuLi, THF, −78 °C → 0°C, 0.5 h, TMS−Cl, 
−78 °C → 0 °C, 0.5 h; (iii) PdCl2·dppf·CH2Cl2, Et3N, 1,4-dioxane, 80 °C, 18 h; (iv) Pd(PPh3)4, Na2CO3, toluene, 
water, 1,4-dioxane, 100 °C, 15 h; (v) m-xylene, 139 °C, 1 h; (vi) Pyr·HBr3, THF, −78 °C → 18 °C, 2 h; (vii) RNH2, 
AcOH, DCE, 18 °C, 4 h. 
Thus, following protocols established by Weinreb et al.,
40
 the readily available N-Boc protected 
pyrrole 47 was subjected to two-fold bromination with N-bromosuccinimide (NBS) and the 
ensuing 2,5-dibrominated derivative 48 was treated with n-BuLi and then trimethylsilyl chloride 
(TMS-Cl). In this manner the C-silylated compound 49
40
 was obtained in 61% yield. Miyaura 
borylation of this material,
34
 using borane 50, then afforded the pyrrole 51 that could be engaged 
in a Suzuki-Miyaura cross-coupling reaction with azafulvene 40 so as to yield a 
chromatographically separable mixture of compounds 52 (23%) and 53 (60%). Heating the 
former product in refluxing xylene effected thermolytic cleavage of the Boc-group and 
delivered further quantities of the TMS-derivative 53 (100%) of the aldehyde 17. The spectral 
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data derived from compound 53 were in full accord with the assigned structure but final 
confirmation of this followed from a single-crystal X-ray analysis. The derived ORTEP diagram 
is shown in Figure 1-8. Surprisingly, the silylated pyrrole 53 failed to engage in a clean ipso-
substitution reaction upon exposure to NBS. In contrast, reaction of substrate 53 with freshly 
prepared pyridinium hydrobromide perbromide
41
 led to the desired compound, 54, in 76% yield.  
 
Figure 1-8: ORTEP derived from the single-crystal X-ray analysis of aldehyde 53. 
1.3.6 The synthesis of tambjamines G, H, I and J 
Following the protocols described above, compound 54 was condensed with the relevant range 
of primary alkyl amines, in the presence of acetic acid. These conditions then afforded, after 
conventional flash chromatographic purification on silica gel, the acetate salts of tambjamines 
8−11 in yields ranging from 81 to 99%. (See Scheme 1-9). The spectral data derived from each 
of these materials matched those reported for the corresponding natural products, some of which 
have also been isolated as their acetate salts.
42
 Tabulation of the NMR data recorded on 
naturally- and synthetically-derived tambjamines G, H, I and J is included in Appendix One 
(page 175). A brief description of the spectral data derived from tambjamine J (11), which is 
typical of these four brominated 5′-brominated tambjamines, follows. 
The 
1
H NMR spectrum recorded on tambjamine J (11) is shown in Figure 2-6. The AA′XY 
system arising from the diasteriotopic methylene protons appears at 3.28 ppm. The chemical 
shifts of the signals observed in the 
1
H NMR spectrum of synthetically-derived tambjamine J 
(11) are in close accord with those recorded on the naturally-derived material (See Table 1-3). 
For instance, all signals expected to arise from protons on the 2-methylbutyl sidechain are 
present and integrate for the anticipated 11 protons. The chemical shifts of pyrrole-bound C−H 
protons show good correlations between the two spectra. The distribution of these signals is 
nearly identical for the two spectra, though those signals derived from the synthetic sample are 
consistently shifted slightly upfield, by 0.04 ppm on average. 
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Figure 1-9: 300 MHz 1H NMR spectrum of tambjamine 11 (recorded in CDCl3).  
 Inset: An expansion of a region from the spectrum. 
The 
13
C spectra recorded for synthetically-derived tambjamine J (11), which displays the 
expected seventeen signals, agrees closely with that reported by Blackman et al.
42
 for a 
naturally-derived sample of the same material (Table 1-3). The average deviation between the 
signals recorded in each spectrum was 0.72 ppm with the largest difference being 0.90 ppm. 
(See Table 1-3). 
The EI mass spectrum displays a pair of molecular ion at m/z 339 and 337. the 1:1 ratio of these 
species is as would be expected for a monobrominated compound. An accurate mass 
measurement on the lighter species established that it was of the expected molecular 
composition, viz. C15H20
79
BrN3O. 
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Table 1-3: Comparison of the 13C and 1H NMR data recorded on naturally- and synthetically-derived 
tambjamine J (11), both isolated as the corresponding acetic acid salt. 
13C NMR Data 13C NMR Data 1H NMR Data 1H NMR Data 
Natural 11 
(δC) 
(75 MHz, CDCl3)
42  
Synthetic 11 
(δC) 
(75 MHz, CDCl3) 
Natural 11 
(δH) 
(300 MHz, CDCl3)
42  
Synthetic 11 
(δH) 
(300 MHz, CDCl3) 
179.0 179.3 13.20 (broad s, 1H) 11.10 (broad s, 2H) 
164.3 163.4 11.10 (broad s, 1H)  
142.3 141.5 7.30 (broad s, 1H) 7.26 (s, 1H) 
142.1 141.3 6.63 (d, J = 4.2 Hz, 1H) 6.56 (d, J = 3.9 Hz, 1H) 
125.1 124.4 6.23 (d, J = 4.2 Hz, 1H) 6.15 (d, J = 3.9 Hz, 1H) 
114.3 113.5 5.90 (s, 1H) 5.87 (s, 1H) 
113.0 112.1 3.90 (s, 3H) 3.86 (m, 3H) 
111.7 110.9 3.33 (m, 2H) 3.28 (m, 2H) 
106.0 105.3 2.14 (m, 1H)  
91.5 90.8 2.10 (s, 3H, CH3CO2
−) 2.09 (s, 3H, CH3CO2
−) 
58.9 58.2  1.73 (m, 1H) 
57.8 57.0 
1.56 (m, 2H) 
1.46 (m, 1H) 
36.6 35.8 1.19 (m, 1H) 
27.2 26.5 1.30 (m, 3H) 
0.93 (m, 6H) 
24.1 24.6 0.98 (t, J = 8.0 Hz, 3H) 
17.4 16.7   
11.8 11.1   
1.4 BIOLOGICAL EVALUATION OF SYNTHETICALLY-DERIVED 
TAMBJAMINES C, E, F, G, H, I AND J, BE-18591 AND A RELATED 
ALKALOID FROM THE MARINE BACTERIUM PSEUDOALTEROMONAS 
TUNICATA 
1.4.1 Introduction 
Natural products continue to provide a rich source of new drugs
43-48
 with those being isolated 
from organisms found in marine and freshwater environments becoming increasingly prominent 
in this regard.
49-55
 For example, micro-organisms, including those found in marine ecosystems, 
provide a remarkable array of biologically active metabolites.
56
 In those instances where limited 
quantities of metabolites have been available from the natural source, synthesis techniques have 
often been deployed to address the problem of supply and thus provide sufficient material for 
extended biological evaluations.
57-60
 It is rare, however, that such techniques have been used to 
deliver samples of almost every member of an entire class of natural product for the purpose of 
carrying out their comprehensive biological evaluation. This section details such a case. 
Specifically, this evaluation of synthetically-derived samples of tambjamines 2−4, 8−11, BE-
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18591 (5) and pyrrole 6 as antimicrobial and cytotoxic agents was conducted by colleagues at 
the Federal University of Ceará in Brazil and at the University of New South Wales, Australia. 
The outcomes of these studies are described in below. 
 
 
Figure 1-10: Synthetically-derived tambjamines that were evaluated for biological activity. 
The first total syntheses of seven of the ten members of the tambjamine class of natural product 
and analogous preparation of BE-18591 (5) and congener 6 by the methods described earlier 
meant that a significant proportion of the members of the entire tambjamine class became 
available for biological screening and thus offered the prospect of developing a structure-
activity relationship (SAR) profile for this family of marine natural product.
28
 Details of the 
outcomes of some such screening regimes are presented below. 
1.4.2 Antimicrobial screening 
Each of the tambjamines 2–6 and 8−11 was tested at 0.1 and 1.0 mg/ml concentrations against 
Candida albicans, Malassezia furfur, Escherichia coli and Staphylococcus aureus using a 
standardized paper disc-agar diffusion method (Bauer and Kirby method).
61
 The potent and 
clinically-employed antifungal agent amphotericin B was used as a positive control and the 
observed diameters of the zones of inhibition are presented in Table 1-4. 
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Table 1-4: Zones of Inhibition Observed During Testing of Tambjamines 1-9 Against C. albicans, M. furfur, E. coli 
and S. aureus Using the Kirby–Bauer or Disc Diffusion Method a 
 C. albicans  M. furfur  E. coli  S. aureus 
Compound [mg/ml] 0.1 1.0  0.1 1.0  0.1 1.0  0.1 1.0 
2 –
 b 7   + c 20  – 18  – 19 
3 – +  – +  – 9  – 9 
4 – +  12  15  – 13  – 20 
8 – +  16  18  – 13  – 20 
9 – 8  15  17  – 14  – 19 
10 – –  17  >17  – 14  8 20 
11 – –  17  >17  – 11  9 20 
5 – 11  + >16  – 9  8 10 
6 – 10  8  >16  – 8  + 8 
Amphotericin B 13 NT
 d  + NT  – NT  – NT 
Methanol 
e  – –  – –  – –  – – 
a Measured in mm. b – = No detectable inhibition. c + = Detectable but modest inhibition.  
d NT = Not tested. e Methanol was used as negative control. 
The results of this antimicrobial screening regime reveal that all of compounds 2–6 and 8−11 
display antibacterial and antifungal effects although at lower concentrations they showed poor 
activity against E. coli and S. aureus and were selectively active against M. furfur over C. 
albicans. Interestingly, this activity against M. furfur (a dandruff-causing organism) was higher 
than that exhibited by amphotericin B. As such the tambjamines could have promising 
applications in this area provided, inter alia, issues surrounding the cost of production can be 
overcome. 
1.4.3 Biological screening against certain human cancer cell lines 
Our objectives in this area were two-fold: (i) to evaluate the cytotoxic potential of compounds 
2–6 and 8−11 against four human cancer cell lines as well as against (normal) human peripheral 
blood mononuclear (PBM) cells and, (ii), to study the underlying molecular mode of cytotoxic 
action of the tambjamines using human promyelocytic leukemia cells (HL-60), a cell line 
particularly suited to examining cell proliferation, cell-cycle and apoptotic events.
62-64
  
The outcomes of the testing of compounds 2–6 and 8−11 against the human cancer cell lines 
HL-60 (promyelocytic leukemia cells), MDA-MB-435 (derived from the M14 melanoma cell 
line), HCT-8 (ileocecal colorectal adenocarcinoma cell line) and SF-295 (glioblastoma cell line) 
as well as PBM cells are presented in Table 1-5. The potent anti-cancer agent doxorubicin 
(Adriamycin™) was used as a positive control. Given the nature of the test protocols used (see 
Experimental), only compounds showing IC50 values of less than 1 μg/ml in at least one cell line 
were considered active. On this basis, then, and with the exception of compound 3, the 
tambjamines and their congeners described herein can be regarded as rather potent cytotoxic 
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agents although most were less active than doxorubicin. Furthermore, none of them was 
especially selective for the cancer cell lines when compared to their effects on PBM cells. 
Table 1-5: Cytotoxic Effects of Compounds 2–6 and 8−11 on Cancer and PBM Cell Lines a 
 Cancer cell lines   
 HL-60 MDA-MB435 HCT-8 SF-295  PBM 
Compound IC50 (CI 95%) 
2 
0.70 
(0.59–0.82) 
3.42 
(2.59–4.52) 
1.41 
(1.25–1.59) 
1.64 
(1.45–1.86) 
2.53 
(1.74–3.68) 
3 >25 (ND
 b) >25 (ND) >25 (ND) >25 (ND) >25 (ND) 
4 
0.80 
(0.67–0.95) 
2.27 
(1.78–2.91) 
1.04 
(0.83–1.30) 
1.08 
(0.87–1.35) 
3.25 
(2.38–4.37) 
8 
0.82 
(0.75–0.88) 
1.19 
(0.98–1.44) 
0.65 
(0.57–0.73) 
0.59 
(0.50–0.69) 
2.10 
(1.45–3.04) 
9 
2.12 
(1.87–2.41) 
2.57 
(2.26–2.93) 
2.46 
(2.07–2.92) 
1.31 
(1.15–1.48) 
4.16 
(3.52–4.93) 
10 
0.61 
(0.49–0.77) 
0.83 
(0.71–0.96) 
0.52 
(0.46–0.59) 
0.41 
(0.35–0.48) 
1.11 
(0.83–1.50) 
11 
0.49 
(0.41–0.60) 
0.61 
(0.52–0.72) 
0.35 
(0.32–0.38) 
0.35 
(0.28–0.43) 
0.77 
(0.55–1.08) 
5 
0.23 
(0.18–0.31) 
0.46 
(0.34–0.63) 
0.54 
(0.43–0.68) 
0.39 
(0.33–0.47) 
0.46 
(0.27–0.80) 
6 
0.69 
(0.60–0.80) 
1.11 
(0.95–1.30) 
0.98 
(0.85–1.12) 
0.83 
(0.73–0.94) 
0.64 
(0.31–1.30) 
Dox
 c 
0.02 
(0.01–0.02) 
0.48 
(0.34–0.66) 
0.23 
(0.19–0.25) 
0.04 
(0.03–0.05) 
0.23 
(0.02–0.56) 
a Data are presented as IC50 [μg/ml]. The 95% confidence intervals (CI 95%) shown were obtained by a non-linear 
regression analysis for all cell lines from three independent experiments. b ND = Not determined. c Doxorubicin 
(Dox) was used as positive control. 
When compounds 2–6 and 8−11 were tested on mouse erythrocytes (red blood cells), which are 
non-nucleated cells in their mature form, they displayed little or no activity (i.e. no hemolytic 
properties) except those (viz. 5 and 6) bearing the longer lipophilic attached to the (1Z)-1-[3-
methoxy-5-(1H-pyrrol-2'-yl)-2H-pyrrolylidene]-methanamine core (Table 1-6). Given that these 
activities of compounds 5 and 6 can probably be attributed to their detergent effects, the 
cytotoxic profiles of the tambjamines as revealed in Table 1-5 could well arise through their 
interactions with nuclear DNA. 
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Table 1-6: Cytotoxic Effects of Compounds 2–6 and 8−11 on Mouse Erythrocytes After 1 and 2 h Periods of 
Incubation a 
 EC50 (CI 95%) 
Compound 1 h 2 h 
2 >200 (ND
 b) >200 (ND) 
3 >200 (ND) >200 (ND) 
4 >200 (ND) >200 (ND) 
8 >200 (ND) >200 (ND) 
9 >200 (ND) >200 (ND) 
10 >200 (ND) >200 (ND) 
11 >200 (ND) >200 (ND) 
5 >200 (ND) 150.8 (127.6–178.2) 
6 40.3 (29.7–54.6) 36.9 (31.3–43.5) 
a Data are presented as EC50 [μg/ml]. The 95% confidence intervals (CI 95%) 
shown were obtained by a non-linear regression analysis for all cell lines from 
three independent experiments. b ND = Not determined. 
As part of initial efforts to understand the mechanism of cytotoxicity of the tambjamines, 
compounds 10 and 11 were chosen for further biological evaluation. In particular, a study was 
conducted so as to examine whether the cytotoxic activity of such compounds involves the 
inhibition of DNA synthesis and the induction of apoptosis. Since HL-60 cells are considered 
particularly good models for such studies,
62-64
 cell viability was determined by a trypan blue dye 
exclusion test
65
 after incubation of the HL-60 cells (3  105 cells/ml) with compounds 10 and 
11. Flow cytometric techniques were used to analyze the outcomes of such experiments. As 
shown in Figure 1-11, both compounds reduced cell viability significantly (and, in the case of 
11, rapidly) at 0.3 and 0.6 μg/ml concentrations, although not quite to the same extent as the 
positive control doxorubicin.  
 
Figure 1-11: Effect of tambjamines I (10) and J (11) on HL-60 cell viability as determined by trypan blue staining 
after 3, 6, 12 and 24 h of incubation. Negative control (C) was treated with the vehicle used for diluting the tested 
substance. Doxorubicin (D, 0.3 μg/ml) was used as positive control. Results are expressed as mean ± standard error of 
measurement (SEM) from three independent experiments. *P <0.05 compared to control. 
An analysis of the cell-death pattern in HL-60 cells caused by contact with compounds I (10) 
and J (11) was carried out using acridine orange (AO) and ethidium bromide (EB) staining 
techniques and then examining the resulting cell populations with a fluorescence microscope.
66
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The various colorations observed allow the cells within the population to be classified as viable 
(live), apoptotic or necrotic (dead).
67,68
 The percentages of the latter two types of cell were then 
calculated after 3, 6, 12 and 24 h and the results of such studies (Figure 1-12) reveal that 
tambjamines 10 and 11 lead to cell death largely through an apoptotic pathway (at least under 
the conditions used here). Once again, however, these compounds were not quite as effective as 
the positive control doxorubicin in triggering this process. 
 
Figure 1-12: Effect of tambjamine I (10) and J (11) on the HL-60 cell death pattern as determined by AO/EB-
staining after 3, 6, 12 and 24 h of incubation. Negative control (C) was treated with the vehicle used for diluting the 
tested substance. Doxorubicin (D, 0.3 μg/ml) was used as positive control. Results are expressed as mean ± standard 
error of measurement (SEM) from three independent experiments. *P <0.05 compared to control. 
In a further effort to unravel the mode of cytotoxic action of the tambjamines, the impact of 
compounds 10 and 11 on the integrity of the plasma membrane of HL-60 cells was evaluated. 
Since the integrity of this membrane is preserved in cells undergoing apoptosis most of its 
functions remain unchanged, including the ability of the membrane to exclude dyes such as 
propidium iodide (PI). In contrast, those cells undergoing necrosis lose membrane integrity and 
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function very early and cannot, therefore, prevent the inclusion of PI. The results of carrying out 
the relevant test
69,70
 are shown in Figure 1-13A and these establish that cell membrane integrity 
is preserved to a high degree (>80%) even in cases where the HL-60 cells have been exposed to 
0.6 μg/ml concentrations of tambjamine 10 or 11. 
Since there are no marked changes in energy metabolism associated with apoptotic cells, the 
morphology of mitochondria in these systems remains unchanged. This is in contrast to 
necrosis, where mitochondrial swelling is one of the earliest changes. Accordingly, the 
mitochondrial transmembrane potential is preserved in apoptotic but not necrotic cells. This 
potential can be assayed by the capacity of the cell to retain the cationic probe rhodamine 
123.
67,68
 The outcomes of the relevant tests are shown in Figure 1-13B and reveal that less than 
10% of the tambjamine-treated HL-60 cells have a low membrane potential (ΔΨm) while more 
than 30% of the doxorubicin-treated cells do. 
The death of cells undergoing apoptosis is preceded by chromatin cleavage at the linker regions 
between nucleosomes by specific endonucleases which results in extensive fragmentation of the 
DNA into oligonucleosomal subunits.
71
 Accordingly, the percentage of DNA fragmentation 
observed in tambjamine-treated cells provides yet another measure of the extent of these 
compounds’ apoptotic effects. Using nuclear fluorescence/flow cytometry methods as described 
by Nicoletti et al.,
71
 the extent of DNA fragmentation of HL-60 cells was determined under the 
relevant set of conditions and the outcomes of such studies are shown in Figure 1-13C. Thus, 
>60% of DNA fragmentation was observed for both doxorubicin- and tambjamine-J-treated 
cells although in the latter case such levels were only observed after 24 h of incubation and 
when 0.6 μg/ml concentrations of the test compound, 11, were used. DNA fragmentation levels 
of >40% were observed when compound 10 was used at the same concentration. Furthermore, 
tambjamines I and J did not promote changes in the cell cycle under the conditions used. 
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Figure 1-13: Effect of tambjamines I (10) and J (11) on HL-60 cells. A = Effect on membrane integrity (as 
determined by a PI exclusion test). B = Effect on mitochondrial transmembrane potential (ΔΨm) (as determined by 
incorporation of rhodamine 123). C = Effect on DNA fragmentation (as determined by PI-induced nuclear 
fluorescence). Negative control (C) was treated with the vehicle used for diluting the tested substance. Doxorubicin 
(D, 0.3 μg/ml) was used as positive control. Results are expressed as mean ± standard error of measurement (SEM) 
from three independent experiments. *P <0.05 compared to control. 
Given the pivotal role that caspases play in apoptosis,
72-74
 the effect of tambjamines I (10) and J 
(11) on the activation of such enzymes in HL-60 cells was measured after 24 h of incubation 
(Figure 1-14). This revealed that both compounds activate caspases 3/7 and 8 although these 
were not quite as those strong as those observed with doxorubicin. Given their effect on the last 
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enzyme, compounds 10 and 11 most likely trigger apoptosis via the so-called death receptor or 
extrinsic pathway. 
 
Figure 1-14: Effect of tambjamines I (10) and J (11) on caspase 3/7 and 8 activation after 24 h of incubation. A = 
Caspase 3/7 activation. B = Caspase 8 activation. Negative control (C) was treated with vehicle used for diluting the 
tested substances. Doxorubicin (D, 0.3 μg/ml) was used as positive control. Results are expressed as mean ± standard 
error of measurement (SEM) from three independent experiments. *P <0.05 compared to control. 
In a further probing of the origins of the cytotoxic effects of compounds 10 and 11, a comet 
assay
75
 was used to detect DNA strand breaks and alkali-labile lesions within the HL-60 cells 
exposed to the drug for 24 h. The outcomes of this assay (Figure 1-15) reveal that, while the 
DNA damage index (DI – arbitrary units used) associated with the tambjamine-treated cells is 
not as high as that associated with those that had been exposed to doxorubicin, the natural 
products are clearly effecting DNA damage. 
 
Figure 1-15: Effect of tambjamine I (10) and J (11) on HL-60 cells DNA damage index after 24 h treatment. 
Negative control (C) was treated with the vehicle used for diluting the tested substance. Doxorubicin (D, 0.3 μg/ml) 
was used as positive control. Results are expressed as mean ± standard error of measurement (SEM) from two 
independent experiments. *P <0.05 compared to control. 
1.5 CONCLUSIONS AND FUTURE WORK 
The tambjamines 2–6 and 8−11 clearly display useful antimicrobial and cytotoxic effects with 
the more lipophilic members of the series seeming to be the more potent in both settings. While 
none of the more cytotoxic compounds was especially selective for the cancer cell lines, the use 
of targeted drug delivery regimes
76
 could be used to make them so. The prospects of achieving 
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this through appropriate functionalization of the alkyl chain attached to the (1Z)-1-[3-methoxy-
5-(1H-pyrrol2'-yl)-2H-pyrrolylidene]methanamine core would seem rather good. 
An investigation of the origins of the cytotoxic properties of the tambjamines indicates that they 
are genotoxic, causing fragmentation of the cellular DNA and, thereby, leading to apoptosis. 
The lack of change in mitochondrial transmembrane potential combined with their activation of 
caspase 3/7 and 8 suggest that apoptosis induced by tambjamines I and J is triggered by an 
extrinsic pathway. Accordingly, compounds 2–6 and 8−11 can be regarded as potentially useful 
lead compounds for drug development and further investigations into their in vitro activities are 
warranted. Investigations of this type will be facilitated by the ready capacity to prepare 
tambjamine analogues through the Schiff-base condensation of a wide range of amines with 
aldehydes such as 17 and 54. 
 
 CHAPTER TWO 
2. THE TOTAL SYNTHESES OF CERTAIN MONOMERIC 
EPOXYQUINOL NATURAL PRODUCTS 
2.1 INTRODUCTION TO THE MONOMERIC EPOXYQUINOL NATURAL 
PRODUCTS 
(+)-Bromoxone (55), (+)-bromoxone acetate (106), (+)-epiepoformin (108), (−)-harveynone 
(148) and (−)-tricholomenyn A (174) are prominent and representative members of a significant 
and growing class of epoxyquinol-based natural products.
77,78
 (See Figure 2-1). 
 
Figure 2-1: Representative epoxyquinol-type natural products 
The densely funtionalized cyclohexene frameworks associated with these compounds together 
with their diverse range of biological properties have prompted a great deal of effort to establish 
economical syntheses of them.
77-102
 Much of this effort has relied upon the acquisition of 
protected forms of bromoxone or its iodo analogue that are then subjected to Heck, 
Sonogashira, Suzuki, or Stille reactions with the relevant cross-coupling partner.
86,89,90,93-96,99
 
The required haloxone derivative is often generated from benzoquinone or protected forms 
thereof
79-81,85,88-90,94,97,98,101
 while enzymatically-mediated desymmetrization or resolution 
processes
80,81,83,85,90,94,96,98,99
 have been used to obtain the required substrates in enantiomerically 
pure form. As a consequence, somewhat lengthy reaction sequences can be involved. 
Accordingly, the research described here was focussed upon the development of abbreviated 
syntheses of the epoxyquinols as well as the certain complex epoxyquinol-derived natural 
products. Ultimately, these efforts were fruitful.
103,104
 A description of the range of epoxyquinol 
natural products and their total syntheses are presented immediately below while syntheses of 
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the structurally more complex dimeric systems (+)-panepophenanthrin (192) and 
(+)-hexacyclinol (233), shown in Figure 2-2, are discussed in Chapter Three. 
 
Figure 2-2: (+)-Panepophenanthrin (192) and (+)-hexacyclinol (233) 
2.2 (+)-BROMOXONE 
2.2.1 Isolation and characterization of (+)-bromoxone 
(+)-Bromoxone (55) and its O-acetyl derivative (106) (Figure 2-3) were both isolated from a 
marine acorn worm and the latter was shown to display anti-tumour properties.
105
 The first of 
these two compounds, 55, was characterized spectroscopically while the absolute configuration 
of naturally-derived acetate 106 was determined by single-crystal X-ray analysis. Acetylation of 
the naturally-derived alcohol 55 afforded a material identical to ester 106, as judged by 
1
H NMR 
spectroscopic and tlc analyses, thus supporting the structure proposed by Higa et al. for the 
latter compound.
105
 
 
Figure 2-3: (+)-Bromoxone (55) and its O-acetyl derivative, (+)-bromoxone acetate (106) 
2.2.2 Previous studies on the synthesis of bromoxone 
Due to the importance of bromoxone as a synthon en route to more elaborate epoxyquinol 
compounds, it has been the subject of a number of total syntheses.
79-83
 A discussion of each of 
these is presented immediately below. 
Taylor’s total synthesis of (±)-bromoxone (1994) 
The first synthesis of bromoxone was described by Taylor et al.
79
 His approach, leading to the 
racemate, is shown in Scheme 2-1 and started with the anodic oxidation of 2-bromo-1,4-
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dimethoxybenzene (56). Regioselective epoxidation of the ensuing quinone monoketal 57 
followed by stereoselective reduction of the ketone moiety within product 58 delivered a 2:1 
mixture of the diastereoisomeric ketals 59 and 60. Exposure of these compounds to 
Montmorillonite K10 clay led to ketones rac-55 and rac-61, respectively, and these could be 
readily separated by conventional chromatographic methods. In this way, pure samples of 
(±)-bromoxone (rac-55) and (±)-epibromoxone (rac-61) were obtained with the former product 
predominating. 
 
Scheme 2-1: Reagents (i) anodic oxidation; (ii) AcOH, acetone; (iii) t-BuOOH, KH; (iv) DIBAL-H; (v) K-10. 
Johnson’s total synthesis of (+)-bromoxone (1995) 
In 1995 Johnson et al.
80
 developed a total synthesis of (+)-bromoxone using the route shown in 
Scheme 2-2. Thus, p-benzoquinone (62) was dibrominated with molecular bromine and the 
ketone moieties within the ensuing product were reduced with sodium borohydride to afford the 
bis-allylic diol 63. Acylation of both hydroxyl groups within compound 63 using acetic 
anhydride afforded diester 64. Chemoenzymatic resolution of the racemic bis-acetates 64 using 
Pseudomonas cepacia lipase (Amano PS-30) effected selective hydrolysis of the levorotatory 
component and provided the corresponding diol [(+)-63], from which (+)-bromoxone was 
subsequently prepared. Thus, mono-protection of diol (+)-63 as the silyl ether 65 followed by 
electrophilic epoxidation of the latter compound with peracetic acid gave epoxy alcohol 66 in a 
diastereoselective manner. Treatment of this compound with the Jones’ reagent effected 
oxidation of the alcohol moiety and thereby facilitated elimination of the elements of HBr to 
afford enone 67. Finally, treatment of compound 67 with hexafluorosilicic acid provided 
(+)-bromoxone (55) in 74% yield. 
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Although not depicted, (−)-bromoxone was readily obtained from diester (+)-64. This 
enantiomer, though resistant to the action of Amano PS-30, underwent cleavage of both acetates 
with titanium(IV) isopropoxide in isopropanol and it was shown that by adhereing to a 
procedure parallel to that described for the synthesis of (+)-bromoxone, the optical antipode, 
(−)-bromoxone (ent-55) could be obtained. 
 
Scheme 2-2: Reagents (i) Br2; (ii) NaBH4; (iii) Ac2O, Et3N, DMAP; (iv) Amano PS-30, pH = 8 phosphate buffer; (v) 
TBSOTf, Et3N; (vi) CF3CO3H, Na2HPO4; (vii) CrO3(py)2; (viii) H2SiF6. 
Altenbach’s total synthesis of (+)-bromoxone (2000) 
(+)-Bromoxone was synthesized by Altenbach et al. using the protocol described in Scheme 
2-3.
81
 These researchers used pig pancreas lipase (PPL) to effect resolution of the enantiomeric 
forms of diester (±)-64, a process analogous to that previously described by Johnson et al.
80
 
(+)-Bromoxone was obtained from the liberated diol [(+)-63] via two rounds of epoxidation 
followed by a Dess-Martin periodinane-mediated oxidation of the ensuing alcohol (−)-69. 
Concomitant and regioselective epoxide-ring-opening within the product ketone then delivered 
the target compound (+)-55. 
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Scheme 2-3: Reagents (i) PPL, buffer pH = 7; (ii) LiOH; (iii) m-CPBA; (iv) DMP. 
Kitahara’s total synthesis of (+)-bromoxone (2003) 
The Kitahara
83
 synthesis of (+)-bromoxone started with a chiral substrate, namely ester 71 
which was obtained via the highly enantioselective reduction of β-ketoester 70 using baker’s 
yeast (Scheme 2-4). The ethyl ester moiety within product 71 was then hydrolyzed and the 
hydroxyl group acylated under standard conditions to afford the acetoxy acid 72. This material 
underwent the Suárez-modified Hunsdiecker reaction to afford iodide 73. Elimination of the 
elements of hydroiodic acid from within compound 73 could be effected with DBU and 
provided an intermediate allylic alcohol, the hydroxyl group of which was protected to afford 
silyl ether 75. Hydrolysis of the ketal moiety within the latter material was effected with PPTS 
in aqueous methanol and nucleophilic epoxidation of the resulting enone delivered epoxy-
ketone 77. An intermediate silyl-enol-ether was generated from this material and this was 
treated with phenylselenium chloride to give α-selenoketone 78. Bromination of this compound 
under basic conditions then afforded compound 79. Oxidative elimination of the phenylselenyl 
moiety within compound 79, followed by treatment of the product enone with hydrofluoric acid 
then yielded (+)-bromoxone in 13% yield over 13 steps. 
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Scheme 2-4: Reagents (i) dry baker’s yeast; (ii) LiOH; (iii) Ac2O, pyridine; (iv) IBDA, I2; (v) DBU; (vi) K2CO3; (vii) 
TBSCl, imidazole; (viii) PPTS, aq. Me2CO; (ix) H2O2, TritonB; (x) LiHMDS, TMSCl, PhSeCl; (xi) DBU, Br2; (xii) 
35% H2O2, NaHCO3; (xiii) 40% HF. 
Maycock’s total synthesis of (+)-bromoxone (2003) 
The first synthesis of (±)-bromoxone that did not rely upon an enzymatic resolution was 
described in 2003 by Maycock et al.
82
 Thus, as depicted in Scheme 2-5, the α,β-unsaturated 
cyclohexenone 81, which was obtained in four steps from the abundant chiron quinic acid (80), 
served as the starting material and was iodinated at the α-position using the Johnson 
procedure.
106
 Gabriel-Cromwell aziridination of the product α-iodoenone with 4-
methoxybenzylamine provided a mixture of the expected diastereoisomeric products 83 and 84 
with the latter predominating. Isomer 84 was treated with sodium hydroxide and through loss of 
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the elements of acetone, an alkene was thereby installed on that side of the six-membered ring 
opposite the aziridine moiety itself. The hydroxyl group of product 85 was converted into the 
corresponding TBS ether 86 which was subject to selective nucleophilic epoxidation. The facial 
selectivity of this reaction was directed by the bulky silyl ether residue. The aziridine ring of 
product 87 was selectively reacted with dilute HBr to give α-bromoenone 67. Treatment of silyl 
ether 67 with HF in acetonitrile then gave (+)-bromoxone in 18% overall yield and seven steps 
from quinic acid (80). 
 
Scheme 2-5: Reagents (i) As described by Maycock et al.106 (ii) I2, DMAP, pyridine; (iii), 4-methoxybenzylamine, 
Cs2CO3, 1,10-phenanthroline; (iv) NaOH; (v) TBSCl, DMAP, (i-Pr)2NEt3; (vi) H2O2, Triton B; (vii) HBr; (viii) HF. 
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2.3 TOTAL SYNTHESIS OF (−)-BROMOXONE AND ITS CHLORO- AND IODO- 
ANALOGUES 
2.3.1 Synthetic strategy associated with the present synthesis of the 
tambjamines 
The development of a rapid synthesis of bromoxone was considered a worthy objective as it was 
anticipated that by doing so, a range of related compounds would also become more accessible. 
In fact, bromoxone and its iodo-congener or protected forms thereof have served as 
intermediates en route to several more elaborate targets. The descriptions of previous syntheses 
of enantiomerically pure bromoxone given above reveal the lengthy nature of the reaction 
sequences required to obtain this important synthetic intermediate. To overcome such 
difficulties, a facile and chemoenzymatic route to several versatile epoxyquinol synthons was 
developed.
104
 Thus, these densely functionalized synthons were obtained in just four steps from 
certain cis-1,2-dihydrocatechols that are themselves readily obtained in large quantity and 
enantiomerically pure form via the enzymatic dihydroxylation of the corresponding 
halobenzenes. The value of these synthons is highlighted, as detailed in the following sections, 
through their application to abbreviated total syntheses of (−)-bromoxone (ent-55), its O-acetyl 
congener (ent-106), (+)-epiepoformin (ent-108), (−)-harveynone (148) and (−)-tricholomenyn A 
(174). Details of these are presented below. Related syntheses of (+)-panepophenanthrin (192), 
and (+)-hexacyclinol (233), structurally more complex natural products arising from the Diels-
Alder dimerization of epoxyquinol monomers, are discussed separately in Chapter Three. 
2.3.2 Regio- and diastereo-selective bromohydrin-forming reactions 
The dihydrocatechols 88-90, readily obtained from the whole-cell biotransformation of the 
corresponding halobenzene,
107-109
 were employed as the starting materials in syntheses of 
(−)-bromoxone and its chloro- and iodo-congeners. The reaction sequences started with 
treatment of the diols with NBS in aqueous THF and thereby affording bromohydrins 91-93 in a 
completely regio- and diastereo-selective manner. This selectivity is the result of certain 
electronic and steric effects. Thus, formation of an intermediate bromonium cation takes place 
first of all and this forms at the more electron-rich of the two double bonds within the starting 
material. Inductive withdrawal of electron density by the appended halogen sufficiently 
deactivated the associated alkene that reaction at this alternate position was not observed. Steric 
effects exerted by the hydroxyl groups directed electrophilic attack by bromine from the less 
hindered β-face. Subsequent nucleophilic opening of the resulting bromonium species by water 
takes place exclusively at the allylic position and thereby providing the illustrated bromohydrins 
91-93 in yields that ranged from 64 to 89% (Scheme 2-6). The outcomes of these 
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bromohydrination reactions are in accord with the results of a study by Seonane et al. on the 
halohydroxylation of a range of protected dihydrocatechols.
110
 
 
Scheme 2-6: Reagents and conditions (i) NBS, H2O, THF, 20 °C, 1h. 
2.3.3 Regioselective epoxide-forming reactions 
Treatment of the bromohydrins 91-93 with sodium methoxide in THF resulted in selective 
epoxide ring formation and generation of compounds 94-96 in yields ranging from 52 to 79%. 
(See Scheme 2-7). 
 
Scheme 2-7: Reagents and conditions (i) NaOMe, THF, 20 °C, 1h. 
The 
13
C NMR spectrum recorded on bromoalkene 95 is shown in Figure 2-4 and reveals signals 
due to two olefinic carbons at δ 130.4 and 124.0. The hydroxyl groups gave rise to a broad 
absorption band at 3229 cm
-1
 in the IR spectrum while in the EI mass spectrum of the mono-
brominated diol 95 displays molecular ions of approximately equal intensity at m/z 208 and 206. 
Such an isotopic distribution is expected for a mono-brominated compound. An accurate mass 
measurement carried out on the former species established the molecular formula of the 
compound is C6H7
79
BrO3 as expected for the assigned structure 95. 
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Figure 2-4: 75 MHz 13C NMR spectrum of epoxide 95 (recorded in d6-DMSO). 
Inset: An expansion of a region from the spectrum. 
The structures of the epoxides 94-96 were confirmed by single-crystal X-ray analyses carried 
out on each of them. An ORTEP derived from the single-crystal X-ray analysis of epoxide 95 is 
shown in Figure 2-5. The anisotropic displacement ellipsoids show 30% probability levels. Full 
X-ray structure reports are provided in the appendix. 
 
Figure 2-5 ORTEP derived from single-crystal X-ray analysis of 95. 
The specific rotation ([α]D) of diol 95 was +16.6 (c 5.0, THF). A comparison of this value with 
those recorded for compounds 94 {[α]D
 
+5.6 (c 5.0, THF)} and 96 {[α]D +26.4 (c 5.0, THF)}, 
indicated that the magnitude of specific rotation increased with the increasing size of the 
appended halogen atom. 
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The high level of selectivity associated with the formation of epoxides 94-96 from 
bromohydrins 91-93 is somewhat surprising at first glance given that in each of the precursors 
91-93 the departing bromine is trans-related to two adjacent hydroxyl groups and thus there is, 
in principle at least, the possibility of forming an isomeric epoxide. It is believed that 
stereoelectronic constraints inhibited the oxygen at the allylic position from participating in the 
alternate epoxide-forming reaction, as shown in Scheme 2-8. 
 
Scheme 2-8: The formation of alkenyl epoxides such as 97 were not observed during the base induced epoxidation 
reactions of bromohydrins 91-93. 
2.3.4 Regioselective Mitsunobu reactions 
Mitsunobu reaction of cis-diols 94-96, using chloroacetic acid as the nucleophile, took place 
selectively at the allylic hydroxyl moiety remote from the halogen atom, presumably because it 
is less sterically encumbered (Scheme 2-9). Initially, diisopropyl azodicarboxylate (DIAD) was 
used in this reaction however the byproduct arising from it, namely diisopropyl 
hydrazinodicarboxylate, often co-eluted with the product during chromatographic purification 
on silica gel. Fortunately, ditertbutyl azodicarboxylate proved to be a suitable alternative since 
the corresponding by-product, ditertbutyl hydrazinodicarboxylate, has a higher mobility on 
silica gel during chromatography and was, therefore, readily separated from the product by such 
means. 
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Scheme 2-9: Reagents and conditions (i) (t-BuOCON)2, PPh3, ClCH2CO2H, THF, 20 °C, 0.25 h. 
The 
1
H NMR spectrum of product 99 (Figure 2-6) displays one-proton multiplets at δ 3.66 and 
3.50 that are assigned to the protons associated with the epoxide ring. A two-proton singlet 
appearing at δ 4.10 is assigned to the CH2 unit of the chloroacetyl residue. Unsurprisingly, the 
spectrum recorded on the corresponding chloro- and iodo-analogues, 98 and 100 respectively, 
are very similar. The ester moieties installed during the Mitsunobu reaction gave rise to strong 
C=O stretching band at 1750 cm
−1
 in the IR spectrum of each of the compounds 98-100. 
 
Figure 2-6: 300 MHz 1H NMR spectrum of ester 99 (recorded in CDCl3) 
Insets: Expansions of two regions from the spectrum. 
2.3.5 Alcohol oxidation and ester cleavage 
Pyridinium dichromate in dichloromethane containing a small amount of acetic acid was used to 
oxidize the hydroxyl group in each of the allylic alcohols 98-100 to the corresponding enones 
101-103 respectively (Scheme 2-10). Acetic acid was added in order to accelerate the oxidation 
reaction.
111
 The oxidation products were isolated in yields ranging from 65 to 77%. During 
attempts to remove the α-chloroacetyl protecting group from these enones they were exposed to 
methanolic potassium carbonate. Unfortunately, these conditions caused rapid decomposition of 
the substrate and/or product. Even the use of relatively mild bases such as pyridine and sodium 
bicarbonate did not alleviate this problem, perhaps due to the facile nature of base-induced 
aromatization processes. However, smooth cleavage of the chloroacetyl esters could be effected 
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using zinc (II) acetate dihydrate in methanol. Under such conditions the chloroacetates could be 
cleaved and (−)-bromoxone (ent-55) and its chloro- and iodo-congeners (104 and 105, 
respectively) were thereby obtained in yields ranging from 84 to 88%. 
 
Scheme 2-10: Reagents and conditions (i) PDC, AcOH, DCM, 20 °C, 1 h; (ii) Zn(OAc)2.2H2O, MeOH, 20 °C, 1 h. 
The 
1H NMR spectrum of (−)-bromoxone (Figure 2-7) exhibited all of the expected proton 
signals except for that derived from the hydroxyl proton that had presumably undergone 
deuterium for proton exchange with the solvent. The specific rotation of this material 
{[α]D −187.1 (c 1.75, acetone)} was of similar magnitude but opposite sign to that reported for 
(+)-bromoxone {[α]D +205.7 (c 0.32, acetone)}.
106
 The remaining spectral data derived from 
this material were identical, in all respects, with those reported in the literature for its optical 
antipode.
79-83,105
 
 
Figure 2-7: 300 MHz 1H NMR spectrum of (−)-bromoxone (recorded in d6-acetone). 
The data presented Table 3-1 reveal that the present work provides the shortest total synthesis of 
enantiomerically pure bromoxone. The overall yield for the synthesis described here is 
unsurpassed and the average yield per reaction step is 81%. Furthermore, as the starting material 
for the synthesis, cis-dihydrocatechol 89, is derived from abundant bromobenzene, the entire 
carbon framework of the final product is derived from this commodity chemical. Conveniently, 
every step of the synthesis of (−)-bromoxone disclosed in this work is conducted at standard 
temperatures and pressures. 
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Table 2-1: A comparison of the key features associated with the seven reported syntheses of bromoxone 
Lead author Publication date Longest linear sequence Overall yield (%) Modification produced 
Taylor79 1994 five steps 15 (±) 
Johnson80 1995 eight steps 5 (+) 
Altenbach81 2000 six steps 14 (+) 
Kitahara83 2003 thirteen steps 13 (+) 
Maycock82 2003 eight steps 18 (+) 
Present work104 2009 five steps 34 (−) 
Schapiro112 2010 twelve steps 4 (+) 
The publication of the work described here was followed by a report by Schapiro et al. on the 
total synthesis of (+)-bromoxone from diol 89 in 12 steps and an overall yield of 4%.
112
 
Deprotection of a certain intermediate on this route also provided diol 95, in five steps and 53% 
yield from the starting diol 89, and thereby constituted a formal total synthesis of 
(−)-bromoxone. 
2.4 (+)-BROMOXONE ACETATE 
2.4.1 Isolation and characterization of (+)-bromoxone acetate 
(+)-Bromoxone acetate (106) and its O-deacetyl congener (+)-bromoxone were both isolated 
from a marine acorn worm (Phylum Himichordata, Order Enteropneusta) and the structure of 
the former was confirmed by single-crystal X-ray analysis.
105
 Compound 106 was also shown to 
be active against P388 leukemia cells (IC50 = 10 ng mL
-1
), a property not displayed by the 
corresponding alcohol. 
 
Figure 2-8: (+)-Bromoxone acetate. 
2.5 SYNTHETIC STRATEGY ASSOCIATED WITH THE PRESENT SYNTHESIS 
OF (−)-BROMOXONE ACETATE 
Although bromoxone (55) has been the subject of a number of total syntheses, its O-acetyl 
congener (106) has not been. In consideration of the successful application of the Mitsunobu 
reaction en route to (−)-bromoxone, as described in the previous section, it was anticipated that 
similar methodology would provide an especially concise route to (−)-bromoxone acetate 
(ent-106). Details of the successful outcome of such an approach are presented below. 
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2.5.1 Proposed synthetic route to (−)-bromoxone acetate 
The previously described and readily available bromoepoxide 95 was selected as the synthon 
from which (−)-bromoxone acetate would be synthesized. It was anticipated that subjection of 
this diol to a Mitsunobu reaction, using acetic acid as the nucleophile, would install the acetate 
residue with the desired stereochemistry (Scheme 2-11). Oxidation of the ensuing alcohol 107, 
in a manner identical to that applied to alcohol 99 in the abovementioned synthesis of 
(−)-bromoxone, should then deliver α,β-unsaturated ketone ent-106 and complete the synthesis 
of (−)-bromoxone acetate in just four steps from the commercially available cis-dihydrocatechol 
89. The successful implementation of these ideas are presented in the following sections. 
 
Scheme 2-11: Proposed synthetic route to (−)-bromoxone acetate 
2.6 TOTAL SYNTHESIS OF (−)-BROMOXONE ACETATE 
2.6.1 The Mitsunobu reaction 
In keeping with the synthetic plan presented immediately above, bromodiol 95 was submitted to 
a Mitsunobu reaction with acetic acid (Scheme 2-12) using conditions analogous to those 
employed earlier in the synthesis of (−)-bromoxone. Once more, the Mitsunobu reaction took 
place selectively at the less-hindered allylic alcohol and provided the anticipated acetate 107 in 
88% yield as a white, crystalline solid. 
 
Scheme 2-12: Reagents and conditions (i) (t-BuOCON)2, PPh3, AcOH, THF, 20 °C, 1 h. 
The 
1
H NMR spectrum of acetate 107 (Figure 2-9) is reminiscent of that obtained from 
α-chloroacetate 99. Thus, the signal arising from the olefinic proton appeared at δ 6.11 while the 
hydroxyl group proton was observed as a doublet (J = 9.9 Hz) at δ 2.80. The acetate group 
carbons gave rise to signals in the 
13C NMR spectrum at δ 169.9 and δ 20.7 whilst the other 
signals in the same spectrum showed only small differences with respect to chemical shifts 
observed for the analogous carbons of the α-chloroacetate 99. An hydroxyl group absorption 
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band was observed at 3457 cm
-1
 in the IR spectrum along with bands at 1737 and 1231 cm
-1
 that 
are attributed to C=O and C−O stretching, respectively. 
 
Figure 2-9: 300 MHz 1H NMR spectrum of alcohol 107 (recorded in CDCl3).  
Insets: Expansions of three regions from the spectrum. 
The EI mass spectrum of acetate 107 shows molecular ions at m/z 248 and 250 and these were 
of approximately equal intensity. Such an isotopic distribution is indicative of a mono-
brominated compound. Accurate mass measurement on the lighter of these established that it 
was of the expected composition, viz. C8H9
79
BrO4. 
2.6.2 Alcohol oxidation 
Oxidation of alcohol 107 was best effected with pyridinium dichromate (PDC) in the presence 
of a small amount of acetic acid and using dichloromethane as solvent (Scheme 2-13).
111
 The 
(−)-bromoxone acetate (ent-106) was thereby obtained in 51% yield. 
 
Scheme 2-13: Reagents and conditions (i) PDC, AcOH, DCM, 20 °C, 1 h. 
The specific rotation of ent-106 {[α]D −278.2 (c 2.55, chloroform)} was of similar magnitude 
but opposite sign to that reported for (+)-bromoxone acetate {[α]D +265 (c 0.12, chloroform)}. 
The associated 
1
H spectrum is shown in Figure 2-10 and matches that reported for the natural 
product.
105
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Figure 2-10: 300 MHz 1H NMR spectrum of (−)-bromoxone acetate (recorded in CDCl3).  
 Insets: Expansions of three regions from the spectrum. 
A comparison of the 
1
H NMR data recorded for naturally- and synthetically-derived bromoxone 
acetate (106 and ent-106, respectively) is shown in Table 2-2. The observed chemical shifts 
differ by no more than 0.02 ppm while the J values, where direct comparisons are possible, vary 
by less than 0.2 Hz. 
Table 2-2: Comparison of the 1H NMR data recorded on naturally- and synthetically-derived bromoxone 
acetate (106 and ent-106, respectively) 
1H NMR Data 1H NMR Data 
Natural 106 
(δH) 
(300 MHz, CDCl3)
105  
Synthetic ent-106 
(δH) 
(300 MHz, CDCl3) 
7.04 (dd, J = 5.3 and 2.3 Hz, 1H) 7.05 (dd, J = 5.4 and 2.4 Hz, 1H) 
5.73 (dt, J = 5.3 and 1.3 Hz, 1H) 5.73 (ddd, J = 5.4, 1.2 and 1.2 Hz, 1H) 
3.75 (ddd, J = 3.4, 2.3 and 1.3 Hz, 1H) 3.77 (m, 1H) 
3.68 (dd, J = 3.4 and 1.2 Hz, 1H) 3.68 (dd, J = 3.6 and 1.2 Hz, 1H) 
2.13 (s, 3H) 2.14 (s, 3H) 
While the remaining spectral data derived from the oxidation product ent-106 depicted in 
Scheme 2-12 were identical, in all respects, with those reported in the literature for its optical 
antipode, final confirmation of the structure of compound ent-106 came from a single-crystal X-
ray analysis. The ORTEP obtained from this analysis is shown in Figure 2-11. The anisotropic 
displacement ellipsoids show 30% probability levels. The full X-ray structure report is provided 
in the appendix. 
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Figure 2-11: ORTEP derived from single-crystal X-ray analysis of (−)-bromoxone acetate. 
2.7 (+)-EPIEPOFORMIN 
2.7.1 Isolation and characterization of (+)-epiepoformin 
The title compound (108) was isolated by Nagasawa et al.
113
 from a culture of an unidentified 
fungus that was, itself, obtained from a diseased leaf of the crape-myrtle tree (Lagerstroemia 
indica L.). The compound was found to exhibit phytotoxic properties, including a capacity to 
inhibit the germination of lettuce seeds, Lactuca sativa L. The basic structure of 
(+)-epiepoformin was established by conventional means while circular dichroism (CD) 
techniques were used to determine its absolute stereochemistry. 
 
Figure 2-12: (+)-Epiepoformin 
2.7.2 Previous studies on the synthesis of epiepoformin 
Epiepoformin has been the subject of six prior total syntheses.
83-88
 The first of these involved the 
synthesis of the racemate from p-benzoquinone. All subsequent syntheses have led to the 
naturally-occurring enantiomeric form of the natural product. 
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Ichihara’s total synthesis of (±)-epiepoformin (1982) 
The first synthesis of epiepoformin, reported by Ichihara et al.
84
 in 1982, provided the racemic 
modification of the natural product. This approach, which is shown in Scheme 2-14, used p-
benzoquinone (62) as the starting material. This was engaged in a Diels-Alder reaction with 6,6-
dimethylfulvene and the conjugated double bond within the adduct was then epoxidized in a 
diastereoselective fashion to afford compound 109.
114
 Sodium borohydride was then used to 
selectively reduce one of the two ketone moieties within this compound and thereby produce an 
epimeric mixture of alcohols, the illustrated trans-epoxy alcohol 110 being obtained in 17% 
yield and the epimeric cis-epoxy alcohol (not shown) being obtained in 19% yield. Compound 
110 was protected as the corresponding acetate, 111, under standard conditions and this was 
then C-alkylated using standard techniques to give, after acetate group cleavage, alcohol 112. 
Heating this last compound in ethyl acetate at 140 °C (sealed tube) effected a retro-Diels-Alder 
reaction and thereby afforded (±)-epiepoformin (rac-108) in 88% yield. 
 
Scheme 2-14: Reagents (i) As described by Ichihara et al.;114 (ii) NaBH4; (iii) Ac2O, pyridine; (iv) KOt-Bu, MeI; (v) 
KOH (10%); (vi) heated at 140 °C for 20 min. 
Ogasawara’s total synthesis of (+)-epiepoformin (1995) 
Ogasawara et al.
85
 described the first enantiocontrolled synthesis of (+)-epiepoformin in 1995 
(Scheme 2-15). The sequence commenced with the optically pure tricyclic allylic alcohol 113 
that had been obtained through the lipase-mediated desymmetrization of a meso-diol precursor 
derived from p-benzoquinone (62).
24,115,116
 The absolute configuration of acetate 113 was 
established using chemical correlation studies.
115
 Following protection of alcohol 113 as the 
corresponding pivalic ester, 114, the acetyl residue within the latter compound was exchanged, 
via two standard steps, for a tert-butyldimethylsilyl group. The ensuing pivalic ester 116 was 
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then treated with methyl lithium in order to cleave the pivaloyl protecting group and thereby 
affording compound 117. PDC-mediated oxidation of allylic alcohol 117 produced an 
intermediate enone from which epoxy-ketone 119 was obtained via nucleophilic epoxidation 
with alkaline hydrogen peroxide. The epoxidation reaction proceeded in a facially-selective 
manner. An axial methyl group, delivered to the exo-face of the enolate derived from ketone 
119, was installed adjacent to the ketone using potassium hydride and methyl iodide. The 
product of this alkylation reaction, epoxy-ketone 120, was then heated in diphenyl ether in order 
to effect a retro-Diels-Alder reaction and thereby restore the alkene moiety present in the natural 
product. This process afforded silyl ether 121 in a high yield and, following HF-mediated 
desilylation of this compound, a 12-step synthesis of (+)-epiepoformin was completed. This 
proceeded in 37% overall yield from p-benzoquinone (62). The acquisition of this material 
served to confirm the absolute configuration originally assigned to the natural product. 
 
Scheme 2-15: Reagents (i) heated at 40 °C for 3 h; (ii) (i-Pr)2AlH; (iii) vinyl acetate, Amano PS-30 lipase; (iv) 
pivalic anhydride, NEt3, DMAP; (v) K2CO3, MeOH; (vi) TBS-OTf, Et3N; (vii) MeLi; (viii) PDC; (ix) 30% H2O2, 
Triton B; (x) KH, MeI; (xi) reflux with diphenyl ether; (xii) 45% HF-MeCN. 
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Maycock’s total synthesis of (+)-epiepoformin (2000) 
Maycock et al.
86
 have developed a series of relatively efficient syntheses of natural products 
closely related to (+)-epiepoformin (108). These were readily modified to give target 108 that 
was obtained via the route shown in Scheme 2-16. Thus, β-hydroxyketone 122, which was 
produced in three steps from (−)-quinic acid (80), was O-silylated with tert-butyldimethylsilyl 
chloride
106
 and the ensuing ether 123 underwent base-induced elimination of the elements of 
acetone to give α,β-unsaturated enone 124. This was accompanied by the trans-O-silylation 
product such that a 1:1 mixture of isomers 124 and 125 was obtained. Recycling of the 
chromatographically separated isomer 125 delivered more of the desired isomer 124 under the 
same basic conditions. Though these regioisomers could be separated, it was considered more 
expedient to engage the mixture in nucleophilic epoxidation and by such means the 
corresponding mixture of epoxyketones 126 and 127 were obtained. These compounds were 
acetylated and the 5-acetoxy intermediate derived from compound 127 underwent elimination 
(presumably via an E1cb pathway) of the elements of acetic acid to give enone 129. The latter 
compound was easily separated from the residual 4-acetoxy byproduct using chromatographic 
methods and then carried forward in the synthesis. Thus, α-iodination of enone 129 with 
molecular iodine and Stille cross-coupling of the ensuing organoiodide with tetramethyltin 
afforded the required α-methylated enone 121. Finally, fluoride-mediated desilylation of silyl 
ether 121 delivered (+)-epiepoformin (108) that was obtained in ten steps and 20% overall yield 
from (−)-quinic acid. This synthesis represents a more direct approach to compound 108 than an 
earlier variant described by Maycock that also started from (−)-quinic acid.117 
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Scheme 2-16: Reagents (i) Acetone, dry HCl; (ii) Ac2O, pyridine; (iii) (a) LiAlH4, (b) NaIO4; (iv) TBS-Cl, 
imidazole; (v) 0.5 N NaOH; (vi) 30% H2O2, Triton B; (vii) Ac2O, (i-Pr)2NEt, DMAP; (viii) I2, DMAP, pyridine; (ix) 
Me4Sn, AsPh3, Pd2(dba)3·CHCl3, CuI; (x) HF (40% in H2O). 
Okamura’s total synthesis of (+)-epiepoformin (2001) 
The key step in the Okamura synthesis of (+)-epiepoformin (Scheme 2-17) was the cinchonine-
catalyzed Diels-Alder reaction of 3-hydroxy-2-pyrone (130) with acrylate (+)-131.
87,118
 While 
the resulting adduct 132 was employed in the depicted synthesis of (+)-epiepoformin, it is 
noteworthy that its optical antipode is accessible from pyrone 130 by utilizing a different chiral 
auxiliary and catalyst system. Exposure of compound 132 to sodium methoxide effected 
displacement of the chiral oxazolone residue and concomitant opening of the bridging lactone 
linkage, such that diester 133 was obtained. Reduction of both methyl ester moieties within 
compound 133 was effected with lithium aluminium hydride and the resulting triol was exposed 
to sodium periodate. Under these conditions, the vicinal diol moiety was oxidatively cleaved 
and ketone 134 thus obtained. α-Face-directed nucleophilic epoxidation of compound 134 was 
effected with basic hydrogen peroxide and afforded epoxyketone 135. Tosylation of the β-
hydroxyl moiety within compound 135 and its subsequent elimination with triethylamine then 
afforded enone 136. Palladium on carbon was used to effect the isomerization of this alkene to 
congener 121, from which (+)-epiepoformin was readily obtained via desilylation with HF. This 
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process thus afforded the natural product in nine steps and in an overall yield of 31% from 3-
hydroxy-2-pyrone (130). 
 
Scheme 2-17: Reagents (i) cinchonine; (ii) TBS-Cl, imidazole; (iii) NaOMe; (iv) LiAlH4; (v) NaIO4; (vi) 30% aq. 
H2O2, Triton B; (vii) p-TsCl, Et3N, DMAP; (viii) Pd/C; (ix) HF. 
Kitahara’s total synthesis of (+)-epiepoformin (2003) 
Kitahara et al.
83
 synthesized (+)-epiepoformin from intermediate epoxyketone 77, a compound 
that was used in their earlier synthesis of (+)-bromoxone (described in Section 2.2.2). Thus, α-
selenation of compound 77 with phenylselenium chloride proceeded via the silyl-enol-ether 
intermediate and delivered selenide 78 as a mixture of diastereomers. The enolate derived from 
compound 78 was then quenched with methyl iodide to yield compound 137 which was also 
obtained as a mixture of diastereomers. The selenide moiety within compound 137 was then 
oxidized with hydrogen peroxide and the resulting selenoxide eliminated thermally to provide 
enone 121 from which (+)-epiepoformin was obtained in 62% yield via a fluoride-induced 
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deprotection step. In this way, the natural product was obtained in a 10% overall yield and in 13 
steps from β-keto-ester 70. 
 
Scheme 2-18: Reagents (i) As described by Kitahara and Tachihara;83 (ii) LiHMDS, TMS-Cl, PhSeCl; (iii) NaH, 
MeI; (iv) 35% aq. H2O2, NaHCO3; (v) 40% aq. HF. 
Carreno’s total synthesis of (+)-epiepoformin (2005) 
The total synthesis of (+)-epiepoformin developed by Carreno et al.
88
 utilized the addition of the 
lithium anion of (S,S)-methyl p-tolylsulfoxide to the carbonyl of p-benzoquinone dimethyl 
acetal (138). The intermediate acetal was then cleaved with oxalic acid to give the dienone 
(S,R)-139. Using Me3Al, a methyl group was delivered in a diastereo- and chemo-selective 
fashion to the β-position of one of the enone moieties associated with compound (S,R)-139. The 
resulting aluminium enolate was then C-brominated with NBS. The product of this process, the 
diastereoisomeric mixture of bromo-ketones (S,R)-140, was treated with Li2CO3/LiCl mixtures 
and thus effecting loss of the elements of HBr to regenerate the 5,6-olefin present in (S,R)-141. 
The sulfone moiety within compound (S,R)-141 was then oxidized to the corresponding 
sulfonate in anticipation of its eventual removal. In the meantime, the less-substituted alkene of 
compound 142 was selectively oxidized with tert-butyl hydroperoxide and Triton B in THF to 
afford epoxyketone 143. The ketone moiety within this last compound was then 
stereoselectively reduced with diisobutyl aluminium hydride to afford alcohol 144. The 
elimination of the elements of methyl p-tolylsulfone from compound 144 was effected with 
cesium carbonate in methanol and produced (+)-epiepoformin (108) in 54% yield. While the 
yield encountered in this elimination step could be improved if the primary hydroxyl group is 
first protected as the corresponding tert-butyldimethylsilyl ether, the losses associated with the 
requisite protection and deprotection steps required for the alternate preparation of this 
compound make this other route less efficient. 
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Scheme 2-19: Reagents (i) (SS)-methyl p-tolylsulfoxide, LDA; (ii) oxalic acid; (iii) Me3Al; (iv) NBS; (v) Li2CO3, 
LiBr; (vi) m-CPBA; (vii) t-BuOOH, Triton B; (viii) (i-Bu)2AlH; (ix) Cs2CO3. 
2.8  SYNTHETIC STRATEGY ASSOCIATED WITH THE PRESENT SYNTHESIS 
OF (−)-EPIEPOFORMIN 
Although epiepoformin has been the subject of six total syntheses (the first afforded a racemic 
sample of the natural product and the rest provided (+)-epiepoformin), the generation of 
(−)-epiepoformin has not been reported previously. In light of the rapid synthesis of 
(−)-bromoxone described in the preceeding section, it was expected that exploitation of a 
similar methodology would lead to a concise total synthesis of (−)-epiepoformin (ent-108), the 
biological evaluation of which would be of some interest. 
2.8.1 Proposed synthetic route to (−)-epiepoformin 
Iodide 103, the synthesis of which was described in Section 2.3.5, was selected as an attractive 
precursor to (−)-epiepoformin because it bears the same oxygenation pattern as the target 
molecule and the halogen atom is positioned appropriately for the intended cross-coupling 
reaction with tetramethyltin. In the interests of maximizing the reactivity of the substrate, it was 
the iodinated (rather than the chlorinated or brominated) congener that was to be utilized in 
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palladium-catalyzed cross-coupling reactions described here. In the event, however, iodide 103 
failed to deliver the desired cross-coupled product (Scheme 2-20). 
 
Scheme 2-20: Reagents and conditions (i) Me4Sn, Pd[0], Ph3As, CuI, THF, 100 °C, 1 h. 
Fortunately, successful Stille cross-coupling reactions with an O-silyl compound analogous to 
ester 103 have been described previously.
86
 On this basis, silyl ether 146 was considered an 
appropriate substrate for a Stille cross-coupling reaction with tetramethyltin (Scheme 2-21). In 
this case, desilylation of the cross-coupling product 147 should deliver (−)-epiepoformin. The 
successful implementation of this approach is described in the following section. 
 
Scheme 2-21: Proposed synthesis of (−)-epiepoformin from the iodide 105, a halo-analogue of (−)-bromoxone. 
2.9 TOTAL SYNTHESIS OF (−)-EPIEPOFORMIN 
2.9.1 The Stille cross-coupling reaction 
In accord with the proposed synthetic plan shown immediately above, alcohol 105 was reacted 
with triethylsilyl chloride in the presence of 2,6-lutidine (Scheme 2-22), a hindered base used to 
facilitate the silylation reaction as well as to reduce the incidence of possible competing (base-
induced) aromatization processes. The desired reaction was complete after one hour and the 
substrate for the planned Stille cross-coupling reaction, silyl ether 146, was thus obtained in 
55% yield. 
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Scheme 2-22: Reagents and conditions (i) TES-Cl, 2,6-lutidine, dichloromethane, 0 → 20 °C, 1 h. 
The 
1
H NMR spectrum of compound 146 is shown in Figure 2-13. Signals arising from protons 
attached to the cyclohexene ring were mostly unchanged with respect to the chemical shifts 
observed in the analogous spectrum of precursor 105. The quartet and triplet observed at δ 0.67 
and 0.98 arise from the three equivalent ethyl groups associated with the triethylsilyl protecting 
group. 
 
Figure 2-13: 300 MHz 1H NMR spectrum of silyl ether 146 (recorded in CDCl3).  
Inset: Expansions of two regions from the spectrum. 
Disappointingly, the foreshadowed palladium-catalyzed cross-coupling reaction of iodide 146 
with tetramethyltin proceeded in only 37% yield to afforded ketone 147 (Scheme 2-23). The 
extended duration of the reaction and the vigorous heating required almost certainly contributed 
to degradation of the substrate and/or product. 
 
Scheme 2-23: Reagents and conditions (i) Me4Sn, Pd[0], Ph3As, CuI, THF, 80 °C, 3 days. 
The 
13
C NMR spectrum recorded on silyl ether 147 is shown in Figure 2-14. The newly 
introduced α-methyl carbon gives rise to a resonance at δ 15.9 while the associated protons give 
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rise to a three-proton singlet at δ 1.82 in the corresponding 1H NMR spectrum. The EI mass 
spectrum displayed a molecular ion at m/z 254 and an accurate mass measurement on this 
species established that it was of the expected composition, viz. C13H22O3Si. 
 
Figure 2-14: 300 MHz 13C NMR spectrum of ketone 147 (recorded in CDCl3). 
As depicted in Scheme 2-24, cleavage of the silyl protecting group of ether 147 with 
HF/pyridine in acetonitrile furnished the target compound (ent-108) as a clear, colorless oil. The 
optical rotation recorded on this material {[α]D −311.0 (c 0.27, ethanol)} was of similar 
magnitude but opposite sign to that reported
113
 for the natural enantiomeric form of 
epiepoformin {[α]D +316.04 (c 0.37, ethanol)}. 
 
Scheme 2-24: HF·pyridine, MeCN, 20 °C, 1 h. 
The 
13
C NMR spectrum recorded on (−)-epiepoformin is shown in Figure 2-15 and proved to be 
fully consistent with the assigned structure. Unfortunately, the 
13
C NMR spectrum of the 
naturally-derived material has not been published so relevant comparisons could not be made. 
Nevertheless, our data compare favourably with those reported for synthetically-derived 
(+)-epiepoformin. 
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Figure 2-15: 75 MHz 13C NMR spectrum of (−)-epiepoformin. 
A tabulation of the 
1
H NMR data recorded on both naturally- and synthetically-derived samples 
of epiepoformin (108 and ent-108, respectively) is shown in Table 2-3. Clearly there is close 
agreement between the two data sets; the maximum deviation between chemical shifts recorded 
on the synthetic sample, with respect to those reported for the naturally-derived material, was 
0.06 ppm and the average deviation was just 0.04 ppm. 
Table 2-3: Comparison of the 1H NMR data recorded on naturally- and synthetically-derived epiepoformin (108 and 
ent-108, respectively) 
1H NMR Data 1H NMR Data 
Natural 108 
(δH) 
(300 MHz, CDCl3)
113  
Synthetic ent-108 
(δH) 
(300 MHz, CDCl3) 
6.40 (m, 1H) 6.46 (m, 1H) 
4.61 (broad s, 1H) 4.66 (broad m, 1H) 
3.73 (m, 1H) 3.79 (m, 1H) 
3.46 (d, J = 4 Hz, 1H) 3.51 (dd, J = 3.6 and 1.2 Hz, 1H) 
2.20 (broad s, 1H) 2.20 (broad d, J = 7.8 Hz, 1H) 
1.82 (s, 3H) 1.84 (broadened s, 3H) 
The present work represents the equal shortest synthesis of epiepoformin as is indicated in 
Table 2-4, and delivers the target compound in an enantiomerically enriched form. The overall 
yield for this synthesis is low, an outcome that is partly attributed to the vigorous reaction 
conditions required for installation of the α-methyl moiety. In consideration of this shortcoming, 
the development of a more efficient cross-coupling regime is considered worthwhile. 
Conveniently, however, as the starting material for the synthesis, cis-dihydrocatechol 100, is 
derived from abundant iodobenzene, all but one of the carbons of target 147 are derived this 
commodity chemical. 
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Table 2-4: A comparison of the key features associated with the seven reported syntheses of epiepoformin 
Lead author Publication date Longest linear sequence Overall yield (%) Modification produced 
Ichihara84 1982 seven steps 7 (±) 
Ogasawara85 1995 twelve steps 37 (+) 
Maycock86 2000 ten steps 20 (+) 
Okamura87 2001 nine steps 29 (+) 
Kitahara83 2003 thirteen steps 10 (+) 
Carreno88 2005 nine steps 9 (+) 
Present work104 2009 seven steps 5 (−) 
2.10 HARVEYNONE 
2.10.1 Isolation and characterisation of harveynone 
(−)-Harveynone [148, aka (−)-PT toxin] was first isolated from the mold Curvularia harveyi 
and shown, at that time, to inhibit spindle formation in sea urchin eggs.
119
 This property is 
shared by its enantiomer, (+)-harveynone (ent-148), a phytotoxic metabolite of the tea gray 
blight fungus Psetalotiopsis theae.
120
 
 
Figure 2-16: (−)-Harveynone 
2.10.2 Previous studies on the synthesis of harveynone 
The (±), (+) and (−) forms of harveynone have each been the subject of total syntheses, most of 
which use Pd[0]-catalyzed cross-coupling reactions to install the enynyl side-chain.
86,89-92
 
However, the most recently reported synthesis of (−)-harveynone used a very different 
methodology. In particular, a tandem reaction sequence involving relay metathesis-induced 
enyne ring-closing metathesis and a metallotropic [1,3]-shift reaction were employed. A 
discussion of each of the reported syntheses is presented immediately below. 
Taylor’s total syntheses of (±)-harveynone (1996) 
By applying Pd[0]-catalyzed cross-coupling reactions to highly functionalized cyclohexenyl 
halides, Taylor et al. generated racemic samples of harveynone and its C-4 epimer via two 
similar routes (Scheme 2-25 and Scheme 2-26).
89
 In the first of these, β-bromocyclohexenone 
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150, which had been used by the same group in a synthesis of bromoxone (Section 2.2.2), was 
cross-coupled with 2-methyl-1-en-3-yne under Sonogoshira conditions. Diisobutylaluminium 
hydride-mediated reduction of the resulting ketone (151) generated a diastereomeric mixture of 
alcohols 152 and Montmorillonite K10-mediated hydrolysis of the dimethyl ketal moiety in the 
product delivered the expected mixture of chromatographically separable trans- and cis-epoxy 
alcohols (rac-148 and rac-153, respectively), the former representing (±)-harveynone. 
 
Scheme 2-25: Reagents (i) As described by Taylor et al.;79 (ii) 2-methylbut-1-en-3-yne, (i-Pr)2NH, Pd(OAc)2, PPh3; 
(iii) (i-Pr)2AlH; (iv) Montrorillonite K10. 
A more efficient protocol for the preparation of (±)-harveynone was later devised by the same 
authors and is shown in Scheme 2-26. In this instance, the Pd[0]-catalyzed cross-coupling 
reaction of a compound containing the fully elaborated core of (±)-harveynone was used 
(Scheme 2-26).
121
 The same starting material, bromoquinol 149, was protected as the 
corresponding dimethyl bis-ketal 154 and then treated with n-butyllithium and molecular iodine 
in order to effect a trans-halogenation reaction. The less-hindered ketal within the resulting 
iodide was selectively hydrolyzed with aqueous acetic acid and the enone so-formed was 
subjected to a facially-selective nucleophilic epoxidation reaction using hydrogen peroxide and 
sodium hydroxide. In this way, epoxide 155 was obtained. Stereoselective reduction of the 
ketone moiety within compound 155 could be achieved using either diisobutyl aluminium 
hydride or lithium triethylborohydride. The first of these reagents selectively produced the 
trans-alcohol and, in a complimentary fashion, the latter reagent delivered its epimer. The acetal 
moiety within the trans-reduction product was hydrolyzed in presence of Montmorillonite K10 
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to give iodide (±)-105. Finally, Stille cross-coupling of this substrate with tri-n-butyl(3-
methylbut-3-en-1-ynyl)stannane (156) afforded (±)-harveynone in 43% yield over the final two 
steps. 
 
Scheme 2-26: Reagents (i) anodic oxidation, MeOH; (ii) BuLi, I2; (iii) aq. AcOH; (iv) H2O2, NaOH; (v) (i-Pr)2AlH, 
Montmorillonite K10; (vi) PdCl2(PPh3)2, CuI. 
Johnson’s total synthesis of (+)-harveynone (1997) 
The initial steps of the Johnson synthesis of (+)-harveynone (Scheme 2-27) are common to the 
route that this group employed in synthesizing (+)-bromoxone (Section 2.2.2).
80,90
 Thus, the 
sequence proceeds from diester (−)-64, which was obtained via the enzymatic resolution process 
described earlier.
80
 Exposure of this material to titanium(IV) isopropoxide cleaved both esters 
and afforded diol (+)-63. This diol was then mono-protected using tert-butyldimethylsilyl 
triflate and triethylamine to give silyl ether (+)-65 in 45% yield. Hydroxyl group directed syn-
epoxidation of ether (+)-65 gave compound (+)-66 and reduction of the vicinal bromide within 
the latter material using zinc metal gave allylic alcohol 157 which was oxidized to enone 129 
with PCC. α-Iodination of the last compound with molecular iodine and pyridine gave 
compound 158 that was then engaged in a Sonogashira cross-coupling reaction with 2-
methylbut-1-en-3-yne to give dienyne 159. Interestingly, this reaction proceeded more rapidly 
in the presence of diisopropylamine than triethylamine. The coupling product 159 so-formed 
was then deprotected with hexafluorosilicic acid in acetonitrile and thereby giving 
(+)-harveynone in 12 steps and an overall yield of 1.4% from p-benzoquinone (62). 
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Scheme 2-27: Reagents (i) Ti(Oi-Pr)4; (ii) TBSOTf, Et3N; (iii) CF3CO3H, Na2HPO4; (iv) Zn; (v) PCC; (vi) I2, 
pyridine (vii) PdCl2(PPh3)2, CuI, i-Pr2NH, 2-methylbut-1-en-3-yne; (viii) H2SiF6. 
Maycock’s total synthesis of (+)-harveynone (2000) 
Maycock et al. described a synthesis of (+)-harveynone from compound 158, an intermediate in 
this synthesis of (+)-epiepoformin and described earlier in this chapter (Section 2.7.2).
86
 As 
depicted in Scheme 2-28, iodide 158 underwent cross-coupling with tri-n-butyl(3-methylbut-3-
en-1-ynyl)stannane (156) under mild conditions to provide target 159 in 98% yield. 
Deprotection of the cross-coupling product with hydrofluoric acid in acetonitrile then gave 
(+)-harveynone [(+)-148] in 92% yield. 
 
Scheme 2-28: Reagents (i) Pd(PPh3)2Cl2, AsPh3, CuI; (ii) 40% aq. HF. 
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Negishi’s total synthesis of (±)-harveynone (2000) 
Negishi et al. applied their signature Pd[0]-catalyzed cross-coupling reaction to a synthesis of 
(±)-harveynone (Scheme 2-29) and this was published alongside a related synthesis of 
tricholomenyn A.
91
 Thus, p-benzoquinone (62) was treated with molecular bromine and the 
resulting dibromo-diketone was reduced to diol 63 with sodium borohydride.
122
 Selective 
monosilylation of this meso-compound afforded an intermediate alkene that underwent 
stereoselective epoxidation upon treatment with the urea/hydrogen peroxide adduct, to afford 
epoxide 66.
90,123
 A suspension of zinc metal in methanol effected reduction of the vicinal 
dibromide moiety within compound 66 and the allylic alcohol so-produced was oxidized to the 
corresponding ketone with PCC. Iodination at the α-position of the ensuing enone was carried 
out with molecular iodine and pyridine and thereby afforded compound (±)-158.
124
 The key step 
in this reaction sequence, the Negishi cross-coupling reaction between alkenyl iodide (±)-158 
and the relevant alkynyl zinc bromide (160), proceeded in 73% yield. Desilylation of the 
resulting coupling product then afforded the target compound [(±)-148] in 80% yield.
125
 
 
Scheme 2-29: Reagents (i) Br2; (ii) NaBH4; (iii) TBS-Cl, imidazole; (iv) NaH2PO4, urea hydrogen peroxide adduct; 
trifluoroacetic anhydride; (v) zinc; (vi) PCC, Celite; (vii) I2, pyridine; (viii) Pd(dba)2, tris(2-furyl)phosphine; (ix) 48% 
hydrofluoric acid (aqueous). 
Lee’s total synthesis of (−)-harveynone (2009) 
Recently, Lee et al.
92
 published an especially novel approach to (−)-harveynone (Scheme 2-30) 
and some related natural products. The key steps in these syntheses were a tandem reaction 
sequence involving relay metathesis-induced enyne ring-closing metathesis and a metallotropic 
[1,3]-shift. The sequence commenced with mono-O-silylation of commercially-available cis-2-
butene-1,4-diol (161) and subsequent Sharpless asymmetric epoxidation of the intermediate 
ether in a manner described previously.
126-128
 Oxidation of the ensuing alcohol (162) with PCC 
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provided an aldehyde that was treated with an acetylide anion and thus generating a 2:1 and 
chromatographically separable mixture of epimeric alcohols 163 and 164. β-Epimer 163 was 
converted into the pivotal acetate 165 via sequential Lindlar reduction and acylation steps. A 
more efficient synthesis of acetate 165 was achieved by oxidation of the epimeric alcohols 163 
and 164 with the Dess-Martin periodinane. Corey-Bakshi-Shibata (CBS) reduction of the 
resulting ketone proceeded diastereoselectively, though the undesired α-epimer predominated. 
Nevertheless, following Lindlar reduction of these alkynes, and a Mitsunobu reaction, ester 165 
was obtained with the desired stereochemistry as shown in Scheme 2-30. Cleavage of the silicon 
protecting group from compound 165 was effected with HF in pyridine and the corresponding 
aldehyde 166 was generated from the ensuing alcoholic intermediate via oxidation with the 
Dess-Martin reagent. Exposure of compound 166 to a catalytic quantity of tetra-n-
butylammonium difluorotriphenylsilicate induced the non-stereoselective attack of a diynyl 
anion [produced in situ from triethyl(penta-1,3-diynyl)silane] on the aforementioned aldehyde. 
Concomitant transfer of the triethylsilyl group from the diyne to oxygen produced a 1:1 mixture 
of the epimeric O-silyl ethers 167, the substrates required for the key step of the reaction 
sequence. 
Treatment of a compound 167, as a dilute solution in dichloromethane, with Grubbs’ second-
generation catalyst provided the chromatographically separable acetates 168 and 169 containing 
the 1,5-diene-3-yne substructures common to (−)-harveynone and the related alkaloid 
(+)-asperpentyn, respectively. This conversion presumably involves initial insertion of the 
ruthenium species into the vinyl moiety of 167. The tethered allyl ether serves as a relay device 
that delivers ruthenium to the cis-alkene and thereby forms a new alkylidene. This alkylidene 
undergoes a ring-closing metathesis reaction with the nearby alkyne to form a third Ru-
alkylidene species. From this species, a metallotropic [1,3]-shift delivers a fully conjugated 
alkylidene. Finally, departure of the ruthenium complex generates the depicted and epimeric 
mixture of cyclohexenes 168 and 169, each incorporating the desired alkynyl substituent. 
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Scheme 2-30: Reagents (i) BuLi, TBS-Cl; (ii) (+)-diethyl tartrate, Ti(Oi-Pr)4, t-BuOOH, 4 Å molecular sieves; (iii) 
PCC, 4 Å molecular sieves; (iv) BuLi, 3-(prop-2-ynyloxy)prop-1-ene; (v) H2, Pd(CaCO3), Pb(OAc)4, quinoline; (vi) 
Ac2O, pyridine; (vii) DMP; (viii) (R)-Me-CBS BH3SMe2; (ix) H2, Pd(CaCO3), Pb(OAc)4, quinoline; (x) DIAD, PPh3, 
AcOH; (xi) HF, pyridine; (xii) DMP; (xiii) triethyl(penta-1,3-diynyl)silane, Ph3SiF2NBu4; (xiv) Grubbs II. 
(−)-Harveynone was thought to be readily accessible from C1-β-epimer 169. In an effort to 
achieve such a conversion (Scheme 2-31), the silyl group of compound 169 was selectively 
cleaved with hydrofluoric acid in pyridine to reveal allylic alcohol 172 which was then oxidized 
with manganese (IV) oxide. However, deacetylation of the resulting ketone 173 could not be 
effected under a range of conditions due to competing aromatization processes, though the 
structure of such undesired products was not explicitly specified. As such, it appeared necessary 
to install a protecting group that could be removed under milder conditions prior to establishing 
the epoxyquinol scaffold. 
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Scheme 2-31: Reagents (i) HF·pyridine; (ii) MnO2. 
Conveniently for Lee et al., the C1-α-epimer 168 underwent selective cleavage of its appended 
acetate ester upon its exposure to potassium cyanide and the liberated alcohol was then 
immediately reprotected as the corresponding triisopropylsilyl ether, viz. compound 170 
(Scheme 2-32). Hydrofluoric acid in pyridine was then used to effect deprotection of the less 
sterically encumbered triethylsilyl protecting group. A MnO2-mediated oxidation of the 
resulting alcohol then afforded ketone 171. A second desilylation reaction, now using 
hydrofluoric acid in acetonitrile, completed this particularly novel route to (−)-harveynone 
which proceeded in 3% overall yield and 17 steps from diol 161. 
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Scheme 2-32: Reagents (i) KCN; (ii) TIPSOTf, Et3N; (iii) HF·pyridine; (iv) MnO2; (v) HF·pyridine. 
2.11 SYNTHETIC STRATEGY ASSOCIATED WITH THE PRESENT SYNTHESIS 
OF (−)-HARVEYNONE 
2.11.1 Proposed synthetic route to (−)-harveynone 
For all of the aforementioned total syntheses of harveynone,
86,89-91
 except that reported by Lee et 
al.,
92
 Pd[0]-catalyzed cross-coupling reactions have been used to introduce the enynyl side-
chain of the natural product, usually in either the last or second-to-last step of the relevant 
reaction sequence. The most frequently employed halide-coupling partner for these late-stage 
cross-coupling reactions was silyl ether 158. Advantageously, the preparation of ester 103 had 
already been carried out earlier en route to the iodo-congener (105) of (−)-bromoxone. Thus, as 
described in Section 2.3, ester 103 is readily prepared from the plentiful and enantiomerically 
pure cis-dihydrocatechol 90 in just four steps. This ester (103) bears an α-chloroacetyl 
protecting group instead of the more usual TBS group as encountered in the proven precursor, 
158, to (−)-harveynone. 
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Figure 2-17: α-Iodo cyclohexenones (−)-158 and 103. 
It was proposed that iodide 103 would serve as a suitable coupling partner with which to engage 
stannane 156 in a Stille cross-coupling reaction (Scheme 2-33). It was also expected that the α-
chloroacetate ester would be readily cleaved from the target compound in a fashion analogous to 
that applied earlier for the synthesis of (−)-bromoxone and its iodo-congener. The successful 
implementation of such a sequence is described in the following section. 
 
Scheme 2-33: The proposed synthesis of (−)-harveynone. 
2.12 TOTAL SYNTHESIS OF (−)-HARVEYNONE 
2.12.1 The Stille cross-coupling reaction 
In accord with the proposed route described immediately above, iodide 103, appended with the 
α-chloroacetyl protecting group was deployed in the Pd[0]-catalyzed cross-coupling reaction 
depicted in Scheme 2-34. The requisite stannane (156) was prepared from 2-methylbut-1-en-3-
yne according to the procedure of Lopez et al.
89,129
 The Stille cross-coupling reaction of 
compounds 103 and 156 afforded dienynyl ketone 173 in 61% yield and was complete in just 
one hour at 20 °C. Treatment of product 173 with zinc (II) acetate in methanol cleaved the α-
chloroacetyl group and delivered (−)-harveynone (148) in 76% yield. The smooth cleavage of 
the α-chloroacetyl protecting group highlights its usefulness as a more labile alternative to the 
typical acetyl ester. The α-chloroacetyl protecting group, selectively installed using the 
Mitsunobu reaction and later removed under mild conditions, has proven particularly useful for 
the synthesis of a range of epoxyquinol natural products. This feature was articulated in a 2009 
publication that documented this preparation of (−)-harveynone and the preparation of some 
other epoxyquinol and dimeric epoxyquinol-derived natural products.
103
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Scheme 2-34: Reagents and conditions (i) Pd[0], Ph3As, CuI, stannane 156, THF, 20 °C, 1 h; (ii) Zn(OAc)2.2H2O, 
MeOH, 20 °C, 1 h. 
The spectral data recorded on (−)-harveynone (148) displayed all of the expected features and 
are in full accord with the data reported for the natural product. The hydroxyl group of 
compound 148 gives rise to an absorption band at 3235 cm
-1
 in the IR spectrum while mass 
spectrometric analysis of this material revealed a molecular ion at m/z 190 and an accurate mass 
measurement on this species indicated that it possessed the expected molecular formula, viz. 
C11H10O3. Furthermore, the specific rotation of this material {[α]D −204.9 (c 0.89, methanol)} 
was of similar magnitude but of opposite sign to that reported
86
 for its optical antipode, 
(+)-harveynone {[α]D +206.6 (c 0.38, methanol)}. 
The 
13
C NMR spectrum recorded on synthetic (−)-harveynone (148) (Figure 2-18) was in 
complete agreement with that reported for the natural product. The resonance due to the ketonic 
carbon (C1) is clearly visible at δ 191.5, while resonances arising from the acetylenic carbons 
C7 and C8 appear at δ 81.2 and 95.9, respectively. 
 
Figure 2-18: 75 MHz 13C NMR spectrum of (−)-harveynone (recorded in CDCl3). 
A comparison of the 
13
C and 
1
H NMR data obtained on naturally- and synthetically-derived 
samples of harveynone (ent-148 and 148, respectively) is shown in Table 2-5. Differences 
between the two 
13
C NMR spectra are no greater than 0.6 ppm in any instance and the average 
difference is just 0.16 ppm. The 
1
H NMR spectra are in good agreement, except for the 
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chemical shift of the hydroxyl proton. The signal arising from this proton appears at δ 2.19 in 
the spectrum of the naturally-derived material and is shifted to δ 3.00 in the spectrum derived 
from the synthetically-derived material. This may be due to subtle differences in acidity or 
concentrations of the samples. The remaining signals, however, are in close accord; the average 
difference between the relevant signals is just 0.02 ppm. 
Table 2-5: Comparison of the 13C and 1H NMR data recorded on naturally- and synthetically-derived 
harveynone (ent-148 and 148, respectively) 
13C NMR Data 13C NMR Data 1H NMR Data 1H NMR Data 
Natural ent-148 
(δC) 
(68 MHz, CDCl3)
120  
Synthetic 148 
(δC) 
(75 MHz, CDCl3)
103 
Natural ent-148 
(δH) 
(270 MHz, CDCl3)
120  
Synthetic 148 
(δH) 
(300 MHz, CDCl3)
103 
191.0 191.5 6.86 (dd, J = 4.9 and 2.4 Hz, 1H) 6.85 (dd, J = 5.4 and 2.7 Hz, 1H) 
145.6 146.1 5.44 (m, 1H) 5.43 (m, 1H) 
125.9 125.9 5.35 (m, 1H) 5.35 (m, 1H) 
124.1 124.1 4.78 (m, 1H) 4.73 (broad m, 1H) 
122.1 122.7 3.82 (m, 1H) 3.85 (m, 1H) 
95.9 95.9 3.58 (dd, J = 3.4 and 1.0 Hz, 1H) 3.55 (dd, J = 3.6 and 1.2 Hz, 1H) 
81.2 81.2 2.19 (d, J = 8.8 Hz, 1H) 3.00 (broad d, J = 9.3 Hz, 1H) 
63.3 63.2 1.94 (s, 3H) 1.93 (s, 3H) 
57.5 57.6   
53.5 53.5   
23.0 23.0   
As is revealed in Table 2-6, the present work represents the shortest total synthesis of enantio-
enriched harveynone. The overall yield for this synthesis is comparable to that achieved by 
Maycock et al.
86
 As the starting material for the synthesis described here, cis-dihydrocatechol 
100, is derived from abundant iodobenzene, all but five of the carbon atoms that comprise target 
148 are derived from this commodity chemical. 
Table 2-6: A comparison of the key features associated with the six reported syntheses of harveynone 
Lead author Publication date Longest linear sequence Overall yield (%) Modification produced 
Taylor89 1996 six steps 5 (±) 
Johnson90 1997 twelve steps 1 (+) 
Maycock86 2000 ten steps 20 (+) 
Negishi91 2000 eight steps 10 (±) 
Lee92 2009 seventeen steps 3 (−) 
Present work104 2009 six steps 18 (−) 
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2.13 (−)-TRICHOLOMENYN A 
2.13.1 Isolation and characterization of (−)-tricholomenyn A 
In 1995, Garlaschelli et al. described the isolation of two new compounds from the fruiting 
bodies of Tricholoma acerbum, a fungus collected from the Italian Appennines.
130
 The basic 
structures of these compounds (see Figure 2-19), designated tricholomenyn A and B (174 and 
175, respectively), were established using NMR spectroscopic and mass spectrometric 
techniques. Circular dichroism was used to assign the absolute stereochemistry of 
tricholomenyn A, the first natural product in the class to incorporate the geranyl acetylenic side-
chain. 
 
Figure 2-19: (−)-Tricholomenyn A (174) and (−)-Tricholomenyn B (175). 
Various tests indicated that tricholomenyn A and B are potent anti-mitotic agents. Thus, when 
tricholomenyn A was assayed with T lymphocyte cultures, after two hours just 3.1% of cultures 
underwent mitosis compared with 5-6% of Colcemid™-treated cultures.130 
2.13.2 Previous studies on the synthesis of tricholomenyn A 
Due to interest in the biological properties of tricholomenyn A as well as its densely 
functionalized cyclohexene framework, this compound has been the subject of a number of total 
syntheses. Due to its structural similarity to harveynone, the strategies used to synthesize 
tricholomenyn A are reminiscent of those described in Section 2.10.2. Accordingly, 
palladium[0]-catalyzed cross-coupling of a cyclohexenyl halide with an acetylenic partner has 
been used to construct the requisite dienynyl framework. The research groups of Ogasawara, 
Taylor, Johnson and Negishi each used similar palladium[0]-catalyzed cross-coupling reactions 
to effect the key C6-C1′ bond-forming event.90,91,101,102 A recent total synthesis of 
(−)-tricholomenyn A by Lee et al. diverges from these earlier approaches in that relay 
metathesis-induced enyne ring closing metathesis and metallotropic [1,3]-shift reactions are 
used to simultaneously establish the cyclohexene framework and the pendant enynyl residue.
92
 
Each of the reported syntheses of tricholomenyn A is described in detail in the following 
sections. 
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Ogasawara’s total synthesis of (−)-tricholomenyn A (1996) 
Ogasawara et al. employed the chiral acetate 113 in their synthesis of (−)-tricholomenyn A 
(Scheme 2-35). This acetate was obtained from the reduction of commercially-available Diels-
Alder adduct 176 followed by an enzymatic desymmetrization reaction. The free allylic alcohol 
unit within compound 113 so-obtained was protected as the corresponding tert-
butyldimethylsilyl ether and the acetate moiety was then cleaved with potassium carbonate to 
reveal an allylic alcohol. Chromium (VI)-mediated oxidation of this alcohol afforded an 
intermediate α,β-unsaturated ketone that was subjected to nucleophilic epoxidation using 
aqueous hydrogen peroxide and Triton B. Heating the ensuing tricycle (177) in diphenyl ether 
induced a retro-Diels-Alder reaction that revealed the previously masked olefin. The ensuing 
enone was α-iodinated with molecular iodine and pyridine to afford compound 158. In order to 
circumvent known difficulties associated with the conduct of Sonogoshira reactions with α-
halogenated substrates,
101,131
 these researchers opted to reduce the ketone moiety with sodium 
borohydride with the intention of restoring it at a later stage of the synthesis. This reduction 
proceeded smoothly and the subsequent Sonogoshira cross-coupling reaction between iodide 
178 and alkyne 179 proceeded in a nearly quantitative yield to afford dienyne 180. As 
foreshadowed, the ketone moiety was restored by exposing alcohol 180 to the Dess-Martin 
periodinane. Removal of the silicon-based protecting group from the ensuing enone and 
subsequent O-acetylation under standard conditions revealed the natural product (174) in 11 
steps and in an overall yield of 18% from adduct 176. 
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Scheme 2-35: Reagents (i) As described by Takano et al.;115 (ii) TBS-Cl, imidazole; (iii) K2CO3, MeOH; (iv) PDC; 
(v) 30 % aq. H2O2, Triton B; (vi) diphenyl ether, reflux; (vii) iodine, pyridine; (viii) NaBH4, CeCl3.7H2O; (ix) 
PdCl2(PPh3)2, CuI, Et3N; (x) DMP; (xi) 46 % aq. HF; (xii) Ac2O, pyridine. 
Taylor’s total synthesis of (±)-tricholomenyn A (1997) 
Taylor et al. subjected dimethyl ketal 155, the synthesis of which has been described previously 
(see Section 2.10.2),
89
 to a Pd[0]-catalyzed cross-coupling reaction with trimethyl(7-methyl-3-
methyleneoct-6-en-1-ynyl)silane (Scheme 2-36).
89,102
 The highly-conjugated dienynone product 
181 was reduced and the ensuing mixture of epimeric alcohols was acylated to afford compound 
182. Hydrolysis of the associated ketal unit, using Montmorillonite K10 clay, established the 
requisite epoxy ketone moiety and afforded a mixture of epimeric esters, the major one being 
the chromatographically separable tricholomenyn A (ent-174). In this way, the natural product 
was obtained in eight steps and in an overall yield of 7% from compound 149. 
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Scheme 2-36: Reagents (i) As described by Taylor et al.;89 (ii) trimethyl(7-methyl-3-methyleneoct-6-en-1-
ynyl)silane, TBAF-SiO2, Pd(OAc)2, CuI; (iii) DIBAL-H; (iv) Ac2O, pyridine; (v) Montmorillonite K10. 
Johnson’s total synthesis of (−)-tricholomenyn A (1997) 
In 1997, Johnson et al. described the synthesis of (−)-tricholomenyn A alongside closely related 
routes to (+)- and (−)-harveynone.90 By applying an enzymatic resolution step, these researchers 
were able to obtain the compound (−)-158 in enantiomerically pure form and 3.5% yield over 
nine steps.
80,90
 A detailed discussion of the preliminary steps of this sequence have been 
provided in Sections 2.2.2 and 2.10.2. α-Iodo-enone (−)-158 was engaged in a Sonogoshira 
cross-coupling reaction with 7-methyl-3-methyleneoct-6-en-1-yne (Scheme 2-37) and the 
product of this reaction, which was obtained in 54% yield, was desilylated with 
hexafluorosilicic acid. Steglich esterification of the resulting alcohol using acetic acid 
introduced the requisite acetyl moiety and thus providing (−)-tricholomenyn A (174) in 1.4% 
yield over 12 steps from p-benzoquinone (62). 
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Scheme 2-37 Reagents (i) As described by Johnson and Miller;80 (ii) As described by Johnson and Miller;90 (iii) 
PdCl2(PPh3)2, CuI, i-Pr2NH, 179; (iv) H2SiF6; (v) DCC, AcOH. 
Negishi’s total synthesis of (±)-tricholomenyn A (2000) 
The synthesis of (±)-tricholemenyn A reported by Negishi et al. (Scheme 2-38) is closely 
related to the same group’s preparation of (±)-harveynone.91 Thus, alkenyl iodide 158 is a 
common intermediate and was obtained as the racemate in seven steps from quinone. 
Compound 158 was cross-coupled with the relevant alkynyl zinc bromide (184) in the presence 
of a Pd[0] catalyst and tris(2-furyl)phosphine. The silyl ether residue associated with product 
185 was cleaved with hydrofluoric acid and the ensuing alcohol was then acetylated (with N,N'-
dicyclohexylcarbodiimide and acetic acid in the presence of dimethylaminopyridine as catalyst) 
to give (±)-tricholomenyn A in overall yield of 10% and in ten steps from p-benzoquinone (62). 
 
Scheme 2-38: Reagents (i) As described by Negishi et al.;91 (ii) Pd(dba)2, tris(2-furyl)phosphine; (iii) 48% 
hydrofluoric acid (aqueous); (iv) DCC, DMAP, AcOH. 
 The total syntheses of certain monomeric epoxyquinol natural products 77 
Lee’s total synthesis of (−)-tricholomenyn A (2009) 
Lee et al. were successful in generating (−)-tricholomenyn A (Scheme 2-39) from aldehyde 166, 
an intermediate associated with their related synthesis of (−)-harveynone. Once again, it was a 
relay metathesis-induced enyne ring-closing metathesis and a subsequent metallotropic [1,3]-
shift reaction that featured as the pivotal transformations in the preparation of the target natural 
product. In order to prepare the substrate for this key reaction, the previously described 
aldehyde 166 was reacted with diyne 186 in the presence of a catalytic quantity of DeShong’s 
silicate. Upon exposure to the Grubbs’ second-generation catalyst the ensuing silyl ether, 189, 
underwent the anticipated metathesis and [1,3]-shift reactions to afford the requisite carbon 
framework of the target natural product. Subsequent desilylation of the enynyl intermediate and 
oxidation of the alcohol so-formed with MnO2 yielded (−)-tricholomenyn A (174) in 12 steps 
and an overall yield of 10% from diol 161.  
 
Scheme 2-39: Reagents (i) As described by Lee et al.;92 (ii) Ph3SiF2NBu4; (iii) Grubbs II; (iv) HF·pyridine; (v) 
MnO2. 
2.14 SYNTHETIC STRATEGY ASSOCIATED WITH THE PRESENT SYNTHESIS 
OF (−)-TRICHOLOMENYN A 
2.14.1 Proposed route to (−)-tricholomenyn A 
It was anticipated that implementation of a cross-coupling strategy analogous to that described 
earlier for the synthesis of (−)-harveynone would provide a concise and very effective route to 
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(−)-tricholomenyn A. The relevant strategy is outlined in Scheme 2-40. Thus, Mitsunobu 
reaction of iodo-diol 96, itself available in just two steps from cis-dihydrocatechol 90, with 
acetic acid was expected to establish the necessary acetate moiety with the desired 
stereochemistry. Oxidation of the allylic alcohol 188 so-formed would then give the 
corresponding ketone 189. Cross-coupling of this with the relevant alkynyl stannane 190 should 
then furnish the target compound. Given the low reactivity of α-haloenones in cross-coupling 
reactions, reversing these final two steps might provide a more efficient route to 
(−)-tricholomenyn A.101,131 As revealed in the following sections, this proposed route proved 
effective. 
 
Scheme 2-40: Proposed synthetic route to (−)-tricholomenyn A. 
2.15 TOTAL SYNTHESIS OF (−)-TRICHOLOMENYN A 
2.15.1 Preparation of the relevant alkynyl stannane 
The alkynyl stannane 190, required for the foreshadowed Stille cross-coupling reaction, was 
obtained in four steps from commercially available prenyl acetone (192) (Scheme 2-41). Thus, 
the kinetic enolate generated from this ketone was trapped with phenyl triflimide to give the 
previously reported enol triflate 193.
90,101,102
 Sonogashira cross-coupling of compound 193 with 
commercially available trimethylsilyl acetylene afforded the anticipated dienyne 194 as a pale-
yellow oil in 82% yield.
101,102
 Under conditions defined by Buchwald,
132
 specifically the 
application of bis(tri-n-butyltin)oxide and a catalytic amount of tetra-n-butylammonium 
fluoride, silane 194 underwent transmetallation from silicon to tin and thereby giving the 
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required alkynyl stannane.
101,102
 Although the yield for this final step was only 20%, sufficient 
quantities of stannane 190 could be accumulated by such means to allow an investigation of the 
pivotal cross-coupling process. 
 
Scheme 2-41: Reagents and conditions (i) LDA, THF/hexane, -78 °C, 1 h; PhN(OTf)2, −78 °C to 20 °C, 20 h; (ii) 
PdCl2(NCMe)2, CuI, trimethylsilyl acetylene, morpholine/THF, 20 °C, 2 h; (iii) (n-Bu3Sn)2O, Bu4NF, THF, 66 °C, 
1 h. 
The 
13
C NMR spectrum recorded on stannane 190 (Figure 2-20) exhibits six low-field signals 
that correspond to the four olefinic and two acetylenic carbon atoms present in the compound. 
The IR spectrum of this compound exhibits a sharp absorption band at 2124 cm
−1
 that is 
attributed to C≡C bond stretching and is intensified by the conjugation of this moiety with the 
nearby olefin. In the same spectrum, prominent absorption bands arising from sp
3 C−H 
stretching and deformation are observed at 2958 and 1455 cm
−1
, respectively. 
 
Figure 2-20: 75 MHz 13C NMR spectrum of alkynyl stannane 190 (recorded in CDCl3).  
Insets: Expansions of two regions of the spectrum. 
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2.15.2 Preparation of acetate cross-coupling partners 
In accord with the planned synthesis of (−)-tricholomenyn A (Scheme 2-42), iodo-diol 96 was 
submitted to a Mitsunobu reaction with acetic acid. As described in Section 2.3.4, these 
substrates undergo this type of reaction regioselectively. Specifically, the less sterically 
encumbered hydroxyl group reacts preferentially under these conditions to form a single mono-
acetate in a yield of 62%. No traces of alternate isomers or diacetate by-products were detected 
following concentration of the reaction mixture. The allylic alcohol 188 obtained from the 
Mitsunobu reaction was oxidized with pyridinium dichromate and the α-iodo enone 189 was 
thereby obtained in 76% yield. 
 
Scheme 2-42: Reagents and conditions (i) (t-BuOCON)2, PPh3, AcOH, THF, 20 °C, 0.25 h; (ii) PDC, AcOH, DCM, 
20 °C, 1h. 
The 
1
H NMR (see Figure 2-21) and 
13
C NMR spectra recorded on alcohol 188 each exhibited a 
close resemblance to the analogous spectra described earlier for the α-chloroacetyl analogue 
100. Thus, the olefinic proton gives rise to a resonance at δ 6.40 which exhibited a multiplicity 
indicative of its interaction with the three other protons attached to the cyclohexene ring. 
Protons of the appended acetate residue resonated as a three-proton singlet at δ 2.08. The ester 
moiety was evident through the appearance of strong absorption bands at 1727 and 1236 cm
-1
. 
The hydroxyl residue also produced a strong absorption band at 3468 cm
-1
. The EI mass 
spectrum of alcohol 188 displayed a molecular ion at m/z 296 and an accurate mass 
measurement of this species established that it possessed the expected molecular formula, viz. 
C8H9IO4. 
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Figure 2-21: 300 MHz 1H NMR spectrum of alcohol 188 (recorded in CDCl3).  
Insets: Expansions of three regions of the spectrum. 
The spectral data recorded on ketone 189 bore a strong resemblance to those recorded on 
congener 103. 
1
H NMR spectroscopy indicated that the olefinic proton had become substantially 
deshielded following the oxidation reaction with the relevant signal appearing as a doublet of 
doublets at δ 7.36 (Figure 2-22). Furthermore, in the 13C NMR spectrum, the resonance derived 
from the ketone carbon appears at δ 187.2. No hydroxyl stretching band, so prominent in the 
precursor, is observed in the IR spectrum of compound 189. In addition, a new and sharp 
absorption band at 1695 cm
-1
, due to ketonic C=O stretching, flanks the ester C=O absorption 
band at 1743 cm
-1
. The absorption from olefinic C=C bond stretching was enhanced due to its 
conjugation with the ketone moiety and appears at 1605 cm
-1
. The CI mass spectrum of ketone 
189 revealed a molecular ion at m/z 294 and an accurate mass measurement of this species 
indicated that it possessed the anticipated molecular formula, viz. C8H7IO4. 
 
Figure 2-22: 300 MHz 1H NMR spectrum of ketone 189 (recorded in CDCl3). 
Insets: Expansions of three regions of the spectrum. 
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2.15.3 The Stille cross-coupling reactions 
Both iodides 188 and 189 underwent Stille cross-coupling with alkynyl stannane 190 (Scheme 
2-43). However, the yield from the first reaction (involving substrate 188) (29%) was 
substantially lower than the analogous reaction with its oxidized counterpart, iodide 189 (72%). 
It is possible that the free hydroxyl group adjacent to the reactive iodide may interfere with the 
reaction. In the latter case, the reaction produced (−)-tricholomenyn A, in good yield, and 
completed the shortest preparation of this natural product reported to date. 
The spectral data recorded on alcohol 191 were in complete accord with the depicted structure. 
Despite being obtained in only a modest yield from the Stille cross-coupling reaction, this 
compound was subsequently oxidized to (−)-tricholomenyn A using pyridinium dichromate and 
a small amount of acetic acid. Samples of this compound were identical to those prepared via 
the alternate pathway that is also shown in Scheme 2-43. 
 
Scheme 2-43: Reagents and conditions (i) compound 190, Pd[0], Ph3As, CuI, Et2O, 20 °C, 1 h; (ii) PDC, AcOH, 
DCM, 20 °C, 1 h. 
The spectral data acquired from synthetic samples of (−)-tricholomenyn A produced from the 
cross-coupling of ketone 189 with stannane 190, and via the oxidation of alcohol 191, were 
identical and in complete agreement with those described in the literature for the natural 
product.
130
 The enonic β-proton of synthetic 174 appeared in the associated 1H NMR spectrum 
(see Figure 2-23) as a doublet of doublets at δ 6.75. The 13C NMR spectrum exhibited the 
anticipated 18 signals with the carbonyl carbon resonances appearing at δ 189.5 and 169.6, 
respectively.  
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Figure 2-23: 300 MHz 1H NMR spectrum of (−)-tricholomenyn A (recorded in CDCl3).  
Insets: Expansions of two regions of the spectrum. 
A comparison of the NMR data recorded on naturally- and synthetically-derived tricholomenyn 
A shows high levels of consistency (Table 2-7). For instance, the maximum difference between 
analagous 
13
C NMR signals is 0.2 ppm and the average difference is just 0.1 ppm. Likewise, 
1
H 
NMR shift frequencies vary by no more than 0.05 ppm in any instance and the average 
difference is 0.02 ppm. As well, coupling constants, where directly comparable, differ by less 
than 0.5 Hz. 
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Table 2-7: Comparison of the 13C and 1H NMR data recorded on naturally- and synthetically-derived tricholomenyn 
A (174) 
13C NMR Data 13C NMR Data 1H NMR Data 1H NMR Data 
Natural 174 
(δC) 
(75 MHz, 
CDCl3)
130 
Synthetic 174 
(δC) 
(75 MHz, 
CDCl3)
104 
Natural 174 
(δH) 
(300 MHz, CDCl3)
130 
Synthetic 174 
(δH) 
(300 MHz, CDCl3)
104 
189.3 189.5 6.80 (dd, J = 5.0 and 2.5 Hz, 1H) 6.75 (ddd, J = 5.4 and 2.4 Hz, 1H) 
169.5 169.6 5.83 (dt, J = 5.0 and 1.2 Hz, 1H) 5.81 (dt, J = 5.4 and 1.2 Hz, 1H) 
140.2 140.3 5.45 (d, J = 2.0 Hz, 1H) 5.44 (m, 1H) 
132.3 132.4 5.35 (d, J = 2.0 Hz, 1H) 5.35 (broad s, 1H) 
130.4 130.5 5.10 (m, 1H) 5.08 (m, 1H) 
124.9 125.0 3.77 (ddd, J = 4.0, 2.5 and 1.2 Hz, 1H) 3.74 (m, 1H) 
123.4 123.5 3.60 (dd, J = 4.0 and 1.2 Hz, 1H) 3.59 (dd, J = 3.6 and 1.2 Hz, 1H) 
122.9 123.0 2.25 (m, 4H) 2.20 (broad s, 4H) 
95.8 95.9 2.14 (s, 3H) 2.14 (s, 3H) 
81.8 81.9 1.68 (d, J = 0.8 Hz, 3H) 1.68 (s, 3H) 
64.0 64.1 1.63 (d, J = 1.0 Hz, 3H) 1.62 (s, 3H) 
54.6 54.7   
52.8 52.9   
36.8 36.9   
26.5 26.6   
25.6 25.7   
20.5 20.6   
17.6 17.7   
In the IR spectrum of (−)-tricholomenyn A, a weak absorption band observed at 2205 cm−1 is 
indicative of C≡C stretching. The ester moiety gives rise to a C=O absorption band at 1758 cm−1 
and a C−O stretching band at 1220 cm−1. The EI mass spectrum displayed a molecular ion at 
m/z 300 and an accurate mass measurement on this species established that it was of the 
expected composition, viz. C18H20O4.  
The total synthesis of (−)-tricholomenyn A (174) described here represents the most concise 
route so far reported. Furthermore, this synthesis matches that of Kamikubo et al. in terms of 
overall yield.
101
 A comparison of the key features associated with the six reported syntheses of 
tricholomenyn A is shown in Table 2-8. 
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Table 2-8: A comparison of the key features associated with the six reported syntheses of tricholomenyn A 
Lead author 
Publication 
date 
Key bond-forming 
event 
Longest linear 
sequence 
Overall yield 
(%) 
Modification 
produced 
Ogasawara85 1996 C6−C1′ (Stille) twelve steps 18 (−) 
Taylor102 1997 C6−C1′ (Sonogashira) eight steps 7 (±) 
Johnson90 1997 C6−C1′ (Sonogashira) twelve steps 1 (−) 
Negishi133 2000 C6−C1′ (Negishi) ten steps 10 (±) 
Lee92 2009 C5−C6 (see text) twelve steps 10 (−) 
Present work104 2009 C6−C1′ (Stille) five steps 18 (−) 
The highly abbreviated nature of this synthesis lends itself to the synthesis of related of related 
acetylenic epoxyquinol natural products such as tricholomenyn B (Figure 2-24). Investigations 
directed towards such ends are now underway in these laboratories. 
 
Figure 2-24: Tricholomenyn B 
2.16 CONCLUSIONS AND FUTURE WORK 
The work described here has culminated in the development of chemoemzymatic techniques 
that allow for the rapid synthesis, at relatively large scale, of many members of the epoxyquinol 
class of natural product. The key feature of this new route is a three-step and highly selective 
reaction sequence for the conversion of enantiomerically pure and enzymatically-derived cis-
1,2-dihydrocatechols into “epoxyquinol building blocks” 101-103. These highly versatile 
building blocks can be elaborated to some half-dozen epoxyquinol-based natural products. 
Since the enantiomeric forms of certain of the starting cis-1,2-dihydrocatechols are readily 
available, the optical antipodes of the naturally-occurring epoxyquinols should also be 
accessible by the methods described here. As such, the development of comprehensive 
structure-activity relationship (SAR) profiles for this fascinating class of natural products has 
become a little easier. 
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3. THE TOTAL SYNTHESES OF DIMERIC EPOXYQUINOL-DERIVED 
NATURAL PRODUCTS 
3.1 (+)-PANEPOPHENANTHRIN 
3.1.1 Isolation and characterization of (+)-panepophenanthrin 
The dimeric epoxyquinol-derived natural product (+)-panepophenanthrin (Figure 3-1) was 
isolated by Sekizawa et al. during the course of screening the cultured broths of various 
mushrooms, including Panus rudis, for inhibition of an ubiquitin-activating enzyme E1.
134
 
(+)-Panepophenanthrin (192) is the first reported inhibitor of E1 derived from a natural source. 
The structure of the title compound was initially established through NMR studies and then 
confirmed by a single-crystal X-ray analysis. Moses and Baldwin proposed that the biosynthesis 
of (+)-panepophenanthrin may involve the Diels-Alder dimerization of two identical epoxquinol 
monomers, both of which are, in turn, derived from 4-hydroxybenzoate and demethylallyl 
pyrophosphate.
96
 
 
Figure 3-1: (+)-panepophenanthrin 
3.1.2 Previous studies on the synthesis of panepophenanthrin 
Panepophenanthrin has been the subject of six previous total syntheses.
95-100
 All of these involve 
the preparation of the same epoxyquinol monomer proposed as the biogenetic precursor to the 
target and which quite clearly engages in the anticipated dimerization process to afford the 
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polycyclic framework of the natural product. The first synthesis of (+)-panepophenanthrin was 
reported by Porco et al. in 2003 and employed a tartrate-mediated asymmetric epoxidation 
reaction as a key step.
95
 This synthesis was followed, in the same year, by another reported by 
Baldwin et al. which used (±)-bromoxone as a key intermediate in the synthesis of the racemic 
form of the target.
96
 In 2006, the same researchers incorporated an enzymatic resolution step 
that provided access to (−)-bromoxone and thereby allowing for the preparation of 
(+)-panepophenanthrin.
99
 Mehta et al. generated (+)-panepophenanthrin via the enzymatic 
desymmetrization of a diol.
97
 Shortly thereafter, this research group produced 
(−)-panepophenanthrin through a procedure that built upon their earlier synthesis of the natural 
enantiomer.
98
 In 2006, Hayashi described the highly enantioselective α-aminoxylation of a 
simple ketone and the conversion of the product of this process into (+)-panepophenanthrin.
100
 
Each of these syntheses is discussed in detail in the following sections. 
Porco’s total synthesis of (+)-panepophenanthrin (2003) 
The Porco total synthesis of (+)-panepophenanthrin (192) (Scheme 3-1) commenced with the 
(diacetoxyiodo)benzene-mediated oxidation of hydroquinone mono-methyl ether 193.
95,135
 The 
ensuing quinone mono-acetal 57 was converted into the corresponding 1,3-dioxane 194, as the 
new protecting group incorporated by this means was found to be more stable under conditions 
employed during the ensuing nucleophilic epoxidation reaction. Thus, (−)-diisopropyl tartrate-
mediated epoxidation of compound 194 was found to take place selectively with the less-
substituted double bond, delivering the depicted enantiomer of keto-epoxide 195 in 95% ee and 
80% yield. Lithium triethylborohydride effected reduction of the ketone moiety within 
compound 195 to deliver the corresponding syn-epoxy alcohol. Displacement of the newly 
introduced hydroxyl moiety in a Mitsunobu reaction and subsequent methanolytic cleavage of 
the intermediate acetate then furnished the desired compound 196. This trans-epoxy alcohol 
was protected as the corresponding tert-butyldimethylsilyl ether, 197, which engaged in a Heck 
cross-coupling reaction with 2-methyl-3-buten-2-ol to afford diene 198. Exposure of the latter 
material to aqueous hydrofluoric acid effected both removal of the silyl protecting group and 
hydrolysis of the ketal. However, a stepwise process involving desilylation of compound 198 
with tetra-n-butylammonium fluoride and cleavage of the acetal with aqueous hydrochloric acid 
was found to deliver a higher yield of pivotal diene 199. Upon storage in the neat state, 
compound 199 engaged in an inverse electron demand Diels-Alder dimerization reaction and a 
subsequent lactol-forming process to afford (+)-panepophenanthrin (192) in an overall yield of 
22% and 10 steps from phenol 193. 
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Scheme 3-1: Reagents (i) PhI(OAc)2, MeOH; (ii) 1,3-propanediol, BF3.OEt2; (iii) Ph3COOH, NaHMDS, 
(−)-diisopropyl tartrate, 4 Å molecular sieves; (iv) LiEt3BH; (v) PPh3, DIAD, p-nitrobenzoic acid; NaOMe, MeOH; 
(vi) TBSCl, imidazole; (vii) Pd(OAc)2, Ag2CO3, 2-methyl-3-buten-2-ol; (viii) TBAF; (ix) H2O, HCl; (x) neat. 
Porco et al. considered that in course of the abovementioned synthesis of 
(+)-panepophenanthrin that an acid-catalyzed ionization of the tertiary alcohol residue of 
compound 199 might take place and that intermolecular attack of the ensuing carbocation by the 
lone pair of electrons of a second molecule of ketone 199 would induce the formation of a 
tethered intermediate, and that the generation of this intermediate may then facilitate a selective 
and high-yielding Diels-Alder reaction. It was shown, however, that model substrates such as 
compounds 202 and 203, which cannot participate in such an ionization process, still undergo 
the Diels-Alder and lactol forming steps to afford the dimeric systems 204 and 205, respectively 
(Scheme 3-2). These results clearly indicate that formation of an ionic intermediate prior to the 
cycloaddition reaction is not necessary or even likely to be involved in the formation of 
compound 192. 
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Scheme 3-2: Reagents (i) Pd(OAc)2, AgCO3, 3,3-dimethylbutene; (ii) TBAF; (iii) AcOH, 1,3-
diisopropylcarbodiimide, DMAP; (iv) aqueous HCl; (v) neat. 
Baldwin’s total synthesis of (±)-panepophenanthrin (2003) 
In the Baldwin synthesis of (±)-panepophenanthrin, racemic bromoxone [(±)-55], prepared in 
five steps according to a previously described sequence,
81
 served as the starting material in a 
short total synthesis of the target (Scheme 3-3).
95
 These researchers found that it was necessary 
to protect the free hydroxyl group of bromoxone [(±)-55] in order to be able to carry out the 
necessary Stille cross-coupling reaction of the alkenyl bromide residue with the requisite 
alkenyl stannane. Thus, a mixture of triethylsilyl chloride and 2,6-lutidine containing a little 4-
(N,N-dimethylamino)pyridine was used to effect the desired protection of compound (±)-55. 
The product from this process, ether (±)-206, was then subjected to the depicted Pd[0]-catalyzed 
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cross-coupling reaction with the indicated alkenyl stannane. From this reaction a mixture of the 
anticipated product, diene (±)-207, and some material arising from Diels-Alder dimerization 
reaction was isolated. However, due to the propensity for the monomer to readily undergo the 
Diels-Alder dimerization reaction, full characterization was only carried out on the dimer. In 
this way, the bis-triethylsilyl protected analogue, (±)-208, of (±)-panepophenanthrin was 
obtained in 75% yield from the O-triethylsilyl protected (±)-bromoxone [(±)-207]. Deprotection 
of the dimeric material with methanolic ammonium fluoride delivered the target compound 
(±)-192 in an overall yield of 11% and in eight steps from p-benzoquinone (62). 
 
Scheme 3-3: Reagents (i) As described by Altenbach et al.;81 (ii) TESCl, 2,6-lutidine, DMAP; (iii) Pd2(dba)3, AsPh3, 
(E)-2-methyl-4-(tributylstannyl)but-3-en-2-ol; (iv) NH4F. 
In later work (2006) directed toward the total synthesis of (+)-panepophenanthrin, Baldwin et 
al. used an enzymatic resolution step to obtain (−)-bromoxone and thereby producing the target 
compound in its naturally occurring enantiomeric form (See Scheme 3-4).
99
 Thus, porcine 
pancreas lipase (PPL) was used to selectively cleave the acetate residues from one enantiomer, 
(−)-64, of a racemic mixture of dibromides. The preparation of compound (±)-64 from p-
benzoquinone (62) and its elaboration into bromoxone [(−)-55] were discussed in detail in 
Section 2.2.2 within the context of the syntheses of bromoxone reported by Johnson and 
Altenbach, respectively.
80,81
 Protection of the hydroxyl moiety within bromoxone [(−)-55] by its 
reaction with triethylsilyl chloride in the presence of 2,6-lutidine afforded silyl ether (−)-206. 
The application of a reaction sequence parallel to that applied earlier (see above) for the 
synthesis of (±)-panepophenanthrin, afforded the natural product and with a slightly improved 
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efficiency over the final two steps. In this way, (+)-panepophenanthrin was obtained in ten steps 
and with an overall yield of 4% from p-benzoquinone 62. 
 
Scheme 3-4: Reagents (i) Br2; (ii) NaBH4; (iii) Ac2O, Et3N, DMAP; (iv) PPL, pH 7.0 phosphate buffer; (v) LiOH; 
(vi) m-CPBA; (vii) DMP; NaHCO3, Na2S2O3; (viii) TESCl, 2,6-lutidine; (ix) Pd2(dba)3, AsPh3, (E)-2-methyl-4-
(tributylstannyl)but-3-en-2-ol.; (x) NH4F. 
Mehta’s total synthesis of (+)-panepophenanthrin (2004) 
The Diels-Alder adduct, 176, of p-benzoquinone and cyclopentadiene served as the starting 
material for the total synthesis of (+)-panepophenanthrin reported by Mehta et al. in 2004 
(Scheme 3-5).
98
 Thus, Luche reduction of both ketone carbonyl units within adduct 176 
delivered an endo, endo-configured meso-diol intermediate. Regioselective monoacylation of 
the ensuing diol, mediated by lipasePS (Amano) and using vinyl acetate as the acyl donor, 
facilitated the desymmetrization of this intermediate and thereby affording ester 113. The 
remaining alcohol residue within compound 113 was O-silylated using tert-butyldimethylsilyl 
chloride and subsequent ester group cleavage with basic methanol exposed the other alcohol 
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that was oxidized with pyridinium dichromate to afford enone 118. The newly formed α,β-
unsaturated ketone moiety was subjected to nucleophilic epoxidation such that oxygen was 
delivered to the exo-face of the molecule. A catalytic amount of DBU was used to effect an 
aldol reaction of ketone 209 with formaldehyde and thereby allowing installation of a 
hydroxymethyl group alpha to the ketone. Compound 210 thus obtained was subjected to a 
retro-Diels-Alder reaction at 240 °C in diphenyl ether. Diisobutylaluminium hydride-mediated 
reduction of the ensuing enone 211 proceeded diastereoselectively, presumably due to chelation 
effects, and delivered a trans-epoxy alcohol intermediate in a completely diastereoselective 
manner. The primary alcohol moiety within this intermediate was selectively oxidized with 
TEMPO, CuCl and oxygen in DMF to the formyl compound 212. This species was, in turn, 
homologated using Wittig methodology to deliver the α,β-unsaturated ester 213. Treatment of 
ester 213 with an excess of methyl lithium led to the formation of tertiary allylic alcohol 214. 
Manganese (IV) oxide was used to oxidize the secondary alcohol moiety within compound 214 
to the corresponding ketone 215. This was followed by a desilylation reaction using the 
HF/pyridine complex in THF and thus delivering the pivotal monomeric precursor, 199, to 
target 192. Incubation of the monomer, in neat form, at 20 °C for 24 h then gave 
(+)-panepophenanthrin which was obtained in 15 steps and 6% overall yield from starting 
material 176. 
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Scheme 3-5: Reagents (i) NaBH4, CeCl3; (ii) lipasePS (Amano), vinyl acetate; (iii) TBSCl, imidazole, DMAP; (iv) 
K2CO3, MeOH; (v) PDC; (vi) H2O2, Na2CO3; (vii) DBU, 35% aqueous formalin; (viii) Ph2O, 240 °C; (ix) diisobutyl 
aluminium hydride; (x) O2, TEMPO, CuCl; (xi) Ph3P=CHCO2Me; (xii) MeLi; (xiii) MnO2; (xiv) HF·pyridine; (xv) 
neat. 
 The total syntheses of dimeric epoxyquinol-derived natural products 95 
Mehta’s total synthesis of (−)-panepophenanthrin (2004) 
In 2004, Mehta et al. synthesized the non-natural or (−)-enantiomeric form, (−)-192, of 
panepophenanthrin (Scheme 3-6). A description of this procedure was published alongside a 
collection of related syntheses that afforded a number of epoxyquinol and dimeric epoxyquinol-
type natural products.
97
 Each of these routes proceeded from the Diels-Alder adduct, 176, of 
cyclopentadiene and p-benzoquinone and involved a late-stage enzymatic resolution step to 
obtain the desired enantiomeric form of the relevant intermediate. For the synthesis of 
(−)-panepophenanthrin, nucleophilic epoxidation of alkene 176 was the first step and this 
proceeded in a stereoselective manner. A catalytic amount of DBU was used to effect an aldol 
reaction of the ensuing intermediate ketone with formaldehyde and thus allowing installation of 
a hydroxymethyl group alpha to the ketone thereby delivering the racemic modification of 
alcohol 217. This alcohol was protected as the corresponding tert-butyldimethylsilyl ether, and 
sodium borohydride was used to effect reduction of the less sterically hindered ketone and 
thereby furnishing the endo-alcohol (±)-218. Enantioselective acetylation of compound (±)-218, 
mediated by lipasePS (Amano) and using vinyl acetate as the acyl donor, faciliated resolution of 
this racemic mixture. In this way, alcohol (−)-218 (45% yield, ~99% ee) and ester (+)-219 (46% 
yield, ~99% ee) were obtained and the latter could be carried forward to (−)-panepophenanthrin 
as described immediately below. 
 
Scheme 3-6: Reagents (i) 30% aqueous H2O2, Na2CO3; (ii) DBU, 40% aqueous formalin; (iii) TBSCl, imidazole, 
DMAP; (iv) NaBH4; (v) Lipase PS-D (Amano), vinyl acetate. 
The final reactions employed in Mehta’s syntheses of (−)-panepophenanthrin are shown in 
Scheme 3-7. Thus, a thermally-promoted retro-Diels-Alder reaction allowed for the conversion 
of compound (+)-219 into enone (+)-220. The silyl protecting group within the latter was then 
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cleaved with the HF/pyridine complex to afford an intermediate ketone that underwent 
chelation-controlled reduction with diisobutyl aluminium hydride to form diol (+)-221. The 
primary alcohol moiety within product (+)-221 was selectively oxidized with TEMPO, CuCl 
and oxygen in DMF to provide the corresponding α,β-unsaturated aldehyde which was reacted 
with the relevant stabilized ylide to yield the pivotal dienyl ester (+)-222. The acetyl protecting 
group within this ester was exchanged for a tert-butyldimethylsilyl ether via hydrolysis with 
lithium hydroxide, in the first instance, and then silylation of the liberated alcohol with the 
appropriate silyl triflate, in the presence of imidazole and a catalytic quantity of 4-(N,N-
dimethylamino)pyridine. The remaining free alcohol within product (+)-224 was oxidized to the 
corresponding ketone using manganese (IV) oxide. The silyl protecting group of the ensuing 
product was removed with HF-pyridine and thereby afforded the epoxyquinol (+)-199. Diels-
Alder dimerization of compound (+)-199 and subsequent lactol formation then took place in a 
spontaneous fashion and thereby delivering (−)-panepophenanthrin in an overall yield of 3% 
and in sixteen steps from adduct 176. This total synthesis is the only one thus far that has 
provided the unnatural enantiomer of panepophenanthrin. 
 The total syntheses of dimeric epoxyquinol-derived natural products 97 
 
Scheme 3-7: Reagents (i) Ph2O, 240 °C; (ii) HF·pyridine; (iii) diisobutylaluminium hydride; (iv) TEMPO, O2, CuCl; 
(v) Ph3P=ChCO2Me; (vi) LiOH, MeOH; (vii) TBSOTf, imidazole, DMAP; (viii) MeLi; (ix) MnO2; (x) HF·pyridine; 
(xi) neat. 
Hayashi’s total synthesis of (+)-panepophenanthrin (2006) 
In 2006, Hayashi et al.
100
 reported a total synthesis of (+)-panepophenanthrin wherein the 
asymmetric α-aminoxylation of 1,4-cyclohexanedione monoethylene ketal (225) represented the 
key and initial step (Scheme 3-8). Thus, 10 mol% (+)-proline was used to catalyze the reaction 
of nitrosobenzene with substrate 225 and thereby giving compound 226 in greater than 99% 
enantiomeric excess and in 93% chemical yield. K-selectride-mediated reduction of product 226 
was followed by palladium[0]-catalyzed hydrogenolysis of the N-O bond and thereby forming 
the cis-vicinal diol 227. Treatment of the latter compound with water, in the presence of acid-
activated Amberlyst 15 resin, resulted in hydrolysis of the ketal. Dehydration of the resulting β-
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hydroxy-ketone then afforded γ-hydroxy-enone 228. The hydroxyl group within product 228 
was protected as the corresponding tert-butyldimethylsilyl ether using tert-butyldimethylsilyl 
chloride and imidazole in DMF. The ensuing enone was subjected to nucleophilic epoxidation 
using hydrogen peroxide and Triton B and thus affording epoxide (−)-77. An enone moiety was 
then installed using the Tsuji-modified Saegusa oxidation procedure and α-iodination of the 
ensuing enone (−)-129 was then effected with molecular iodine in the presence of pyridine. 
Stille cross-coupling of the ensuing iodide (−)-158 with the requisite alkenyl stannane and 
deprotection of the resulting silyl ether delivered diol 199, the by now well-established 
precursor to (+)-panepophenanthrin. Neat storage of this monomer for 33 h resulted in the 
anticipated Diels-Alder dimerization reaction and subsequent lactol formation. In this way 
(+)-panepophenanthrin was obtained in 18% overall yield and in 12 steps from ketone 225. 
As part of their work in this area, Hayashi et al. also performed a kinetic study of the Diels-
Alder dimerization of compound 199 in a variety of solvents and neat.
100
 Unsurprisingly, it was 
observed that the reaction proceeded most rapidly in the absence of solvent. Furthermore, heavy 
water was shown to promote a more rapid reaction than either methanol or tetrahydrofuran, 
supporting the notion that this reaction is biomimetic. In the latter solvents, the reaction ceased 
at less than 20% conversion after several hours. 
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Scheme 3-8: Reagents (i) Nitrosobenzene, (+)-proline; (ii) K-selectride; (iii) Pd/C, H2; (iv) H2O, amberlyst 15; (v) 
TBSCl, imidazole; (vi) H2O2, triton B; (vii) LHMDS, TMSCl; (viii) diallylcarbonate, [Pd2(dba)3]·CHCl3; (ix) I2, 
pyridine; (x) [Pd2(dba)3]·CHCl3, AsPh3, (E)-2-methyl-4-(tributylstannyl)but-3-en-2-ol; (xi) NH4F; (xii) neat. 
3.2 SYNTHETIC STRATEGY ASSOCIATED WITH THE PRESENT SYNTHESIS 
OF (+)-PANEPOPHENANTHRIN 
3.2.1 Proposed synthetic route to (+)-panepophenanthrin 
In the present work, a sequence of reactions involving Stille cross-coupling of stannane 229 and 
iodide 100, followed by oxidation of the allylic alcohol moiety within the product, was expected 
to deliver enone 230. Removal of the α-chloroacetyl protecting group from product 230 would 
then provide epoxyquinol monomer 199. At this point, the total synthesis of 
(+)-panepophenanthrin would be secure as the transformation of compound 199 into the target 
is well established. This approach has the advantage that intermediate 100 can be readily 
obtained in just three steps and in enantiomerically pure form from the abundant cis-
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dihydrocatechol, 90 as described in Section 2.3. The successful application of this synthetic 
route to (+)-panepophenanthrin is described in the following section. 
 
Scheme 3-9: The planned synthesis of (+)-panepophenanthrin 
3.3 TOTAL SYNTHESIS OF (+)-PANEPOPHENANTHRIN 
Though iodide 100 is available in just three steps and in enantiomerically pure form from the 
abundant cis-dihydrocatechol 90, it was necessary to prepare stannane 229 in order to carry out 
the proposed Stille cross-coupling reaction. Efforts to do so are described immediately below 
and followed by a discussion of the Stille cross-coupling and subsequent reactions en route to 
(+)-panepophenanthrin. 
3.3.1 Preparation of the trans-alkenyl stannane 
Target stannane 229 was readily obtained, as a clear, colorless oil, after chromatography and in 
94% yield, via Pd[0]-catalyzed hydrostannylation of the commercially available propargyl 
alcohol 232 with tri-n-butyl hydride (Scheme 3-10).
136
 According to literature descriptions of 
this process, the tin radical formed in situ adds to the unsubstituted terminus of alkyne 232 and 
thereby providing the more substituted vinyl radical. In the second step of the process, addition 
of a hydrogen atom then takes place on the less substituted side of this radical thus producing 
the addition product and a tri-n-butyl tin radical and thereby allowing the radical chain reaction 
to continue. While the kinetic product of this process is the Z-isomer, clean isomerization of this 
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compound, via a radical pathway, affords the more thermodynamically stable E-isomer 229 as 
the only isolable product of the reaction. 
 
Scheme 3-10: Reagents and conditions (i) n-Bu3SnH, Pd[0], THF, 20 °C, 1 h. 
The 
13
C NMR spectrum recorded on stannane 229 is shown in Figure 3-2 and, in accord with 
the depicted structure, eight distinct carbon signals are observed. The signals due to the sp
2
-
hybridized carbons are observed at δ 155.5 and 122.3 as compared with shifts of δ 89.0 and 70.2 
for the analogous carbons in the alkynic precursor. As expected for a stannane such as 229, the 
13
C NMR spectrum exhibits certain carbon to tin couplings. From the butyl residues, those 
13
C 
nuclei one to three bonds removed from 
117
Sn or 
119
Sn display through-bond coupling, with 
magnitudes ranging from 682.8 Hz (for one bond coupling) to 40.8 Hz (for three bond 
coupling). In addition, the sp
2
-hybridized 
13
C nuclei adjacent to 
117
Sn or 
119
Sn exhibit coupling 
constants of 752.6 and 719.4 Hz, respectively. The IR spectrum recorded on this sample shows 
the anticipated hydroxyl-stretching band at 3364 cm
−1
. The ESI mass spectrum displays an 
[M+H]
+
 ion at m/z 375 and accurate mass measurement of this species established that it was of 
the expected composition, viz. C17H36O
120
Sn. 
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Figure 3-2: 300 MHz 13C NMR spectrum of alkenyl stannane 229 (recorded in CDCl3).  
Insets: Expansions of three regions of the spectrum showing couplings between 13C and 117/119Sn nuclei. 
3.3.2 The Stille cross-coupling reaction 
Stille cross coupling of compound 229 with iodide 100 (Scheme 3-11) proceeded under the 
same conditions as those employed earlier for the synthesis of (−)-harveynone (Section 2.15.3). 
The product diol, 231, was thereby obtained in 47% yield. 
 
Scheme 3-11: Reagents and conditions (i) Pd[0], Ph3As, CuI, acetone, 50 °C, µwave, 1 h. 
The 300 MHz 
1
H NMR spectrum of compound 231 (Figure 3-3) displays a pair of mutually 
coupled doublets arising from the olefinic protons of the pendant sidechain, and these have a 
coupling constant of 16.2 Hz. This indicates that the trans-geometry of the coupling partner 229 
has been maintained in the course of the cross-coupling process. 
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Figure 3-3: 300 MHz 1H NMR spectrum of diene 231 (recorded in CDCl3).  
Insets: Expansions of two regions of the spectrum. 
3.3.3 Alcohol oxidation and ester cleavage 
In accord with the planned synthetic scheme, alcohol 231, obtained as described above, was 
subjected to oxidation with PDC in the presence of acetic acid to give enone 230 in 68% yield 
(Scheme 3-12). Treatment of the product with zinc acetate in methanol at 20 °C for 1 h then 
gave the epoxyquinol monomer 199 in 82% yield. 
 
Scheme 3-12: Reagents and conditions (i) PDC, AcOH, DCM, 20 °C, 5 h; (ii) Zn(OAc)2.2H2O, MeOH, 20 °C, 1 h. 
The 
1
H NMR spectrum recorded on monomer 199, and shown in Figure 3-4, is in agreement 
with that reported by Porco et al. for the same compound.
95
 Thus, the C5 proton resonated as a 
doublet of doublets at δ 6.57 due to its coupling to the protons at C3 and C4. The magnitude of 
the coupling (J = 16.2 Hz) between the pair of mutually coupled doublets arising from the 
protons on the exo-cyclic alkene clearly indicates that the olefin possesses the E-configuration. 
The geminally-related methyl groups of the sidechain are diastereotopic and appear as a pair of 
singlets at δ 1.34 and 1.32. 
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Figure 3-4: 300 MHz 1H NMR spectrum of alcohol 199 (recorded in CDCl3).  
Inset: Expansions of two regions from the spectrum. 
Hydroxyl stretching results in a broad absorption band centred at 3411 cm
−1
 in the IR spectrum 
of alcohol 199. The conjugated enone moiety gives rise to a strong C=O absorption band at 
1683 cm
−1
 while the EI mass spectrum displays an ion at m/z 195 that derives from the loss of a 
methyl group from the parent ion. An accurate mass measurement on this species established 
that it was of the expected composition, viz. C10H11O4. Since epoxyquinol product 199 is a 
known precursor to (+)-panepophenanthrin, the synthesis of the natural product was formally 
established at this point. 
3.3.4 The Diels-Alder dimerization reaction 
While compound 199 could be subjected to full spectroscopic characterization, it displayed a 
propensity to undergo dimerization to give (+)-panepophenanthrin (192). Thus, on standing at 
ca. 20 °C for 72 h, neat samples of compound 199 were converted into the dimer 192 via a 
[4 + 2] cycloaddition reaction and a subsequent lactol forming reaction (Scheme 3-13). The 
product was obtained in a quantitative yield and as a crystalline solid with a melting point of 
140−144 °C. This compared favourably with the reported value, viz. 145−148 °C.134 The optical 
rotation recorded on this material is [α]D +144 (c 0.5, methanol) and was, therefore, of similar 
magnitude to that reported for the natural product {[α]D +146 (c 1.0, methanol)}.
134
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Scheme 3-13: Reagents and conditions (i) neat, 20 ºC, 72 h. 
The
 1
H NMR spectrum of (+)-panepophenanthrin (192) is shown in Figure 3-5. The chemical 
shifts for signals appearing in this spectrum, as well as the remaining spectroscopic data, are in 
good agreement with those published earlier for the target compound.
95-100
 A comparison of the 
13
C and 
1
H NMR data recorded on naturally- and synthetically-derived (+)-panepophenanthrin 
(192) is shown in Table 3-1. 
 
Figure 3-5: 300 MHz 1H NMR spectrum of (+)-panepophenanthrin (recorded in d4-methanol).  
Inset: Expansions of two regions from the spectrum. 
It can be seen in Table 3-1 that the 
13
C NMR spectrum recorded on the synthetically-derived 
compound closely matches that recorded on the natural product. The Δδ values of the relevant 
signals are less than 0.2 ppm. The 
1
H NMR spectral data are equally well-matched with Δδ 
values for the relevant signals being 0.05 ppm or less. 
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Table 3-1: Comparison of the 13C and 1H NMR data recorded on naturally- and synthetically-derived 
(+)-panepophenanthrin (192) 
13C NMR Data 13C NMR Data 1H NMR Data 1H NMR Data 
Natural 192 
(δC) 
(75 MHz, 
CDCl3)
134 
Synthetic 192 
(δC) 
(75 MHz, 
CDCl3) 
Natural 192 
(δH) 
(300 MHz, CDCl3)
134 
Synthetic 192 
(δH) 
(300 MHz, CDCl3) 
196.2 196.2 6.81 (dd, J = 5.0 and 3.0 Hz, 1H) 6.77 (dd, J = 4.5 and 2.7 Hz, 1H) 
143.0 142.9 5.99 (d, J = 16.0 Hz, 1H) 5.96 (d, J = 16.5 Hz, 1H) 
139.9 140.0 5.68 (d, J = 16.0 Hz, 1H) 5.64 (d, J = 16.5 Hz, 1H) 
138.8 138.8 4.55 (broad dd, J = 2.0 Hz, 1H) 4.52 (broad s, 1H) 
129.2 129.3 4.35 (broad t, J = 2.0 Hz, 1H) 4.32 (broad s, 1H) 
102.6 102.7 3.84 (broad t, J = 4.0 Hz, 1H) 3.80 (t, J = 3.6 Hz, 1H) 
79.2 79.1 3.50 (broad t, J = 4.0 Hz, 1H) 3.46(broad t, J = 3.6 Hz, 1H) 
71.8 71.8 3.42 (d, J = 4.0 Hz, 1H) 3.39 (d, J = 4.2 Hz, 1H) 
69.0 69.0 3.35 (dd, J = 5.0 and 2.0 Hz, 1H) 3.28-3.26 (m, 2H) 
66.2 66.2 3.32 (d, J = 4.0 Hz, 1H)  
60.7 60.6 2.33 (m, 1H) 2.28 (d, J = 9.3 Hz, 1H) 
57.3 57.4 2.03 (broad d, J = 10.0 Hz, 1H) 1.99 (d, J = 9.3 Hz, 1H) 
57.2 57.2 1.45 (s, 3H) 1.41 (s, 3H) 
57.1 57.1 1.35 (s, 3H) 1.31 (s, 3H) 
55.6 55.6 1.20 (s, 3H) 1.16 (s, 3H) 
55.1 55.1 1.17 (s, 3H) 1.13 (s, 3H) 
51.2 51.2   
50.0 49.9   
32.3 32.3   
30.3 30.3   
29.4 29.5   
26.1 26.2   
Scheme 3-14 provides an overview of the reaction sequence leading to the total synthesis of 
(+)-panepophenanthrin from iodide 100. As iodide 100 is readily obtained from cis-
dihydrocatechol 90 in just three steps (see Section 2.3), this synthesis delivered the target in an 
overall yield of 11% and in just seven steps from the commercially available cis-
dihydrocatechol 90. 
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Scheme 3-14: Reagents and conditions (i) n-Bu3SnH, Pd[0], THF, 20 °C, 1 h; (ii) Pd[0], Ph3As, CuI, acetone, 50 °C, 
μwave, 0.3 h; (iii) PDC, acetic acid, dichloromethane, 20 °C, 1h; (iv) Zn(OAc)2.2H2O, MeOH, 20 °C, 1 h; (v) neat, 
20 °C, 72 h. 
As Table 3-3 indicates, the new synthetic route described in this work provides the shortest 
linear sequence for the preparation of panepophenanthrin. This route also avoids the use of 
silicon-based protecting groups and the associated cleavage of these groups with hazardous 
fluoride-based reagents. 
Table 3-2: A comparison of the key features associated with the seven reported syntheses of panepophenanthrin 
Lead author Publication date Longest linear sequence Overall yield (%) Modification produced 
Porco93 2003 ten steps 22 (+) 
Baldwin96 2003 ten steps 4 (±) 
Mehta98 2004 fifteen steps 6 (+) 
Mehta97 2004 sixteen steps 3 (−) 
Hayashi134 2006 twelve steps 18 (+) 
Present work104 2009 seven steps 11 (+) 
Lee137 2010 twenty steps 2 (+) 
Following the publication of the present work, Lee and Li reported their total synthesis of 
(+)-panepophenanthrin.
137
 This route made use of the enyne metathesis and [1,3]-metallotropic 
shift methodology that was used by the same researchers in earlier syntheses of (−)-harveynone 
and (−)-tricoholomenyn A (see Sections 2.10.2 and 2.13.2, respectively).92 Although this 
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synthesis was lengthy and relatively low-yielding, it did demonstrate that a relay metathesis-
based tandem ring-closing metathesis and cross metathesis approach is an alternative to Pd[0]-
catalyzed cross-coupling reactions for the construction of the scaffold of epoxyquinol-based 
natural products. 
3.4 (+)-HEXACYCLINOL 
3.4.1 Isolation and characterization of (+)-hexacyclinol 
In an effort to identify new bioactive metabolites, (+)-hexacyclinol (233) (Figure 3-6) was 
isolated by Gräfe et al. from a cultured fungus, identified as Panus rudis HKI 0254, that had 
been collected from fallen timber near Irkutsk in Siberia.
138
 A study of the biological activity of 
this isolate revealed that it possessed some antiproliferative properties and displayed moderate 
inhibitory activity against Plasmodium falciparum, the protozoan parasite responsible for the 
most dangerous form of malaria in humans. An unusual oligocyclic structure containing epoxide 
and endoperoxide groups was initially assigned to this compound and a total synthesis of this 
structure was claimed by La Clair but has since been shown to be bogus.
139
 The correct structure 
for (+)-hexacyclinol, viz. the dimeric epoxyquinol system 233, was proposed by Rychnovsky 
with the aid of computational methods. Two subsequent and related computational studies 
supported this reassignment.
140,141
 Computationally-predicted 
13
C shift values for this structure 
correlated well with experimental data collected on other structurally related and highly 
oxygenated natural products. It was initially considered that (+)-hexacyclinol was produced by 
via a silica gel-mediated rearrangement of the structurally-related natural product 
(+)-panepophenanthrin.
93
 As this proposal was disproven, it is now expected that the 
biosynthesis of (+)-hexacyclinol is similar to that of (+)-panepophenanthrin and that both of 
these natural products are derived from the Diels-Alder dimerization of the corresponding 
epoxyquinol monomers.
94
 
 
Figure 3-6: (+)-Hexacyclinol. 
3.4.2  Previous studies on the synthesis of hexacyclinol 
Hexacyclinol has been the subject of two previous total syntheses.
93,94
 Both of these involve the 
preparation of the same epoxyquinol monomer proposed as the biogenetic precursor to the 
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target and which quite clearly engages in the anticipated dimerization process en route to the 
natural product. 
Porco’s total synthesis of (+)-hexacyclinol (2006) 
Since it was considered possible that (+)-hexacyclinol may have been produced via a silica gel-
mediated rearrangement of (+)-panepophenanthrin in the presence of methanol, Porco et al. 
exposed synthetically-derived (+)-panepophenanthrin to a range of acids in the presence of 
methanol. However, these efforts failed to effect the desired outcome. Subsequently, the same 
authors developed a total synthesis of (+)-hexacyclinol that proceeded from enantiopure epoxy 
alcohol 196 (Scheme 3-15).
93
 Alcohol 196 was obtained from hydroquinone mono-methyl ether 
193 in five steps including an asymmetric epoxidation reaction mediated by (−)-tartaric acid.135 
This epoxyalcohol was utilized in an earlier synthesis of (+)-panepophenanthrin.
95
 From 
compound 196, an α,β-unsaturated ketone was revealed by hydrolysis with K10 clay in 
dichloromethane, and the liberated hydroxyl group was protected to afford triethylsilyl ether 
234. Stille cross-coupling of this compound with the relevant alkenyl stannane took place at 
100 °C over one hour and thereby afforded dienyl ether 235. The triethylsilyl protecting group 
within compound 235 was cleaved with the hydrofluoric acid/triethylamine complex and the 
ensuing alcohol was incubated, neat, for 72 h. This facilitated an exo-Diels-Alder dimerization 
reaction, that is probably biomimetic, and that afforded (+)-pre-hexacyclinol (236) in 87% yield 
over just two steps. K10 clay was employed a second time in order to effect an SN′ 
rearrangement of compound 236, in which methanol was expelled from the molecule and 
(+)-hexacyclinol was thus delivered in 99% yield. This route produced (+)-hexacyclinol in an 
overall yield of 30% and in 11 steps from phenol 193. A single-crystal X-ray analysis of 
racemic hexacyclinol, obtained using the same protocols as described here but proceeding from 
(±)-196, was carried out and reported as part of the Porco synthesis. 
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Scheme 3-15: Reagents (i) As described by Porco et al.;95 (ii) K10 clay; (iii) TESCl, 2,6-lutidine, DMAP; (iv) 
[Pd2(dba)3], AsPh3, (E)-tributyl(3-methoxy-3-methylbut-1-enyl)stannane; (v) Et3N·3HF; (vi) neat; (vii) K10 clay. 
Mehta’s total synthesis of (+)-hexacyclinol (2008) 
Mehta’s 2008 total synthesis of (+)-hexacyclinol started with the commercially-available Diels-
Alder adduct (176) of cyclopentadiene and p-benzoquinone (Scheme 3-16). Following a 
procedure described previously by Ogasawara and Kamikubo, γ-siloxy enone 118 was obtained 
from adduct 176 in six steps and in a completely enantioselective manner.
85
 Advanced 
intermediate 211, common to an earlier synthesis of the related natural product 
(+)-panepophenanthrin, was obtained from enone 118 in a further three steps and via protocols 
described in Section 3.1.2.
98
 This enone was reduced in a diastereoselective manner with 
diisobutyl aluminium hydride to afford an intermediate diol. Due to the steric demands of the 
reagent, only the primary allylic alcohol of this intermediate was oxidized by the N-
oxoammonium salt generated from TEMPO, CuCl and oxygen. The resulting aldehyde 237 was 
engaged in a Wittig reaction with a stabilized ylide and thereby afforded dienyl ester 238, which 
was converted into tertiary alcohol 239 via exposure of the former species to excess methyl 
lithium in THF. Allylic oxidation of the secondary alcohol within compound 239 re-established 
the ketone moiety. A Dowex-1 resin-mediated SN1 reaction involving methanol as nucleophile 
resulting in the tertiary hydroxyl group being replaced by a methyl ether. Deprotection of the 
silyl ether residue also took place under these conditions and thereby affording the desired 
monomeric precursor 240 to (+)-hexacyclinol. This material subsequently engaged in a highly 
selective Diels-Alder dimerization reaction that yielded (+)-pre-hexacyclinol (236) in 99% 
yield. Dowex-1 resin was then used to trigger a subsequent SN′ displacement and cyclization 
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reaction that afforded (+)-hexacyclinol (233) in 99% yield. This seventeen-step synthesis of 
(+)-hexacyclinol afforded the target compound in an overall yield of 7% from adduct 176. 
 
Scheme 3-16: Reagents (i) As described by Ogasawara and Kamikubo;85 (ii) As described by Mehta et al.;98 (ii) 
diisobutylaluminium hydride; (iii) TEMPO, CuCl, O2; (iv) Ph3P=CHCO2Me; (v) MeLi; (vi) MnO2; (vii) Dowex-1, 
MeOH; (viii) neat; (ix) Dowex-1. 
3.5 SYNTHETIC STRATEGY ASSOCIATED WITH THE PRESENT SYNTHESIS 
OF (+)-HEXACYCLINOL 
3.5.1 Proposed synthetic route to (+)-hexacyclinol 
Preceding syntheses of (+)-hexacyclinol established epoxyquinol monomer 240 as a key 
intermediate from which the target is obtained via two high-yielding and probably biomimetic 
reactions. As such, the synthetic efforts of the author were directed toward the rapid attainment 
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of compound 240 (Scheme 3-17). Porco et al. installed the alkenyl side-chain of alcohol 240 via 
the Stille cross-coupling reaction of alkenyl bromide 234 with stannane 241.
93
 In accord with 
this approach, it was proposed that alkenyl iodide 100 would serve as a suitable substrate for a 
cross-coupling reaction with the same stannane. As described in Section 2.3, iodide 100 was 
obtained from commercially available diol 90 in three steps and 40% yield.
103
 It was anticipated 
that oxidation of the cross-coupling product would furnish diene 242 and that cleavage of the 
protecting group from this compound would deliver pivotal alcohol 240. Analogous conditions 
to those applied in earlier syntheses would, at this juncture, be applied in order to generate 
(+)-hexacyclinol (233) from monomeric precursor 240. 
As (+)-hexacyclinol has been shown to exhibit interesting biological activity, the development 
of an abbreviated synthesis of this compound is of considerable importance.
94,138
 The 
implementation of a Pd[0]-catalyzed cross-coupling reaction is especially desirable as it lends 
itself to the incorporation of alternate side-chains, in the event that analogues of the the 
hexacyclinol are sought. As well, the removal of the chloroacetyl protecting group has been 
shown to proceed under mild conditions and avoids the use of hazardous fluoride reagents. 
 
Scheme 3-17: Proposed synthetic route to (+)-hexacyclinol. 
3.6  TOTAL SYNTHESIS OF (+)-HEXACYCLINOL 
Though iodide 100 is available in just three steps and in enantiomerically pure form from the 
abundant cis-dihydrocatechol 90, it was necessary to prepare stannane 241 in order to carry out 
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the intended cross-coupling reaction. Efforts to do so are described immediately below and 
followed by a discussion of the Stille cross-coupling and subsequent reactions en route to 
(+)-hexacyclinol. 
3.6.1 Preparation of the relevant trans-alkenyl stannane 
The required alkenyl stannane 241 was obtained from 2-methylbut-3-yn-2-ol via sequential O-
methylation of the substrate with dimethyl sulfate and sodium hydride in DMF then the 
palladium[0]-catalyzed hydrostannylation of the ensuing ether 243 with tri-n-butyltin hydride 
(Scheme 3-18).
93,142
 Ether 243 was obtained, after purification by distillation, as a clear, 
colorless oil, bp = 78-80 °C @ 760 mm Hg (lit.
142
 bp = 78-80 °C @ 760 mm Hg). As the 
relatively high molecular weight of stannane 241 precludes its purification by distillation, a 
modification was made to the stoichiometry of the reaction so as minimize the production of 
distannyl biproducts. In particular, a 5% excess of alkyne 243 relative to tri-n-butyltin hydride 
was used. This modification reduced the prevalence of distannyl by-products to such an extent 
that satisfactory purification of the product was achieved by passing it through TLC-grade silica 
gel as a solution in n-hexane, followed by concentration of the filtrate. In this way, column 
chromatography on expensive reverse-phase silica gel was avoided. 
 
Scheme 3-18: Reagents and conditions (i) (MeO)2SO2, NaH, DMF, 0→20 °C, 0.75 h; (ii) n-Bu3SnH, Pd[0], THF, 
20 °C, 1 h. 
3.6.2 The Stille cross-coupling reaction 
The pivotal cross-coupling reaction of stannane 241 and iodide 100 (Scheme 3-19) was 
complete after 0.3 h at 50 °C and diene 244 was isolated from the reaction mixture as a pale-
orange oil in 47% yield. The ester carbonyl gives rise to a signal at δ 166.5 in the 13C NMR 
spectrum while, due to their chemical inequivalence, the carbons of the two geminal methyl 
groups produced two signals at δ 25.8 and 25.3. The IR spectrum displayed an absorption band 
due to hydroxyl stretching at 3401 cm
−1
. The intense absorption appearing at 1761 cm
−1
 in the 
same spectrum was attributed to stretching of the ester carbonyl stretching mode. The EI mass 
spectrum displayed a 3:1 ratio of molecular ions at m/z 302 and 304, as would be expected for a 
mono-chlorinated compound. An accurate mass measurement on the former species established 
that it was of the anticipated composition, viz. C14H19
35
ClO5. 
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Scheme 3-19: Reagents and conditions (iii) Pd[0], Ph3As, CuI, THF, 50 °C, 0.3 h 
The
 1
H NMR spectrum of diene 244 (Figure 3-7) displayed two mutually coupled doublets 
arising from the protons on the exo-cyclic alkene residue. The magnitude of the coupling (J = 
16.2 Hz) clearly indicates that the E-configured alkene has been obtained. The proton appended 
to the cyclic olefin is shielded by 0.8 ppm following the cross-coupling reaction, an effect that is 
partly attributed to greater steric compression in the coupling product. 
 
Figure 3-7: 300 MHz 1H NMR spectrum of diene 244 (recorded in CDCl3).  
Inset: An expansion of a region from the spectrum. 
3.6.3 Alcohol oxidation and ester cleavage 
Dienyl ether 244, obtained from the cross-coupling reaction shown in Scheme 3-19, was 
oxidized with pyridinium dichromate and thereby affording the anticipated enone 242 as a clear, 
colorless oil in 91% yield. Methanolic zinc (II) acetate was used to cleave the chloroacetyl 
residue within compound 242 and alcohol 240 was thereby obtained in 78% yield (Scheme 
3-20). The specific rotation of this material {[α]D −139.9 (c 2.05, CHCl3)} was of the same sign 
but of slightly lower magnitude than that described in the literature {lit.
94
 [α]D −170.5 (c 0.54, 
CHCl3)}. 
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Scheme 3-20: Reagents and conditions (i) PDC, AcOH, CH2Cl2, 20 °C, 1 h; (ii) Zn(OAc)2.2H2O, MeOH, 20 °C, 1 h. 
The IR spectrum recorded on alcohol 240 displays a broad absorption band at 3385 cm
−1
 and 
this is assigned to the hydroxyl stretching mode of the alcohol moiety while a sharp absorption 
at 1687 cm
−1
 is consistent with the presence of the α,β-unsaturated ketone. In the 1H NMR 
spectrum of this compound the C5 proton resonates as a doublet of doublets at δ 6.48 (J = 5.4 
and 3.0 Hz). This and other spectral features were in accord with those reported by Mehta et 
al.
94
 Once again, the geminally-related methyl groups gave rise to two distinct signals in the 
13
C 
NMR spectrum (Figure 3-8), both appearing at δ 29.7. 
 
Figure 3-8: 75 MHz 13C NMR spectrum of alcohol 240 (recorded in CDCl3). 
3.6.4 The Diels-Alder dimerization reaction 
Neat samples of alcohol 240 stored at 20 °C for 72 h underwent the anticipated exo-Diels-Alder 
dimerization reaction and delivered (+)-pre-hexacyclinol (236) quantitatively. This was 
consistent with literature descriptions of the process.
93,94
 The direction of the specific rotation 
recorded on the product of the cycloaddition reaction {[α]D +30.8 (c 2.35, CHCl3)} was inverted 
relative to the monomeric precursor and agreed closely with that reported by Porco et al.
93
 but 
was higher in magnitude than that reported by Mehta et al.
94
 
116 Chapter Three  
 
Scheme 3-21: Reagents and conditions (i) neat, 20 °C, 72 h. 
The 
13
C NMR spectrum recorded on (+)-pre-hexacyclinol agreed closely with that reported by 
both Porco and Mehta although some small discrepancies were apparent. Comparisons of 
13
C 
NMR data arising from the present work with those reported in the literature are shown in Table 
3-3. In the spectrum recorded by Porco et al., 22 of the 24 chemically unique carbon signals 
were observed with two “missing” signals presumably obscured or overlapping with others. 
Mehta et al. observed all 24 carbon signals while in the current work 23 signals were observed. 
The particular signal absent in the present study was also obscured in the spectrum recorded by 
Porco et al. Nevertheless, the remaining chemical shift values extracted from the 
13
C NMR 
spectrum were in good agreement with the literature values; Δδ values are ≤ 0.8 ppm for 20 of 
the 23 observed signals and the average Δδ value, for all of the observed signals, was less than 
0.5 ppm (Table 3-3). 
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Table 3-3: Comparison of the 13C NMR data recorded for different synthetically-derived samples of 
(+)-pre-hexacyclinol (236) 
Acquired by Porco et al.93 
(δC) 
(75 MHz, CDCl3) 
Acquired by Mehta et al.94 
(δC) 
(75 MHz, CDCl3) 
Acquired by Pinkerton et al.104 
(δC) 
(75 MHz, CDCl3) 
203.0 202.6 203.4 
194.7 194.4 194.9 
138.6 138.5 138.5 
134.2 138.4 137.9 
130.9 133.9 134.5 
not observed 130.7 130.8 
77.5 77.3 77.0 
75.5 75.2 75.5 
69.6 69.7 68.4 
68.1 68.0 67.5 
61.6 61.5 61.3 
59.3 59.0 59.4 
55.5 55.2 55.5 
53.7 53.5 53.6 
53.6 53.5 53.5 
not observed 52.9 not observed 
50.6 50.4 50.6 
49.9 49.5 50.3 
48.7 48.5 48.4 
46.5 46.3 46.3 
26.3 26.1 26.0 
25.3 25.1 25.1 
24.7 24.6 24.4 
23.6 23.5 23.1 
The 
13
C NMR spectrum recorded on (+)-pre-hexacyclinol is depicted in Figure 3-9. The signals 
due to the carbonyl carbons C6 and C1 appear at δ 203.4 and 194.9, respectively. In addition, 
the olefinic carbons give rise to a set of four signals between δ 140 and 130. Signal broadening 
is apparent for the remaining signals, all of which appear below δ 78 and this effect is probably 
due to the slowed rotation of the methyl ether sidechains about the core due to their severely 
sterically-crowded environments. 
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Figure 3-9: 75 MHz 13C NMR spectrum of (+)-pre-hexacyclinol (recorded in CDCl3).  
 Inset: An expansion of a region from the spectrum. 
The 
1
H NMR spectrum recorded on (+)-pre-hexacyclinol is in good agreement with the 
analogous spectra recorded by Porco and Mehta.
93,94
 A comparison of these sets of spectral data 
is presented in Table 3-4. In each data set, signals integrating to 31 protons are observed. In the 
current work, signals ascribed to the two hydroxyl protons appear at relatively low-field 
positions. The relevant chemical shifts of these signals are δ 4.07 and 3.72, as opposed to δ 3.05 
and 2.82 reported by Porco et al. and δ 3.02 and 2.76 ppm reported by Mehta et al. 
The IR spectrum of (+)-pre-hexacyclinol exhibits a broad absorption band at 3424 cm
−1
 that is 
attributed to hydroxyl groups while absorptions due to the two epoxy ketones overlap at 
1699 cm
−1
. The ESI mass spectrum displays an [M+Na]
+
 ion at m/z 471 and accurate mass 
measurement of this species established that it was of the expected composition, viz. 
C24H32NaO8. 
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Table 3-4: Comparison of the 1H NMR data recorded for different synthetically-derived samples of 
(+)-pre-hexacyclinol (236) 
Acquired by Porco et al.93 
(δH) 
(300 MHz, CDCl3) 
Acquired by Mehta et al.94 
(δH) 
(300 MHz, CDCl3) 
Acquired by Pinkerton et al.104 
(δH) 
(300 MHz, CDCl3) 
6.71 (dd, J = 4.3 and 2.6 Hz, 1H) 6.73 (dd, J = 4.3 and 2.6 Hz, 1H) 6.69 (m, 1H) 
5.80 (d, J = 16.9 Hz, 1H) 5.80 (d, J = 17.0 Hz, 1H) 5.84 (d, J = 16.8 Hz, 1H) 
5.41 (d, J = 16.9 Hz, 1H) 5.44 (d, J = 17.0 Hz, 1H) 5.40(d, J = 16.8 Hz, 1H) 
4.43 (broad s, 1H) 4.46 (broad s, 1H) 4.44 (broad s, 1H) 
4.15 (dd, J = 8.2 and 4.7 Hz, 1H) 4.17 (d, J = 8.4 Hz, 1H) 4.21 (m, 1H) 
  4.07 (d, J = 5.4 Hz, 1H) 
  3.72 (d, J = 5.4 Hz, 1H) 
3.57 (d, J = 3.6 Hz, 1H) 3.59 (d, J = 3.3 Hz, 1H) 3.60 (m, 2H) 
3.55 (d, J = 3.4 Hz, 1H) 3.57 (d, J = 3.4 Hz, 1H)  
3.45 (m, 2H) 3.46 (m, 2H) 3.49 (d, J = 3.6 Hz, 1H) 
  3.44 (broad s, 1H) 
3.32 (d, J = 3.4 Hz, 1H) 3.34 (d, J = 3.2 Hz, 1H) 3.35 (d, J = 3.6 Hz, 1H) 
3.18 (s, 3H) 3.20 (s, 3H) 3.16 (s, 3H) 
3.05 (m, 4H) 3.07 (s, 3H) 3.05 (s, 3H) 
 3.02 (broad s, 1H) not observed 
2.82 (d, J = 6.4 Hz, 1H) 2.76 (broad s, 1H) not observed 
2.68 (ddd, J = 10.8, 5.2 and 3.4 Hz, 1H) 2.72-2.68 (m, 1H) 2.67 (m, 1H) 
2.58 (t, J = 4.6 Hz, 1H) 2.61 (t, J = 4.7 Hz, 1H) 2.52 (broad s, 1H) 
1.23 (s, 3H) 1.25 (s, 3H) 1.22 (s, 6H) 
1.22 (s, 3H) 1.25 (s, 3H)  
1.20 (s, 3H) 1.23 (s, 3H) 1.19 (s, 3H) 
1.12 (s, 3H) 1.14 (s, 3H) 1.12 (s, 3H) 
3.6.5 The acid-catalyzed intramolecular SN′ reaction – Conversion of 
(+)-pre-hexacyclinol into (+)-hexacyclinol 
Exposure of (+)-pre-hexacyclinol (236) to a catalytic amount of acid, in this case that present in 
untreated chloroform or deuterochloroform, induced the previously described SN′ reaction to 
form (+)-hexacyclinol (Scheme 3-22). The reaction proceeded almost quantitatively at 20 °C 
over 72 h to afford the desired product, (+)-hexacyclinol, as a white, crystalline solid, mp 176-
178 °C (lit.
94
 mp 176-178 °C) following removal of the reaction solvent under vacuum. 
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Scheme 3-22: Reagents and conditions (vii) H+/D+, CDCl3, 20 °C, 72 h. 
X-ray crystallographic analysis of (+)-hexacyclinol afforded the ORTEP shown in Figure 3-10. 
This structure matches that of the natural product and is in accord with a previous X-ray crystal 
structure obtained on the racemic material and published by Porco et al.
93
 
 
Figure 3-10: ORTEP derived from the single-crystal X-ray analysis of (+)-hexacyclinol. 
The specific rotation measured on (+)-hexacyclinol {[α]D +129.6 (c 0.36, methanol)} was in the 
same direction and of very similar magnitude to that described by Mehta et al. {[α]D +130.9 
(c 0.42, methanol)}.
94
 The 
13
C
 
and 
1
H NMR spectra (Figure 3-11 and Figure 3-12, respectively) 
were in accord with those described for the natural product.
93,94,138
 The two signals due to the 
carbonyl carbons C6 and C1 appear at δ 203.1 and 193.2, respectively, in the 13C NMR 
spectrum. As the latter carbonyl moiety is conjugated with an alkene, the associated carbonyl 
carbon (C1) remains relatively more shielded. 
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Figure 3-11: 75 MHz 13C NMR spectrum of (+)-hexacyclinol (recorded in CDCl3).  
Insets: An expansion of a region of the spectrum. 
The 
1
H NMR spectrum recorded on (+)-hexacyclinol (Figure 3-12) was entirely consistent with 
that obtained from the natural product and from other synthetically-derived samples.
93,94,138
 The 
olefinic proton at the β-position of the enone appeared as a doublet of doublets at δ 6.72 (J = 6.0 
and 2.4 Hz). A lone doublet (J = 9.3) at δ 5.47 is assigned to the proton at C17 while the 
resonance at δ 3.02 was attributed to the methyl ether.  
 
Figure 3-12: 300 MHz 1H NMR spectrum of (+)-hexacyclinol (recorded in CDCl3). 
A comparison of the 
13
C and 
1
H NMR data recorded on naturally- and synthetically-derived 
(+)-hexacyclinol (233) is presented in Table 3-5. The two 
13
C NMR spectra are in close 
agreement with the Δδ values for relevant 13C nuclei being ≤ 0.6 ppm and an average value of 
0.2 ppm. The chemical shifts of those 
1
H NMR signals that are not part of the complex multiplet 
appearing between δ 3.70 and 3.54 show Δδ values ≤ 0.1 ppm. 
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Table 3-5: Comparison of the 13C and 1H NMR data recorded on naturally- and synthetically-derived 
(+)-hexacyclinol (233) 
13C NMR Data 13C NMR Data 1H NMR Data 1H NMR Data 
Natural 233 
(δC) 
(75 MHz, 
CDCl3)
138 
Synthetic 233 
(δC) 
(75 MHz, 
CDCl3) 
Natural 233 
(δH) 
(300 MHz, CDCl3)
138  
Synthetic 233 
(δH) 
(300 MHz, CDCl3) 
202.9 203.1 6.73 (dd, J = 5.3 and 2.4 Hz, 1H) 6.72 (dd, J = 6.0 and 2.4 Hz, 1H) 
192.8 193.2 5.46 (d, J = 10.1 Hz, 1H) 5.47 (d, J = 9.3 Hz, 1H) 
142.2 142.3 4.99 (broad d, J = 5.2 Hz, 1H) 5.00 (m, 1H) 
139.0 139.6 4.82 (d, J = 10.1 Hz, 1H) 4.82 (d, J = 9.3 Hz, 1H) 
132.5 132.6 3.80 (broad dd, J = 9.5 and 
1.5 Hz, 1H) 
 
120.7 120.5 3.64 (m, 1H) 3.70-3.54 (complex m, 3H) 
77.3 77.3 3.59 (d, J = 5.3 Hz, 1H)  
75.8 75.7 3.55 (m, 1H)  
72.7 72.5 3.51 (dd, J = 2.9 and 0.5 Hz, 1H) 3.52 (d, J = 3.6 Hz, 1H) 
71.5 71.4 3.29 (d, J = 3.2 Hz, 1H) 3.29 (d, J = 2.7 Hz, 1H) 
61.0 61.0 3.23 (broad d, J = 3.5 Hz, 1H) 3.24 (d, J = 3.6 Hz, 1H) 
60.5 60.3 3.02 (s, 3H) 3.02 (s, 3H) 
54.5 54.4 2.74 (dd, J = 7.8 and 5.2 Hz, 1H) 2.74 (dd, J = 9.9 and 5.1 Hz, 1H) 
53.2 53.2 1.77 (s, 3H) 1.77 (s, 3H) 
53.1 53.0 1.72 (s, 3H) 1.72 (s, 3H) 
49.1 49.1 1.26 (s, 3H) 1.27 (s, 3H) 
47.8 47.6 1.15 (s, 3H) 1.15 (s, 3H) 
40.9 40.6   
40.4 40.1   
26.6 26.6   
26.1 26.2   
24.7 24.6   
18.6 18.4   
The hydroxyl groups of compound 233 produce a broad absorption band at 3433 cm
−1
 in the IR 
spectrum while carbonyl stretches produce a pair of partially overlapping absorption bands at 
1711 and 1698 cm
−1
. The cyclic alkene gives rise to an absorption band at 1626 cm
−1
, the 
intensity of which is enhanced by conjugation with the adjacent ketone. The ESI mass spectrum 
displays an [M+Na]
+
 ion at m/z 439 and accurate mass measurement of this species established 
that it was of the expected composition, viz. C23H28NaO7. 
Scheme 3-23 provides a summary of the reaction sequence employed in the synthesis of 
(+)-hexacyclinol from the epoxyquinol synthon 100. By such means, the target (+)-hexacyclinol 
was obtained in an overall yield of 15% and in eight steps from the commercially available cis-
dihydrocatechol 90. 
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Scheme 3-23: Reagents and conditions (i) (MeO)2SO2, NaH, DMF, 0-20 °C, 0.75 h; (ii) n-Bu3SnH, Pd[0], THF, 
20 °C, 1 h; (iii) Pd[0], Ph3As, CuI, THF, 50 °C, 0.3 h; (iv) PDC, AcOH, CH2Cl2, 20 °C, 1 h; (v) Zn(OAc)2.2H2O, 
MeOH, 20 °C, 1 h; (vi) neat, 20 °C, 72 h; (vii) H+/D+, CDCl3, 20 °C, 72 h. 
The present work represents the shortest total synthesis of (+)-hexacyclinol reported to date 
(Table 3-6). Although the overall yield for this sequence is surpassed by the earlier work of 
Porco et al., the average yield per reaction step in the newer sequence is, at 79%, substantial. 
Conveniently, every step in the synthesis of (+)-hexacyclinol described here is conducted at 
standard temperatures and pressures, with the exception of the Stille cross-coupling reaction for 
which only mild heating is required. 
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Table 3-6: A comparison of the key features associated with the three reported syntheses of (+)-hexacylinol 
Lead author Publication date Longest linear sequence Overall yield (%) 
Porco93 2006 eleven steps 30 
Mehta94 2008 seventeen steps 7 
Present work104 2009 eight steps 15 
3.7 CONCLUSIONS AND FUTURE WORK 
Commercially available iodo-diol 100, obtained via the chemoenzymatic dihydroxylation of 
iodobenzene, served as the starting material for rapid total syntheses of the dimeric 
epoxyquinol-derived natural products, (+)-panepophenanthrin and (+)-hexacyclinol. Seven and 
eight steps afforded the target compounds in 11 and 15% yields, respectively. In each case, the 
work here represents the shortest synthetic route to these structurally complex natural products. 
As well, more than half of the carbon atoms that comprise the framework of these target 
molecules are drawn from abundant iodobenzene. Given the benign nature of the reaction 
conditions employed in these sequences and their brevity, the methodology described here lends 
itself to the further investigation of these and related compounds for medicinal applications. 
 CHAPTER FOUR 
4. EXPERIMENTAL PROCEDURES ASSOCIATED WITH WORK 
DESCRIBED IN CHAPTERS ONE, TWO AND THREE 
4.1 GENERAL PROCEDURES 
Proton (
1
H) and carbon (
13
C) NMR spectra were recorded on a Varian Gemini machine 
operating at 300 MHz. Unless otherwise specified, spectra were acquired at 20 °C in 
deuterochloroform (CDCl3) that had been stored over anhydrous sodium carbonate. Chemical 
shifts are recorded as δ values in parts per million (ppm). Infrared spectrums (νmax) were 
normally recorded on a Perkin–Elmer 1800 Series FTIR Spectrometer and samples were 
analyzed as thin films on KBr plates (for liquids) or as a KBr disc (for solids). Low-resolution 
ESI mass spectra were recorded on a Micromass–Waters LC-ZMD single quadrupole liquid 
chromatograph-mass spectrometer while low- and high-resolution EI mass spectra were 
recorded on a VG Fisons AUTOSPEC three-sector double-focusing instrument. Melting points 
were measured on Reichert hot-stage microscope or a Stanford Research Systems Optimelt – 
Automated Melting Point System and are uncorrected. Analytical thin layer chromatography 
(TLC) was performed on aluminum-backed 0.2 mm thick silica gel 60 F254 plates as supplied 
by Merck. Eluted plates were visualized using a 254 nm UV lamp and/or by treatment with a 
suitable dip followed by heating. These dips included a mixture of vanillin: sulfuric acid: 
ethanol (1 g : 1 g : 18 mL) or phosphomolybdic acid : ceric sulfate : sulfuric acid (conc.) : water 
(37.5 g : 7.5 g : 37.5 g : 720 mL). The retardation factor (Rf) values cited here have been 
rounded at the first decimal point. Flash chromatographic separations were carried out following 
protocols defined by Still et al.
143
 with silica gel 60 (0.040–0.0063 mm) as the stationary phase 
and using the AR- or HPLC-grade solvents indicated. Starting materials and reagents were 
generally available from the Sigma–Aldrich, Merck, TCI, Strem or Lancaster Chemical 
Companies and were either used as supplied or, in the case of liquids, distilled when required. 
Drying agents and other inorganic salts were purchased from the AJAX, BDH or Unilab 
Chemical Companies. THF, dichloromethane, acetonitrile and benzene were dried using a Glass 
Contour solvent purification system that is based upon a technology originally described by 
Grubbs et al.
144
 Spectroscopic grade solvents were used for all analyses. Where necessary, 
reactions were performed under a nitrogen or argon atmosphere.  
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4.2 EXPERIMENTAL PROCEDURES FOR CHAPTER ONE 
2-bromo-6-diethylamino-4-methoxy-1-azafulvene (40) 
 
A solution phosphorus oxybromide (12.4 g, 43.3 mmol) in chloroform (15 mL) was added to 
solution of diethyl formamide (5.8 mL, 52.1 mmol) in chloroform (5 mL) at 0 ºC. The resulting 
suspension was stirred at 0 ºC for 30 minutes, and the solvent was removed by rotary 
evaporation to obtain the Vilsmeier complex as a white solid. After drying in vacio for 20 min, 
chloroform (10 mL) was added to the solid and cooled to 0 ºC. A solution of 21 (2.0 g, 
17.7 mmol) in chloroform (20 mL) was added dropswise and the mixture was heated at 60 ºC 
for 5 h. The mixture was poured onto ice (75 mL), and the pH of the aqueous solution was 
adjusted to pH 7-8 by treatment with a 2M aqueous solution of potassium carbonate. Ethyl 
acetate (40 mL) was added and the mixture was filtered over Celite® to remove the black solid 
containing the phosphorus salts. The layers were separated and the aqueous later was extracted 
with ethyl acetate (3 × 100 mL). The combined organic fractions were washed with brine (3 × 
200 mL) before being dried (MgSO4), filtered and concentrated under reduced pressure. 
Subjection of the ensuing material to flash chromatography (silica, 1:4 v/v ethyl acetate/n-
hexane elution) and concentration of the relevant fractions (Rf 0.3 in 20% v/v ethyl acetate/n-
hexane) afforded azafulvene 40 (2.3 g, 49%) as an oil that solidified on standing at 18 ºC as a 
tan solid, mp 38-40 ºC (lit. mp 38-40 ºC) (lit.
25
 mp = 38-40 ºC). 
1
H NMR (300 MHz, CDCl3) δ 7.04 (s, 1H), 5.63 (s, 1H), 4.11 (q, J = 7.5 Hz, 2H), 3.78 (s, 3H), 
3.42 (q, J = 7.5 Hz, 2H), 1.33-1.23 (complex m, 6H). 
13
C NMR (75 MHz, CDCl3) δ 165.1, 138.5, 133.3, 120.2, 96.2, 57.9, 51.0, 44.4, 14.5, 12.4. 
IR (KBr) νmax 3430, 2950, 1635, 1530, 1410, 1280, 1115, 910, 720 cm
−1
. 
Mass spectrum (EI, 70 eV) m/z 260 and 258 (M
+•
, both 95%), 231 and 229 (97 and 100), 215 
and 217 (95 and 90). 
HREIMS Found: M
+•
, 258.0364. C10H15
79
BrN2O requires M
+•
, 258.0368. 
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4-methoxy-2,2’-bipyrrole-5-carboxaldehyde (17) 
 
Triphenylphosphine (460 mg, 1.7 mmol) was added to a magnetically stirred suspension of 
palladium(II) acetate (86 mg, 0.38 mmol) in degassed toluene (1.5 mL) and the mixture was 
heated to 70 ºC for 20 min under an atmosphere of nitrogen. N-Boc-pyrrole-2-boronic acid (23) 
(1.22 g, 5.8 mmol) and azafulvene 40 (1.0 g, 3.9 mmol) were dissolved in 1:9 v/v water/1,4-
dioxane (15 mL). This solution was degassed, purged with nitrogen gas, and then transferred to 
the suspension of Pd(PPh3)4 in toluene. Sodium carbonate (1.2 g, 11.3 mmol) was added and the 
resulting mixture was stirred at 100 ºC for 2 h and then poured onto water (100 mL). The pH of 
the mixture was lowered to pH 7 with HCl (2M aqueous solution). The brown precipitate was 
recovered by filtration and washed with water (10 mL), cold acetone (10 mL) and cold diethyl 
ether (2 × 10 mL) to reveal the title aldehyde 17 (700 mg, 95%) as a yellow solid, mp 222-225 
ºC (lit.
25
 mp 224-227 ºC). 
1
H NMR (300 MHz, d6-DMSO) δ 11.50 (s, 1H), 11.20 (s, 1H), 9.30 (s, 1H), 6.92 (s, 1H), 6.76 
(s, 1H), 6.28 (s, 1H), 6.13 (t, J = 3.0 Hz, 1H), 3.85 (s, 3H). 
13
C NMR (75 MHz, d6-DMSO) δ 171.7, 158.8, 133.3, 123.74, 120.4, 117.4, 109.4, 108.4, 90.9, 
57.8. 
IR (KBr) νmax 3248, 3200, 1606, 1362, 1162, 1014, 772 cm
−1
. 
Mass spectrum (EI, 70 eV) m/z 190 (M
+•
, 100%), 161 (40), 143 (40), 108 (50), 92 (60), 91 
(65). 
HREIMS Found: (M+H)
+
, 191.0821. C10H10N2O2 requires (M+H)
+
, 191.0821. 
Tambjamine C (4) 
 
Acetic acid (150 µL, 2.6 mmol) and isobutyl amine (260 µL, 2.6 mmol) were added to a 
magnetically stirred solution of aldehyde 17 (50 mg, 0.26 mmol) in DCE (5 mL). The ensuing 
mixture was stirred at 18 °C for 3 h, diluted with dichloromethane (5 mL), rinsed with water (3 
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× 10 mL) then concentrated under reduced pressure to afford the title alkaloid 4
6
 (77 mg, 97%) 
as a yellow oil. 
1
H NMR (300 MHz, CDCl3) δ 11.1 (broad s, 2H), 7.28 (s, 1H), 7.04 (m, 1H), 6.70 (m, 1H), 
6.24 (m, 1H), 5.95 (s, 1H), 3.90 (s, 3H), 3.24 (d, J = 6.6 Hz, 1H), 2.08 (s, 3H, CH3CO2
-
), 1.98 
(m, 1H), 0.99 (d, J = 6.6 Hz, 6H). 
13
C NMR (75 MHz, CDCl3) δ 178.8, 163.5, 142.8, 140.8, 123.6, 122.9, 112.5, 110.7, 109.9, 
91.0, 58.5, 58.0, 29.4, 24.4, 19.6. 
IR (KBr) νmax 3440, 3190, 2960, 1670, 1620, 1525 cm
−1
. 
Mass spectrum (EI, 70 eV) m/z 245 (M
+•
, 90%), 230 (40), 202 (100). 
HREIMS Found: M
+•
, 245.1527. C14H19N3O requires M
+•
, 245.1528. 
Tambjamine E (2) 
 
Acetic acid (150 µL, 2.6 mmol) and ethylamine (1.3 mL of a 2 M solution in methanol, 
2.6 mmol) were added to a magnetically stirred solution of aldehyde 17 (50 mg, 0.26 mmol) in 
DCE (5 mL). The ensuing mixture was stirred at 50 °C for 3 h, diluted with dichloromethane 
(5 mL), rinsed with water (3 × 10 mL) then concentrated under reduced pressure to afford the 
title alkaloid 2
145
 (50 mg, 69%) as a yellow oil. 
1
H NMR (300 MHz, CDCl3) δ 11.1 s, 2H), 7.30 (s, 1H), 6.83 (s, 1H), 6.57 (m, 1H), 6.19 (m, 
1H), 5.94 (s, 1H), 3.85 (s, 3H), 3.32 (q, J = 7.5 Hz, 2H), 2.10 (s, 3H, CH3CO2
-
), CH3CO2
-
), 1.18 
(t, J = 7.5 Hz, 3H). 
13
C NMR (75 MHz, CDCl3) δ 179.2, 162.9, 143.6, 140.5, 124.9, 121.8, 114.2, 110.4, 109.6, 
91.6, 68.0, 45.6, 24.7, 15.7. 
IR (KBr) νmax 3198, 2926, 1669, 1616, 1528, 1343, 1261, 1162, 1136, 1117, 1035, 1012, 965, 
771, 733 cm
−1
. 
Mass spectrum (EI, 70 eV) m/z 217 (M
+•
, 100%), 202 (75), 175 (70). 
HREIMS Found: M
+•
, 217.1205. C12H15N3O requires M
+•
, 217.1215. 
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Tambjamine F (3) 
 
Acetic acid (150 µL, 2.6 mmol) and β-phenethylamine (330 µL, 2.6 mmol) were added to a 
magnetically stirred solution of aldehyde 17 (50 mg, 0.26 mmol) in DCE (5 mL). The ensuing 
mixture was stirred at 50 °C for 3 h, diluted with dichloromethane (5 mL), rinsed with water (3 
× 10 mL) then concentrated under reduced pressure to afford the title alkaloid 3
145
 (91 mg, 98%) 
as a yellow oil. 
1
H NMR (300 MHz, CDCl3) δ 12.2 (s, 2H), 7.32-7.19 (complex m, 5H), 7.08 (s, 1H), 6.68 (m, 
1H), 6.25 (m, 1H), 5.89 (s, 1H), 3.81 (s, 3H), 3.64 (t, J = 7.2 Hz, 2H) 3.00 (t, J = 7.2 Hz, 2H), 
2.10 (s, 3H, CH3CO2
-
). 
13
C NMR (75 MHz, CDCl3) δ 179.1, 163.5, 142.8, 140.5, 137.4, 128.8, 128.6, 126.6, 123.5, 
122.9, 112.5, 110.8, 110.0, 91.1, 58.0, 52.3, 36.6, 24.6. 
IR (KBr) νmax 3220, 2926, 1680, 1625, 1534, 1407, 1312, 1188, 1119, 1036, 1011, 884, 775, 
745, 707, 643 cm
−1
. 
Mass spectrum (ESI, 70 eV) m/z 217 [(M+H)
+
, 100%]. 
HRESIMS Found: (M+H)
+
, 294.1597. C18H19N3O requires (M+H)
+
, 294.1606. 
BE-18591 (5) 
 
Acetic acid (150 µL, 2.6 mmol) and dodecylamine (480 mg, 2.6 mmol) were added to a 
magnetically stirred solution of aldehyde 17 (50 mg, 0.26 mmol) in DCE (5 mL). The ensuing 
mixture was stirred at 50 °C for 3 h, diluted with dichloromethane (5 mL), rinsed with water (3 
× 10 mL) then concentrated under reduced pressure to afford the title alkaloid 5
1
 (110 mg, 
100%) as a yellow oil. 
1
H NMR (300 MHz, CDCl3) δ 11.4 (s, 2H), 7.26 (s, 1H), 7.00 (m, 1H), 6.64 (m, 1H), 6.21 (m, 
1H), 5.89 (s, 1H), 3.83 (s, 3H), 3.37 (t, J = 7.1 Hz, 2H), 2.06 (s, 3H, CH3CO2
-
), 1.66 (m, 2H), 
1.22 (m, 18H), 0.85 (t, J = 6.8 Hz, 3H). 
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13
C NMR (75 MHz, CDCl3) δ 179.0, 163.2, 142.6, 140.5, 123.4, 123.1, 112.3, 110.9, 109.9, 
91.0, 58.0, 50.9, 31.8, 30.3, 29.5, 29.4, 29.3, 29.2, 29.1, 26.4, 24.6, 22.6, 14.0. 
IR (KBr) νmax 3436, 2923, 1665, 1604, 1550, 1510, 1465, 1309, 1250, 1164, 1137, 1044, 1009, 
967, 808, 729 cm
−1
. 
Mass spectrum (ESI, 70 eV) m/z 358 [(M+H)
+
, 100%], 358 (50), 360 (10), 60 (10). 
HRESIMS Found: (M+H)
+
, 358.2853. C22H35N3O requires (M+H)
+
, 358.2858. 
N-tosyldodec-3-yn-1-amine (45) 
 
n-Butyllithium (56 mL of a 1.6 M solution in hexanes, 89.6 mmol) was added, dropwise, to a 
magnetically stirred solution of 1-decyne (44) (16.0 mL, 88.9 mmol) in anhydrous THF (50 mL) 
at 18 ºC under a nitrogen atmosphere. The resulting solution was stirred at 18 ºC for 20 minutes 
before being treated with a solution of aziridine 43 (4.32 g, 21.9 mmol) in THF (25 mL). The 
ensuing mixture was stirred at 18 ºC for a further 4 h then treated with sodium bicarbonate (50 
mL of a saturated aqueous solution) and extracted with diethyl ether (3 × 100 mL). The organic 
extract was dried (MgSO4), filtered and concentrated under reduced pressure. Subjection of the 
ensuing residue to flash chromatography (silica, 55% v/v ethyl acetate/n-hexane elution and 
concentration of the appropriate fractions (Rf 0.37, 11:9 v/v ethyl acetate/n-hexane) afforded the 
title alkyne 45 (3.1 g, 42 %) as a yellow oil that solidified on standing at 18 ºC as a clear 
crystalline solid. 
1
H NMR (300 MHz, CDCl3) δ 7.75 (d, J = 8.4 Hz, 2H), 7.31 (d, J = 8.4 Hz, 2H), 4.70 (t, J = 
6.3 Hz, 1H), 3.04 (dt, J = 6.3 and 6.3 Hz, 2H), 2.43 (s, 3H), 2.29 (tt, J = 6.3 Hz and 2.4 Hz, 
2H), 2.09 (tt, J = 7.1 and 2.4 Hz, 2H), 1.50-1.20 (m, 12H), 0.88 (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 143.4, 136.9, 129.7, 127.0, 83.2, 75.6, 42.1, 31.8, 29.1, 29.1, 
28.9, 28.8, 22.6, 21.5, 19.8, 18.6, 14.1. 
IR (KBr) νmax 3268, 2926, 2853, 1319, 1165, 1155, 1076, 815, 551 cm
−1
. 
Mass spectrum (EI, 70 eV) m/z 693 [(2M+Na)
+
, 15%], 374 [(M+K)
+
, 10), 358 [(M+Na)
+
, 100], 
336 [(M+H)
+
, 80]. 
HRESIMS Found: (M−H)−, 334.1832. C19H28NO2S requires (M−H)
−
, 334.1841. 
Microanalysis Calculated for C19H29NO2S C, 68.02; H, 8.71; N, 4.17. Found C, 68.24; H, 8.47; 
N, 3.90%. 
Experimental procedures associated with work described in Chapters One, Two and Three 131 
(Z)-N-tosyldodec-3-en-1-amine (46) 
 
Lindlar’s catalyst (34 mg) was added to a magnetically stirred solution of alkyne 45 (2.21 g, 
6.58 mmol) and quinoline (0.35 mL, 2.5 mmol) in n-hexane (10 mL) and the ensuing mixture 
was stirred at 18 ºC under an atmosphere of hydrogen for 2 h then filtered and concentrated 
under under reduced pressure to provide a yellow oil. This oil was subsequently redissolved in 
diethyl ether (30 mL) and rinsed with hydrochloric acid (3 × 30 mL of a 0.01 M aqueous 
solution) and brine (30 mL) then dried (MgSO4), filtered and concentrated under reduced 
pressure to yield the title olefin 46 (2.2 g, 99%) as a yellow oil. 
1
H NMR (300 MHz, CDCl3) δ 7.74 (d, J = 8.4 Hz, 2H), 7.30 (d, J = 8.4 Hz, 2H), 5.49 (m, 1H), 
5.15 (m, 1H), 4.40 (t, J = 6.2 Hz, 1H), 2.96 (m, 2H), 2.42 (s, 3H), 2.19 (m, 2H), 1.94 (m, 2H), 
1.25 (m, 12H), 0.88 (t, J = 6.6 Hz, 3H). 
13
C NMR (75 MHz, CDCl3) δ 143.3, 134.0, 129.7, 127.1, 124.4, 42.7, 31.8, 29.5, 29.5, 29.3, 
27.3, 22.7, 21.5, 14.1 (two signals obscured or overlapping). 
IR (KBr) νmax 3283, 2925, 2854, 1328, 1161, 1095, 814, 663, 551 cm
-1
. 
Mass spectrum (EI, 70 eV) m/z 697 [(2M+Na)
+
, 10%], 360 [(M+Na)
+
, 80], 338 [(M+H)
+
, 100]. 
HRESIMS Found: (M+H)
+
, 338.2165. C19H31NO2S requires (M+H)
+
, 338.2154. 
(Z)-dodec-3-en-1-amine (47) 
 
Sodium (274 mg, 11.9 mmol) was added to a magnetically stirred solution of naphthalene 
(904 mg, 7.1 mmol) in 1,2-dimethoxyethane (15 mL). The resulting mixture was stirred at 18 ºC 
for 150 min. After this time, a solution of alkene 46 (598 mg, 1.77 mmol) was added and the 
ensuing mixture was stirred at 18 ºC for 1 h and then quenched by the addition of ethanol 
(1 mL). The solvent was removed under reduced pressure and the residue was subjected to 
chromatography (silica, methanol elution). Concentration of the appropriate fractions (Rf 0.15, 
methanol) afforded the title amine 47 (200 mg, 72%) as a yellow oil. 
1
H NMR (300 MHz, CDCl3) δ 5.49 (m, 1H), 5.32 (m, 1H), 2.72 (t, J = 6.9 Hz, 2H), 2.19 (m, 
2H), 2.02 (m, 2H), 1.96 (s, 2H), 1.25 (m, 12H), 0.87 (t, J = 6.8 Hz, 3H). 
13
C NMR (75 MHz, CDCl3) δ 132.4, 126.4, 31.8, 31.9, 31.2, 29.7, 29.5, 29.3 (×2), 27.4, 22.7, 
14.1. 
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IR (KBr) νmax 3431, 2924, 2854, 1577, 1467, 1379, 1326, 722 cm
-1
. 
Mass spectrum (EI, 70 eV) m/z 184 [(M+H)
+
, 65%], 111 (40), 97 (95), 83 (100), 69 (100), 54 
(95). 
HREIMS Found: (M+H)
+
, 184.2066. C12H25N requires (M+H)
+
, 184.2065. 
Compound 6 
 
Acetic acid (60 µL, 1.1 mmol) and amine 47 (195 mg, 1.1 mmol) were added to a magnetically 
stirred solution of aldehyde 17 (50 mg, 0.26 mmol) in DCE (10 mL) maintained under nitrogen. 
The ensuing mixture was stirred at 18 °C for 2 h then diluted with water (10 mL) and 
dichloromethane (10 mL). The separated organic layer was washed with water (2 × 10 mL) then 
concentrated under reduced pressure to afford a yellow oil. Subjection of this material to flash 
chromatography (silica, ethyl acetate → methanol gradient elution) and concentration of the 
appropriate fractions (Rf = 0.15 in ethyl acetate) afforded the title alkaloid 6
2
 (35 mg, 32%) as a 
yellow oil. 
1
H NMR (300 MHz, CDCl3) δ 11.4 (s, 2H), 7.28 (s, 1H), 7.04 (m, 1H), 6.69 (m, 1H), 6.25 (m, 
1H), 5.94 (s, 1H), 5.54 (m, 1H), 5.34 (m, 1H), 3.89 (s, 3H), 3.45 (t, J = 6.9 Hz, 2H), 2.45 (m, 
2H), 2.09 (s, 3H, CH3CO2
-
), 2.02 (m, 2H), 1.22 (m, 12H), 0.85 (t, J = 6.8 Hz, 3H). 
13
C NMR (75 MHz, CDCl3) δ 179.0, 163.5, 142.9, 140.6, 134.1, 123.9, 123.7, 123.1, 112.5, 
110.9, 110.1, 91.2, 58.2, 50.8, 31.8, 29.7, 29.5, 29.3, 29.3, 28.4, 27.4, 24.5, 22.6, 14.1. 
IR (KBr) νmax 3431, 2925, 2853, 1666, 1601, 1576, 1528, 1426 cm
-1
. 
Mass spectrum (ESI, 70 eV) m/z 356 [(M+H)
+
, 100%]. 
HRESIMS Found: (M+H)
+
, 356.2694. C22H33N3O requires (M+H)
+
, 356.2702. 
tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trimethylsilyl)-pyrrole-1-
carboxylate (51) 
 
[1,1′-Bis(diphenylphosphino)ferrocene]dichloropalladium(II)/CH2Cl2 complex (71 mg, 
0.087 mmol) was suspended in a magnetically stirred solution of pyrrole 49 (1.0 g, 3.15 mmol) 
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and triethylamine (1.4 mL, 10 mmol) in 1,4-dioxane (15 mL). Pinacolborane (50) (0.7 mL, 
4.8 mmol) was added and the ensuing suspension was stirred for at 80 ºC for 20 h. After this 
time, the mixture was diluted with n-hexane and rinsed with water (3 × 50 mL). The organic 
layer was dried (MgSO4), filtered and concentrated under reduced pressure to afford the title 
pyrrole 51 (0.91 g, 80%) as tan crystals, mp = 86 ºC. 
1
H NMR (300 MHz, CDCl3) δ 6.72 (d, J = 3.0 Hz, 1H), 6.44 (d, J = 3.0 Hz, 1H), 1.62 (s, 9H), 
1.32 (s, 12H), 0.26 (s, 9H). 
13
C NMR (75 MHz, CDCl3) δ 151.5, 140.4, 124.0, 123.1, 84.2, 83.4, 27.9, 24.8, -0.1 (one signal 
obscured or overalapping). 
IR (KBr) νmax 2980, 1735, 1534, 1460, 1340, 1206, 1145, 1081, 841, 688 cm-1. 
Mass spectrum (EI, 70 eV) m/z 365 (M
+•
, 25%), 294 (80), 265 (78), 250 (99), 194 (100), 83 
(50), 57 (80). 
HREIMS Found: M
+•
, 365.2193. C18H32BNO4Si requires M
+•
, 365.2194. 
3-Methoxy-5-(1-(tert-butoxycarbonyl)-5-(trimethylsilyl)-pyrrol-2-yl)pyrrole-2-
carbaldehyde (52) and 3-Methoxy -5-(5-(trimethylsilyl)-pyrrol-2-yl)pyrrole-2-
carbaldehyde (53) 
 
Pd(PPh3)4 was generated in situ by adding triphenyl phosphine (1.0 g, 3.8 mmol) to a 
magnetically stirred suspension of palladium(II) acetate (191 mg, 0.85 mmol) in degassed 
toluene (3 mL) then heating the ensuing mixture to 70 °C for 0.33 h under nitrogen. In a 
separate flask, a solution of pyrrole 51 (4.2 g, 11.5 mmol) and azafulvene 40 (2.0 g, 7.7 mmol) 
in water/1,4-dioxane (30 mL of a 1:9 v/v mixture) was degassed, purged with nitrogen and then 
transferred to the suspension of Pd(PPh3)4 in toluene prepared as described above. Sodium 
carbonate (2.4 g, 22.6 mmol) was then added to the reaction mixture that was then stirred at 
100 °C for 15 h before being cooled and poured into water (100 mL). The mixture was 
neutralized throught the addition of HCl (2M aqueous solution) then extracted with 
dichloromethane (3 × 100 mL). the combined organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure and the ensuing brown oil was subjected to flash 
chromatography (silica, 1:3 v/v ethyl acetate/hexane elution). In this manner two fractions, A 
and B, were obtained. 
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Concentration of fraction A (Rf = 0.4 in 1:3 ethyl acetate/hexane) afforded aldehyde 52 
(660 mg, 23%) as white crystals, mp = 147 °C. 
1
H NMR (300 MHz, CDCl3) δ 9.50 (s, 1H), 8.90 (s, 1H), 6.47 (d, J = 3.3 Hz, 1H), 6.43 (d, J = 
3.3 Hz, 1H), 5.91 (d, J = 2.7 Hz, 1H), 3.88 (s, 3H), 1.41 (s, 9H), 0.30 (s, 9H). 
IR (KBr) νmax 3215, 1748, 1608, 1363, 1321, 1167, 1137, 1020, 844 cm
-1
. 
Mass spectrum (EI, 70 eV) m/z 362 (M
+•
, 15%), 306 (70), 291 (45), 263 (65), 262 (100), 247 
(80), 57 (74). 
HREIMS Found: M
+•
, 362.1661. C18H26N2O4Si requires M
+•
, 362.1662. 
This somewhat unstable compound was used immediately in the next step of the reaction 
sequence. 
Concentration of fraction B (Rf = 0.3 in 1:3 ethyl acetate/hexane) afforded the title aldehyde 53 
(1.22 g, 60%) as pale-yellow crystals, mp = 115 °C. 
1
H NMR (300 MHz, CDCl3) δ 12.01 (s, 1H), 11.90 (s, 1H), 9.18 (s, 1H), 6.70 (m, 1H), 6.46 (m, 
1H), 6.03 (d, J = 2.7 Hz, 1H), 3.94 (s, 3H), 0.34 (s, 9H). 
13
C NMR (75 MHz, CDCl3) δ 170.2, 162.2, 137.0, 135.7, 127.0, 118.5, 118.1, 111.5, 91.4, 57.9, 
0.9 cm
-1
. 
IR (KBr) νmax 3259, 3191, 2955, 1595, 1344, 1247, 1166, 1020, 951, 839 cm
-1
. 
Mass spectrum (EI, 70 eV) m/z 262 (M
+•
, 100%), 247 (75). 
HREIMS Found: M
+•
, 262.1138. C13H18N2O2Si requires M
+•
, 262.1138. 
3-Methoxy-5-(5-(trimethylsilyl)-pyrrol-2-yl)pyrrole-2-carbaldehyde (53) 
 
A solution of aldehyde 52 (370 mg, 1.01 mmol) in m-xylene (20 mL) was heated at reflux for 1 
h and then cooled and concentrated under reduced pressure to give the title aldehyde 53 
(270 mg, 100%) as pale-yellow crystals. This material was identical, in all respects, with an 
authentic sample generate as described immediately above. 
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3-Methoxy-5-(5-bromopyrrol-2-yl)pyrrole-2-carbaldehyde (54) 
 
Pyridinium hydrobromide perbromide (730 mg, 2.3 mmol) was added, in one portion, to a 
magnetically stirred solution of aldehyde 53 (580 mg, 2.2 mmol) in THF (30 mL) maintained at 
− 78 ºC. The ensuing mixture was slowly warmed to 18 ºC, stirred at this temperature for 2 h 
then poured into water (100 mL) and extracted into ethyl acetate (3 × 100 mL). The combined 
organic extracts were diluted with ethanol (100 mL), then dried (MgSO4), filtered and 
concentrated under reduced pressure to afford the title aldehyde 54 (455 mg, 76%) as green 
crystals, mp = 163 ºC (dec.). 
1
H NMR (300 MHz, d6-DMSO) δ 11.87 (s, 1H), 11.43 (s, 1H), 9.32 (s, 1H), 6.77 (s, 1H), 6.33 
(s, 1H), 6.18 (s, 1H), 3.83 (s, 3H). 
13
C NMR (75 MHz, d6-DMSO) δ 172.2, 158.5, 131.9, 125.3, 117.6, 111.5, 109.6, 100.3, 91.3, 
57.9. 
IR (KBr) νmax 3245, 3209, 2923, 1594, 1519, 1504, 1427, 1342, 1298, 1166, 1021, 832, 773 
cm
-1
. 
Mass spectrum (EI, 70 eV) m/z 270 and 268 (M
+•
, both 100%), 190 (25). 
HREIMS Found: M
+•
, 267.9847. C10H9
79
BrN2O2Si requires M
+•
, 267.9847. 
Microanalysis Calculated for C10H9BrN2O2Si C, 44.63; H, 3.37; N, 10.41. Found C, 44.48; H, 
3.23; N, 10.15%. 
Tambjamine G (8) 
 
Acetic acid (110 μL, 1.9 mmol) and ethylamine (1 mL of a 2 M solution in methanol, 2.0 mmol) 
were added to a magnetically stirred solution of aldehyde 54 (58 mg, 0.22 mmol) in 1,2-
dichloroethane (10 mL) under an atmosphere of nitrogen and the ensuing mixture was stirred at 
60 ºC for 3 h then diluted with water (10 mL) and dichloromethane (10 mL). The layers were 
separated and the organic layer was rinsed with water (2 × 10 mL) then concentrated under 
reduced pressure to afford the title imine 8
42
 (69 mg, 90%) as a yellow oil. 
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1
H NMR (300 MHz, CDCl3) δ 11.10 (broad s, 2H), 7.34 (s, 1H), 6.58 (d, J = 3.9 Hz, 1H), 6.16 
(d, J = 3.9 Hz, 1H), 5.89 (s, 1H), 3.87 (s, 3H), 3.50 (t, J = 7.2 Hz, 2H), 2.11 (s, 3H, CH3CO2
−
), 
1.36 (t, J = 7.2 Hz, 3H). 
13
C NMR (75 MHz, CDCl3) δ 179.7, 163.6, 141.6, 140.9, 124.6, 113.8, 112.5, 111.2, 105.4, 
91.1, 58.5, 45.9, 24.9, 15.8 cm
-1
. 
IR (KBr) νmax 3429, 2930, 1668, 1610, 1526, 1407, 1344, 1260, 1157, 1011, 979, 800 cm
-1
. 
Mass spectrum (ESI, 70 eV) m/z 298 and 296 [(M+H)
+
, both 100%], 217 (65), 175 (25), 140 
(10), 112 (5). 
HRESIMS Found: (M+H)
+
, 296.0393. C12H14
79
BrN3O requires (M+H)
+
, 296.0393. 
Tambjamine H (9) 
 
Acetic acid (125 μL, 2.2 mmol) and n-propylamine (180 μL, 2.2 mmol) were added to a 
magnetically stirred solution of aldehyde 54 (58 mg, 0.22 mmol) in 1,2-dichloroethane (10 mL) 
under an atmosphere of nitrogen and the ensuing mixture was stirred at 18 ºC for 4 h then 
diluted with water (10 mL) and dichloromethane (10 mL). The layers were separated and the 
organic layer was rinsed with water (2 × 10 mL) then concentrated under reduced pressure to 
afford the title alkaloid 9
42
 (78 mg, 99%) as a yellow oil. 
1
H NMR (300 MHz, CDCl3) δ 11.30 (broad s, 2H), 7.29 (s, 1H), 6.53 (d, J = 3.6 Hz, 1H), 6.14 
(d, J = 3.6 Hz, 1H), 5.84 (s, 1H), 3.84 (s, 3H), 3.37 (t, J = 7.1 Hz, 2H), 2.08 (s, 3H, CH3CO2
−
), 
1.71 (m, 2H), 0.96 (t, J = 7.4 Hz, 3H). 
IR (KBr) νmax 29303436, 2930, 1669, 1619, 1527, 1405, 1365, 1306, 1232, 1160, 1013, 777, 
647 cm
-1
. 
Mass spectrum (EI, 70 eV) m/z 311 and 309 [(M+H)
+
, both 80%], 296 and 294 (both 30), 282 
and 280 (both 50), 255 and 253 (both 30), 231 (50), 43 (100). 
HREIMS Found: (M+H)
+
, 310.0556. C13H16
79
BrN3O requires (M+H)
+
, 310.0555. 
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Tambjamine I (10) 
 
Acetic acid (110 μL, 1.9 mmol) and i-butylamine (190 μL, 1.9 mmol) were added to a 
magnetically stirred solution of aldehyde 54 (50 mg, 0.19 mmol) in 1,2-dichloroethane (10 mL) 
under an atmosphere of nitrogen and the ensuing mixture was stirred at 18 ºC for 4 h then 
diluted with water (10 mL) and dichloromethane (10 mL). The layers were separated and the 
organic layer was rinsed with water (2 × 10 mL) then concentrated under reduced pressure to 
afford the title imine 10
42
 (58 mg, 81%) as a yellow oil. 
1
H NMR (300 MHz, CDCl3) δ 11.10 (broad s, 2H), 7.26 (s, 1H), 6.55 (d, J = 3.6 Hz, 1H), 6.15 
(d, J = 3.6 Hz, 1H), 5.86 (s, 1H), 3.86 (s, 3H), 3.23 (d, J = 6.6 Hz, 1H), 2.08 (s, 3H, CH3CO2
−
), 
1.97 (m, 1H), 0.97 (d, J = 6.9 Hz, 6H). 
13
C NMR (75 MHz, CDCl3) δ 179.2, 163.4, 141.5, 141.3, 124.4, 113.5, 112.1, 110.8, 105.2, 
90.7, 58.6, 58.2, 29.4, 24.5, 19.7 cm
-1
. 
IR (KBr) νmax 3436, 2961, 1667, 1619, 1527, 1402, 1304, 1238, 1148, 1014, 779, 646 cm
-1
. 
Mass spectrum (EI, 70 eV) m/z 325 and 323 (M
+•
, both 25%), 310 and 308 (both 10), 282 and 
280 (both 30), 245 (10), 202 (15), 186 (15), 85 (62), 83 (100), 43 (53). 
HREIMS Found: M
+•
, 324.0724. C14H18
79
BrN3O requires M
+•
, 324.0711. 
Tambjamine J (11) 
 
Acetic acid (110 μL, 1.9 mmol) and 2-methylbutylamine (225 μL, 1.9 mmol) were added to a 
magnetically stirred solution of aldehyde 54 (52 mg, 0.19 mmol) in 1,2-dichloroethane (10 mL) 
under an atmosphere of nitrogen and the ensuing mixture was stirred at 18 ºC for 4 h then 
diluted with water (10 mL) and dichloromethane (10 mL). The layers were separated and the 
organic layer was rinsed with water (2 × 10 mL) then concentrated under reduced pressure to 
afford the title imine 11
42
 (69 mg, 90%) as a yellow oil. 
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1
H NMR (300 MHz, CDCl3) δ 11.10 (broad s, 2H), 7.26 (s, 1H), 6.56 (d, J = 3.9 Hz, 1H), 6.15 
(d, J = 3.9 Hz, 1H), 5.87 (s, 1H), 3.86 (s, 3H), 3.28 (m, 1H), 2.09 (s, 3H, CH3CO2
−
), 1.73 (m, 
1H), 1.46 (m, 1H), 1.19 (m, 1H), 0.93 (m, 6H). 
13
C NMR (75 MHz, CDCl3) δ 179.3, 163.4, 141.5, 141.3, 124.4, 113.5, 112.1, 110.9, 105.3, 
90.8, 58.2, 57.0, 35.8, 26.5, 24.6, 16.7, 11.1 cm
-1
. 
IR (KBr) νmax 3436, 2963, 1663, 1613, 1525, 1402, 1337, 1228, 1157, 1008, 775, 647 cm
-1
. 
Mass spectrum (EI, 70 eV) m/z 339 and 337 (M
+•
, both 15%), 310 and 308 (both 10), 282 and 
280 (both 20), 259 (5), 202 (15), 186 (10), 45 (58), 43 (100). 
HREIMS Found: M
+•
, 337.0789. C15H20
79
BrN3O requires M
+•
, 337.0790. 
4.3 EXPERIMENTAL PROCEDURES FOR CHAPTER TWO 
(1S,2R,3R,4S)-3-bromo-6-chlorocyclohex-5-ene-1,2,4-triol (91) 
 
A magnetically stirred solution of compound 88 (10.2 g, 69.8 mmol) in THF/H2O (4:1, v/v, 
200 mL) was treated with N-bromosuccinimide (12.4 g, 69.8 mmol). The ensuing mixture was 
stirred at 20 °C for 0.5 h. Na2S2O3 (0.48 g, 1.9 mmol) was added and after a further 0.5 h, the 
mixture was diluted with brine (200 mL) and extracted with diethyl ether (3 × 150 mL). The 
combined organic extracts were dried (MgSO4), filtered and concentrated under reduced 
pressure to an amber-colored oil. Subjection of this material to flash chromatography (silica, 1:1 
v/v ethyl acetate/hexane elution) and concentration of the appropriate fractions (Rf = 0.3) then 
gave the title compound 91 (10.8 g, 64%) as a white, crystalline solid, m.p. = 58-60 °C. 
1
H NMR (300 MHz, d6-DMSO) δ 5.80 (d, J = 2.4 Hz, 1H), 5.72 (br s, 1H), 5.52 (br s, 1H), 4.18 
(dd, J = 8.4 and 2.4 Hz, 1H), 3.98 (d, J = 3.6 Hz, 1H), 3.91 (dd, J = 11.4 and 8.4 Hz, 1H), 3.56 
(dd, J = 11.4 and 3.6 Hz, 1H) (one signal due to hydroxyl group signal not observed). 
13
C NMR (75 MHz, d6-DMSO) δ 132.6, 130.9, 72.0, 71.7, 70.3, 59.8. 
IR (KBr) νmax 3316, 1655, 1445, 1330, 1241, 1193, 1092, 1061, 1035, 1008, 879 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 244 and 242 (M
+•
, 2 and 1%), 226 and 224 (both 30), 209 and 
207 (6 and 4), 191 and 189 (10 and 9), 163 (100), 145 (90), 20 (96), 91 (85), 81 (75), 53 (100). 
HREIMS Found: M
+•
, 241.9336. C6H8
79
Br
35
ClO3 requires M
+•
, 241.9345. 
Optical rotation [α]D −67.0 (c 5.0, THF). 
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(1S,2R,3R,4S)-3,6-dibromocyclohex-5-ene-1,2,4-triol (92) 
 
Compound 89 (5.30 g, 27.8 mmol) was subjected to the same procedure as employed for the 
conversion 88 → 91 and an orange crystalline solid was thereby obtained. Subjection of this 
material to flash chromatography (silica, 1:1 v/v ethyl acetate/hexane elution) and concentration 
of the appropriate fractions (Rf = 0.3) then gave the title compound 92 (7.00 g, 89%) as a white, 
crystalline solid, m.p. = 116-118 °C. 
1
H NMR (300 MHz, d6-DMSO) δ 6.00 (d, J = 2.1 Hz, 1H), 5.79 (d, J = 7.2 Hz, 1H), 5.73 (d, J 
= 6.3 Hz, 1H), 5.47 (d, J = 7.8 Hz, 1H), 4.14 (m, 1H), 4.05 (m, 1H), 3.91 (m, 1H), 3.58 (m, 
1H). 
13
C NMR (75 MHz, d6-DMSO) δ 135.0, 123.6, 73.3, 73.1, 70.5, 59.7. 
IR (KBr) νmax 3271, 1641, 1471, 1277, 1193, 1095, 1065, 1024, 998, 894, 869, 749 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 288 (M
+•
, <1%), 272, 270 and 268 (2, 5 and 2), 191 and 189 
(90 and 85), 166 and 164 (87 and 86), 82 (85), 81 (95), 71 (87), 53 (100). 
HREIMS Found: M
+•
, 287.8825. C6H8
79
Br
81
BrO3 requires M
+•
, 287.8820. 
Optical rotation [α]D −61.7 (c 5.0, EtOH). 
(1S,2R,3R,4S)-3-bromo-6-iodocyclohex-5-ene-1,2,4-triol (93) 
 
Compound 90 (10.6 g, 44.6 mmol) was subjected to the same procedure as employed for the 
conversion 88 → 91 and a light-yellow oil was thereby obtained. Subjection of this material to 
flash chromatography (silica, 1:1 v/v ethyl acetate/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.3) then gave the title compound 93 (9.84 g, 66%) as a white, 
crystalline solid, m.p. = 125-127 °C. 
1
H NMR (300 MHz, d6-DMSO) δ 6.22 (d, J = 2.4 Hz, 1H), 5.77 (d, J = 7.2 Hz, 1H), 5.66 (d, J 
= 6.3 Hz, 1H), 5.44 (d, J = 7.5 Hz, 1H), 4.09 (m, 2H), 3.91 (m, 1H), 3.58 (m, 1H). 
13
C NMR (75 MHz, d6-DMSO) δ 142.0, 100.4, 76.1, 74.5, 70.3, 59.9. 
IR (KBr) νmax 3255, 1629, 1281, 1191, 1106, 1065, 1021, 998, 890, 863 cm
–1
. 
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Mass spectrum (EI, 70 eV) m/z 336 and 334 (M
+•
, both 10%), 237 (100), 212 (95), 191 (45), 
128 (35), 110 (75), 82 (60), 43 (60). 
HREIMS Found: M
+•
, 333.8700. C6H8
79
Br
127
IO3 requires M
+•
, 333.8702. 
Optical rotation [α]D −63.5 (c 5.0, THF). 
(1R,2S,5S,6S)-3-chloro-7-oxabicyclo[4.1.0]hept-3-ene-2,5-diol (94) 
 
A magnetically stirred solution of compound 91 (3.34g, 13.7 mmol) in THF (35 mL) was 
treated with finely-ground sodium methoxide (820 mg, 15.2 mmol). The ensuing mixture was 
stirred at 20 °C for 1 h and then passed through a plug of silica gel and concentrated under 
reduced pressure to afford a dark-brown oil. Subjection of this material to flash chromatography 
(silica, 3:1 v/v ethyl acetate/hexane elution) and concentration of the appropriate fractions (Rf = 
0.3) then gave the title compound 94 (1.17 g, 52%) as a white, crystalline solid, m.p. = 140-
142 °C. 
1
H NMR (300 MHz, d6-DMSO) δ 5.78 (d, J = 7.5 Hz, 1H), 5.53 (dd, J = 4.1, 2.0 Hz, 1H), 5.46 
(d, J = 6.6 Hz, 1H), 4.38 (m, 1H), 4.24 (m, 1H) (signals due to hydroxyl group proton not 
observed). 
13
C NMR (75 MHz, d6-DMSO) δ 131.3, 126.3, 65.0, 64.8, 54.5, 54.1. 
IR (KBr) νmax 3246, 1654, 1409, 1351, 1280, 1255, 1045, 923, 811, 766, 661, 595 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 164 and 162 (M
+•
, <1% and 3%), 127 (40), 115 (50), 109 (40), 
81 (85), 71 (100), 53 (85), 41 (95). 
HREIMS Found: M
+•
, 162.0086. C6H7
35
ClO3 requires M
+•
, 162.0084. 
Optical rotation [α]D +5.6 (c 5.0, THF). 
(1R,2S,5S,6S)-3-bromo-7-oxabicyclo[4.1.0]hept-3-ene-2,5-diol (95) 
 
Compound 92 (1.69 g, 5.88 mmol) was subjected to the same procedure as employed for the 
conversion 91 → 94 and a dark-brown oil was thereby obtained. Subjection of this material to 
flash chromatography (silica, 3:1 v/v ethyl acetate/hexane elution) and concentration of the 
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appropriate fractions (Rf = 0.3) then gave the title compound 95 (0.670 g, 56%) as a white, 
crystalline solid, m.p. = 134-136 °C. 
1
H NMR (300 MHz, d6-DMSO) δ 5.80 (d, J = 7.8 Hz, 1H), 5.76 (d, J = 2.1 Hz, 1H), 5.48 (d, J 
= 6.6 Hz, 1H), 4.32 (m, 1H), 4.24 (m, 1H), 3.48-3.30 (complex m, 2H). 
13
C NMR (75 MHz, d6-DMSO) δ 130.4, 124.0, 65.8, 65.5, 54.4, 54.2. 
IR (KBr) νmax 3229, 1647, 1747, 1348, 1281, 1254, 1039, 943, 919, 882, 760 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 208 and 206 (M
+•
, both 15%), 191 and 189 (both 10), 161 and 
159 (both 30), 127 (60), 81 (70), 71 (95), 54 (100). 
HREIMS Found: M
+•
, 205.9579. C6H7
79
BrO3 requires M
+•
, 205.9579. 
Optical rotation [α]D +16.6 (c 5.0, THF). 
(1R,2S,5S,6S)-3-iodo-7-oxabicyclo[4.1.0]hept-3-ene-2,5-diol (96) 
 
Compound 93 (9.84 g, 29.4 mmol) was subjected to the same procedure as employed for the 
conversion 91 → 94 and a dark-brown oil was thereby obtained. Subjection of this material to 
flash chromatography (silica, 3:1 v/v ethyl acetate/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.3) then gave the title compound 96 (5.89 g, 79%) as a clear, 
crystalline solid, m.p. = 124-126 °C. 
1
H NMR (300 MHz, d6-DMSO) δ 6.06 (dd, J = 4.4 and 2.0 Hz, 1H), 5.83 (d, J = 8.1 Hz, 1H), 
5.47 (d, J = 6.6 Hz, 1H), 4.26 (m, 1H), 4.13 (m, 1H) (signals due to hydroxyl group protons not 
observed). 
13
C NMR (75 MHz, d6-DMSO) δ 138.3, 103.7, 67.1, 66.2, 54.2, 53.5. 
IR (KBr) νmax 3232, 1630, 1282, 1050, 1035, 915, 874, 757, 651 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 254 (M
+•
, 100%), 207 (20), 127 (85), 109 (50), 81 (85), 71 
(60), 53(99), 43(98). 
HREIMS Found: M
+•
, 253.9442. C6H7
127
IO3 requires M
+•
, 253.9440. 
Optical rotation [α]D +26.4 (c 5.0, THF). 
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(1S,2R,5S,6R)-4-chloro-5-hydroxy-7-oxabicyclo[4.1.0]hept-3-en-2-yl 2-chloroacetate (98) 
 
A magnetically stirred solution of compound 94 (1.41 g, 8.69 mmol) in THF (30 mL) was 
treated with chloroacetic acid (1.01 g, 10.7 mmol), ditertbutyl azodicarboxylate (2.02 g, 
8.78 mmol) and triphenylphosphine (2.28 g, 8.69 mmol). Then ensuing mixture was stirred at 
20 °C for 0.25 h and then concentrated under reduced pressure to an amber-colored oil. 
Subjection of this material to flash chromatography (silica, 1:2 v/v ethyl acetate/hexane elution) 
and concentration of the appropriate fractions (Rf = 0.3) then gave the title compound 98 
(1.50 g, 72%) as a white solid, m.p. = 78-81 °C. 
1
H NMR (300 MHz, d6-DMSO) δ 5.88 (ddd, J = 5.1, 1.7 and 1.7 Hz, 1H), 5.61 (ddd, J = 5.1, 
2.4, 1.7 Hz, 1H), 4.51 (m, 1H), 4.10 (s, 2H), 3.68 (m, 1H), 3.50 (m, 1H), 2.78 (broad s, 1H). 
13
C NMR (75 MHz, d6-DMSO) δ 166.4, 138.0, 120.1, 67.1, 66.2, 54.4, 53.2, 40.5. 
IR (KBr) νmax 3449, 1753, 1656, 1402, 1324, 1298, 1188, 963, 930, 895, 832 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 238 (M
+•
, 1%), 162 (40), 146 and 144 (46 and 95), 81 (95), 77 
(100), 71 (80), 53(90). 
HREIMS Found: M
+•
, 237.9799. C8H8
35
Cl2O4 requires M
+•
, 237.9800. 
Optical rotation [α]D −147.6 (c 5.0, CHCl3). 
(1S,2R,5S,6R)-4-bromo-5-hydroxy-7-oxabicyclo[4.1.0]hept-3-en-2-yl 2-chloroacetate (99) 
 
Compound 95 (1.90 g, 9.19 mmol) was subjected to the same procedure as employed for the 
conversion 94 → 98 and an amber-colored oil was thereby obtained. Subjection of this material 
to flash chromatography (silica, 1:2 v/v ethyl acetate/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.3) then gave the title compound 99 (1.52 g, 59%) as a white solid, 
m.p. = 99-102 °C. 
1
H NMR (300 MHz, d6-DMSO) δ 6.13 (m, 1H), 5.51 (m, 1H), 4.52 (m, 1H), 4.10 (s, 2H), 3.66 
(mz, 1H), 3.50 (m, 1H), 2.75 (broad s, 1H). 
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13
C NMR (75 MHz, d6-DMSO) δ 166.4, 130.3, 124.2, 67.63, 67.1, 54.3, 53.3, 40.5. 
IR (KBr) νmax 3241, 1750, 1631, 1407, 1325, 1296, 1169, 1057, 989, 949, 897, 830, 787 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 208 and 206 [(M−ClCHCO)+•, both 10%], 190 and 188 (both 
50), 127 (50), 109 (80), 81 (100). 
HREIMS Found: (M−ClCHCO)+•, 207.9557. C8H8
79
BrClO4 requires (M−ClCHCO)
+•
, 
207.9558. 
Optical rotation [α]D −145.8 (c 3.5, CHCl3). 
(1S,2R,5S,6R)-5-hydroxy-4-iodo-7-oxabicyclo[4.1.0]hept-3-en-2-yl 2-chloroacetate (100) 
 
Compound 96 (1.92 g, 7.56 mmol) was subjected to the same procedure as employed for the 
conversion 94 → 98 and a amber-colored oil was thereby obtained. Subjection of this material 
to flash chromatography (silica, 1:2 v/v ethyl acetate/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.3) then gave the title compound 100 (1.92 g, 77%) as a white, 
crystalline solid, m.p. = 112-114 °C. 
1
H NMR (300 MHz, d6-DMSO) δ 6.45 (m, 1H), 5.37 (ddd, J = 4.8, 2.4 and 1.5 Hz, 1H), 4.44 
(m, 1H), 4.11 (s, 2H), 3.61 (m, 1H), 3.52 (m, 1H), 2.80 (broad s, 1H). 
13
C NMR (75 MHz, d6-DMSO) δ 166.4, 132.2, 109.0, 68.7, 67.3, 53.5, 53.4, 40.5. 
IR (KBr) νmax 3241, 1750, 1631, 1407, 1325, 1296, 1169, 1057, 989, 949, 897, 830, 787 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 332 and 330 (M
+•
, 3 and 10%), 236 (95), 206 (18), 127 (70), 
109 (85), 81 (100), 76 (83). 
HREIMS Found: M
+•
, 329.9161. C8H8
35
Cl
127
IO4 requires M
+•
, 329.9156. 
Optical rotation [α]D −72.5 (c 5.0, CHCl3). 
(1S,2R,6S)-4-chloro-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl 2-chloroacetate (101) 
 
A magnetically stirred solution of compound 98 (481 mg, 2.01 mmol) in DCM (45 mL) was 
treated with acetic acid (0.14 mL, 2.45 mmol) and pyridinium dichromate (835 mg, 2.22 mmol). 
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The ensuing mixture was stirred at 20 °C for 1 h and then diluted with diethyl ether and passed 
through a plug of silica gel. The filtrate was concentrated under reduced pressure to a dark-
brown oil. Subjection of this material to flash chromatography (silica, 1:4 v/v ethyl 
acetate/hexane elution) and concentration of the appropriate fractions (Rf = 0.3) then gave the 
title compound 101 (310 mg, 65%) as a white solid, m.p. 84-85 °C. 
1
H NMR (300 MHz, d6-DMSO) δ 6.78 (dd, J = 5.4 and 2.4 Hz, 1H), 5.87 (ddd, J = 5.4, 1.5 and 
1.5 Hz, 1H), 4.13 (s, 2H), 3.80 (m, 1H), 3.68 (m, 1H). 
13
C NMR (75 MHz, d6-DMSO) δ 185.4, 166.2, 134.3, 134.0, 66.2, 54.4, 53.2, 40.2. 
IR (KBr) νmax 1767, 1703, 1317, 1157, 975, 787 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 238 and 236 (M
+•
, 3 and 5%), 162 and 160 (30 and 65), 131 
(80), 115 (52), 76 and 77 (60 and 100), 51 (90). 
HREIMS Found: M
+•
, 235.9643. C8H6
35
Cl2O4 requires M
+•
, 235.9643. 
Optical rotation [α]D −327.3 (c 5.0, CHCl3). 
(1S,2R,6S)-4-bromo-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl 2-chloroacetate (102) 
 
Compound 99 (518 mg, 1.83 mmol) was subjected to the same procedure as employed for the 
conversion 98 → 101 and a dark-brown oil was thereby obtained. Subjection of this material to 
flash chromatography (silica, 1:4 v/v ethyl acetate/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.3) then gave the title compound 102 (394 mg, 77%) as a pale-
yellow oil. 
1
H NMR (300 MHz, d6-DMSO) δ 7.04 (dd, J = 5.4 and 2.4 Hz, 1H), 5.78 (ddd, J = 5.4, 1.2 and 
1.2 Hz, 1H), 4.13 (s, 2H), 3.80 (m, 1H), 3.68 (m, 1H). 
13
C NMR (75 MHz, d6-DMSO) δ 185.5, 166.2, 138.3, 126.0, 66.6, 54.4, 52.7, 40.2. 
IR (KBr) νmax 1767, 1703, 1317, 1157, 975, 787 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 284, 282 and 280 (M
+•,
 2, 10 and 8%), 206 and 204 (both 75), 
177 and 175 (both 70), 97 (60), 79 (87), 77 (95), 51 (100). 
HREIMS Found: M
+•
, 279.9139. C8H6
79
Br
35
ClO4 requires M
+•
, 279.9138. 
Optical rotation [α]D −251.3 (c 5.0, CHCl3). 
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(1S,2R,6S)-4-iodo-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl 2-chloroacetate (103) 
 
Compound 100 (3.45 g, 10.4 mmol) was subjected to the same procedure as employed for the 
conversion 98 → 101 and a dark-brown oil was thereby obtained. Subjection of this material to 
flash chromatography (silica, 1:4 v/v ethyl acetate/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.3) then gave the title compound 103 (2.57 g, 75%) as a pale-yellow 
oil. 
1
H NMR (300 MHz, d6-DMSO) δ 7.37 (dd, J = 5.4 and 2.4 Hz, 1H), 5.69 (ddd, J = 5.4, 1.2 and 
1.2 Hz, 1H), 4.14 (s, 2H), 3.82 (m, 1H), 3.68 (dd, J = 3.6 and 1.2 Hz, 1H). 
13
C NMR (75 MHz, d6-DMSO) δ 186.9, 166.2, 146.1, 105.6, 67.2, 54.5, 51.1, 40.2. 
IR (KBr) νmax 1767, 1697, 1318, 1157, 1003, 969, 781 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 330 and 328 (M
+•
, 25 and 60%), 252 (100), 223 (63), 125 (66), 
125 (66), 77 (85). 
HREIMS Found: M
+•
, 327.8996. C8H6
35
ClIO4 requires M
+•
, 327.8999. 
Optical rotation [α]D −140.2 (c 3.2 acetone). 
(1S,5R,6S)-3-chloro-5-hydroxy-7-oxabicyclo[4.1.0]hept-3-en-2-one (104) 
 
A magnetically stirred solution of compound 101 (295 mg, 1.24 mmol) in methanol (10 mL) 
was treated with zinc(II) acetate dihydrate (600 mg, 2.73 mmol). The ensuing mixture was 
stirred at 20 °C for 1 h and then concentrated under reduced pressure to afford a white solid. 
This material was treated with ethyl acetate (20 mL) and the resulting mixture washed with 
water (1 × 20 mL) and brine (1 × 20 mL) before being dried (MgSO4), filtered and concentrated 
under reduced pressure to give a white solid. Subjection of this material to flash 
chromatography (silica, 2:3 v/v ethyl acetate/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.35) then gave the title compound 104 (168 mg, 84%) as a white, 
crystalline solid, m.p. = 127-128 °C. 
146 Chapter Four  
1
H NMR (300 MHz, d6-acetone) δ 7.00 (dd, J = 5.1, 2.1 Hz, 1H), 5.17 (br s, 1H), 4.79 (br d, J = 
5.4 Hz, 1H), 3.86 (ddd, J = 3.6, 2.1, 1.2 Hz, 1H), 3.67 (dd, J = 3.6, 1.2 Hz, 1H). 
13
C NMR (75 MHz, d6-acetone) δ 206.4, 187.4, 142.4, 130.9, 64.3, 58.5, 54.5. 
IR (KBr) νmax 3494, 1686, 1613, 1391, 1041, 1030, 986, 798 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 160 and162 (M
+•
, 11 and 4%), 131 and 133 (70 and 33), 125 
(100), 103 and 105 (88 and 41), 97 (99), 71 (100), 39 (69). 
HREIMS Found: M
+•
, 159.9927. C6H5
35
ClO3 requires M
+•
, 159.9927. 
Optical rotation [α]D −290.5 (c 3.45, acetone). 
Compound ent-55 [(−)-bromoxone] 
 
A magnetically stirred solution of compound 102 (132 mg, 0.469 mmol) in methanol (10 mL) 
was treated with zinc(II) acetate dihydrate (245 mg, 1.12 mmol). The ensuing mixture was 
stirred at 20 °C for 1 h and then concentrated under reduced pressure to afford a white solid. 
This material was treated with ethyl acetate (20 mL) and the resulting mixture washed with 
water (1 × 20 mL) and brine (1 × 20 mL) before being dried (MgSO4), filtered and concentrated 
under reduced pressure to give a white solid. Subjection of this material to flash 
chromatography (silica, 2:3 v/v ethyl acetate/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.35) then gave the title compound ent-55 (850 mg, 88%) as a white, 
crystalline solid, m.p. = 131-134 °C. 
1
H NMR (300 MHz, d6-acetone) δ 7.23 (dd, J = 5.1 and 2.1 Hz, 1H), 5.17 (broad s, 1H), 4.69 
(broad d, J = 4.2 Hz, 1H), 3.83 (m, 1H), 3.63 (m, 1H). 
13
C NMR (75 MHz, d6-acetone) δ 187.4, 146.8, 122.5, 65.0, 58.5, 54.0. 
IR (KBr) νmax 3467, 1689, 1611, 1254, 1046, 975, 896, 867, 791, 613, 545 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 206 and 204 (M
+•
, 15%), 177 and 175 (both 30), 149 and 147 
(both 30), 125 (100), 97 (62), 71 (60), 39 (55). 
HREIMS Found: M
+•
, 203.9424. C8H5
79
BrO3 requires M
+•
, 203.9422. 
Optical rotation [α]D −187.1 (c 1.75, acetone). 
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(1S,2R,5S,6R)-4-bromo-5-hydroxy-7-oxabicyclo[4.1.0]hept-3-en-2-yl acetate (107) 
 
A magnetically stirred solution of compound 95 (300 mg, 1.45 mmol) in THF (5 mL) was 
treated with acetic acid (125 µL, 2.19 mmol), ditertbutyl azodicarboxylate (337 mg, 1.46 mmol) 
and triphenylphosphine (387 mg, 1.48 mmol). The ensuing mixture was stirred at 20 °C for 0.25 
h and then concentrated under reduced pressure to an amber-colored oil. Subjection of this 
material to flash chromatography (silica, 1:2 v/v ethyl acetate/hexane elution) and concentration 
of the appropriate fractions (Rf = 0.3) then gave the title compound 107 (316 mg, 88%) as a 
white solid, m.p. = 75-77 °C. 
1
H NMR (300 MHz, CHCl3) δ 6.11 (ddd, J = 4.5, 1.8, 1.8 Hz, 1H), 5.44 (dm, 1H), 4.50 (m, 
1H), 3.63 (dm, J = 9.9 Hz, 1H), 3.46 (m, 1H), 2.80 (d, J = 9.9 Hz, 1H), 2.09 (s, 3H) (signal due 
to the hydroxyl proton not observed). 
13
C NMR (75 MHz, CHCl3) δ 169.9, 129.2, 125.2, 67.2, 65.5, 54.3, 53.7, 20.7. 
IR (KBr) νmax 3457, 2928, 1737, 1648, 1372, 1231, 1060, 1024, 893, 610 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 250 and 248 (M
+•
, both 3%), 208 and 206 (both 40), 190 and 
188 (both 49), 127 (61), 109 (69), 81 (81), 43 (100). 
HREIMS Found: M
+•
, 247.9684. C8H9BrO4 requires M
+•
, 247.9684. 
Optical rotation [α]D −127.8 (c 5.0, CHCl3). 
Compound 106 [(−)-O-acetylbromoxone] 
  
A magnetically stirred solution of compound 107 (118 mg, 0.47 mmol) in DCM (10 mL) was 
treated with acetic acid (40 µL, 0.63 mmol) and PDC (235 mg, 0.62 mmol). The ensuing 
mixture was stirred at 20 °C for 1.5 h and then treated with silica gel (5 mL) and diethyl ether 
(10 mL). The resulting mixture was filtered through Celite™ and the filtrate concentrated under 
reduced pressure to give a pale-orange oil. Subjection of this material to flash chromatography 
(silica, 1:3 v/v ethyl acetate/hexane elution) and concentration of the appropriate fractions (Rf = 
0.3) then gave the title compound ent-106 (60 mg, 51%) as a white, crystalline solid, m.p. = 
93.0-93.2 °C [lit.
105
 m.p. (for 106) = 93-94 °C]. 
148 Chapter Four  
1
H NMR (300 MHz, CDCl3) δ 7.05 (dd, J = 5.4 and 2.4 Hz, 1H), 5.73 (ddd, J = 5.4, 1.2 and 
1.2 Hz, 1H), 3.77 (m, 1H), 3.68 (dd, J = 3.6 and 1.2 Hz, 1H), 2.14 (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 185.9, 169.5, 139.6, 125.4, 65.2, 54.9, 52.9, 20.5. 
IR (KBr) νmax 1742, 1704, 1614, 1371, 1225, 1030, 971, 787 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 248 and 246 (M
+•
, both 5%), 206 and 204 (both 61), 177 and 
175 (both 43), 97 (62), 51 (59), 43 (100). 
HREIMS Found M
+•
, 245.9535. C8H7
79
BrO4 requires M
+•
, 245.9528. 
Optical rotation [α]D −278.2 (c 2.55, CHCl3) {lit.
105
 [α]D (for 1) +265 (c 0.12, CHCl3)}. 
(1S,5R,6S)-5-hydroxy-3-iodo-7-oxabicyclo[4.1.0]hept-3-en-2-one (105) 
 
Compound 103 (152 mg, 0.463 mmol) was subjected to the same procedure as employed for the 
conversion 102 → ent-55 and a white solid was thereby obtained. Subjection of this material to 
flash chromatography (silica, 2:3 v/v ethyl acetate/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.35) then gave the title compound 105 (101 mg, 87%) as a clear, 
crystalline solid, m.p. = 131-133 °C. 
1
H NMR (300 MHz, d6-acetone) δ 7.58 (dd, J = 5.4 and 2.4 Hz, 1H), 5.20 (d, J = 8.7 Hz, 1H), 
4.61 (m, 1H), 3.87 (m, 1H), 3.63 (dd, J = 3.6 and 1.5 Hz, 1H). 
13
C NMR (75 MHz, d6-acetone) δ 188.9, 155.0, 101.7, 65.8, 58.6, 52.4. 
IR (KBr) νmax 3480, 3049, 1678, 1595, 1246, 1043, 865, 786, 598, 538 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 252 (M
+•
, 70%), 223 (20), 125 (100), 97 (50), 71 (40), 53 (40), 
39 (42). 
HREIMS Found: M
+•
, 251.9283. C6H5
127
IO3 requires M
+•
, 251.9283. 
Optical rotation [α]D −102.1 (c 1.05, acetone). 
(1S,5R,6S)-5-triethylsilyloxy-3-iodo-7-oxabicyclo[4.1.0]hept-3-en-2-one (146) 
 
A magnetically stirred solution of compound 105 (1.52 g, 6.04 mmol) in DCM (25 mL) 
maintained at 0 °C was treated with 2,6-lutidine (1.05 mL, 8.94 mmol) and chlorotriethylsilane 
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(1.50 mL, 8.94 mmol). The ensuing mixture was stirred for 0.5 h and ethyl acetate (25 mL) was 
added and the solution was washed with NH4Cl (25 mL of a saturated aqueous solution) and 
brine (25 mL of a saturated aqueous solution). The separated organic layer was dried (MgSO4), 
filtered and concentrated under reduced pressure to yield a pale-yellow oil. Subjection of this 
material to flash chromatography (silica, 2:50 v/v diethyl ether/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.2) then gave the title compound 146 (1.21 g, 
55%) as a pale-yellow oil. 
1
H NMR (300 MHz, CDCl3) δ 7.28 (dd, J = 5.4 and 2.4 Hz, 1H), 4.57 (m, 1H), 3.69 (m, 1H), 
3.61 (dd, J = 3.6 and 1.2 Hz, 1H), 0.98 (t, J = 8.1 Hz, 9H), 0.67 (q, J = 8.1 Hz, 6H). 
13
C NMR (75 MHz, CDCl3) δ 187.5, 152.6, 102.0, 65.8, 58.2, 51.7, 6.6, 4.7. 
IR (KBr) νmax 2956, 2877, 1696, 1091, 789, 748 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 366 (M
+•
, 25%), 337 (70), 210 (100), 182 (60). 
HREIMS Found: M
+•
, 366.0157. C12H19
127
IO3Si requires M
+•
, 366.0148. 
Optical rotation [α]D −107.7 (c 1.65, CHCl3). 
(1S,5R,6R)-3-methyl-5-(triethylsilyloxy)-7-oxabicyclo[4.1.0]hept-3-en-2-one (147) 
 
A magnetically stirred solution of compound 146 (150 mg, 0.410 mmol) and tetramethyl 
stannane (225 mg, 1.26 mmol) in THF was treated with palladium(II) acetate (6 mg, 27 μmol), 
copper(I) iodide (7 mg, 37 μmol) and triphenylarsine (24 mg, 78 μmol). The ensuing mixture 
was heated at 80 °C in a sealed tube for 72 h, cooled and diluted with Na2SO3 (5 mL of a 10% 
w/w aqueous solution) and KF (5 mL of a 10% w/w aqueous solution) and extracted with 
diethyl ether (3 × 10 mL). The combined organic extracts were washed with brine, dried 
(MgSO4), filtered and concentrated under reduced pressure to afford a pale-yellow oil. 
Subjection of this material to flash chromatography (silica, 2:50 v/v diethyl ether/hexane 
elution) and concentration of the appropriate fractions (Rf = 0.2) then gave the title compound 
147 (39 mg, 37%) as a clear oil. 
1
H NMR (300 MHz, CDCl3) δ 6.29 (m, 1H), 4.62 (m, 1H), 3.64 (m, 1H), 3.48 (dd, J = 3.6 and 
1.2 Hz, 1H), 1.82 (broadened s, 3H), 0.99 (t, J = 8.1 Hz, 9H), 0.67 (q, J = 8.1 Hz, 6H). 
13
C NMR (75 MHz, CDCl3) δ 193.9, 139.5, 133.4, 63.7, 58.4, 53.4, 15.9, 6.7, 4.8. 
IR (KBr) νmax 2957, 1685, 1092, 1074, 1005, 825, 747, 745 cm
–1
. 
150 Chapter Four  
Mass spectrum (EI, 70 eV) m/z 254 (M
+•
, 10%), 225 (100), 197 (90), 103 (80), 95 (77), 87 
(55), 75 (85), 59 (65). 
HREIMS Found: M
+•
, 254.1332. C13H22O3Si requires M
+•
, 254.1338. 
Optical rotation [α]D −192.7 (c 0.95, Et2O). 
Compound ent-108 [(−)-Epiepoformin] 
 
A magnetically stirred solution of compound 147 (28 mg, 0.11 mmol) in acetonitrile (1.2 mL) 
was treated with hydrogen fluoride pyridine (200 μL, hydrogen fluoride, ~70%, pyridine, 
~30%). The ensuing mixture was stirred at 20 °C for 1 h and then diluted with NaHCO3 (5 mL 
of a saturated aqueous solution) and extracted with ethyl acetate (3 × 5 mL). The combined 
organic extracts were washed with water and brine and then concentrated under reduced 
pressure to yield a pale-yellow oil. Subjection of this material to flash chromatography (silica, 
1:2 v/v ethyl acetate/hexane elution) and concentration of the appropriate fractions (Rf = 0.35) 
then gave the title compound ent-108 (12 mg, 78%) as a white, crystalline solid, m.p. = 85-
85 °C. 
1
H NMR (300 MHz, CDCl3) δ 6.46 (m, 1H), 4.66 (broad m, 1H), 3.79 (m, 1H), 3.51 (dd, J = 
3.6 and 1.2 Hz, 1H), 2.20 (broad d, J = 7.8 Hz, 1H), 1.84 (broadened s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 194.5, 139.1, 134.3, 63.2, 57.7, 53.4, 15.9. 
IR (KBr) νmax 3420, 2925, 1670, 1040, 825 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 140 (M
+•
, 20%), 111 (100), 97 (60), 83 (50), 71 (68), 69 (75), 
55 (60), 39 (60). 
HREIMS Found: M
+•
, 140.0471. C7H8O3 requires M
+•
, 140.0473. 
Optical rotation [α]D −311.0 (c 0.27, EtOH) {lit.
85
 [α]D (for 108) +316.04 (c 0.37, EtOH)}. 
tributyl(3-methylbut-3-en-1-ynyl)stannane (156) 
 
A magnetically stirred solution of 2-methylbut-1-en-3-yne (0.690 g, 10.4 mmol, ex. Aldrich) in 
THF (30 mL) was cooled to −78 °C then treated with n-BuLi (7.5 mL of a 1.6 M solution in 
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hexanes, 12.0 mmol). The ensuing mixture was warmed to 0 °C over 1 h and then cooled to 
−78 °C and treated with tri-n-butyltin chloride (3.1 mL, 11.4 mmol) before being warmed to 
20 °C over 1 h and then filtered through a pad of TLC-grade silica gel. The filtrate thus obtained 
was concentrated under reduced pressure to afford the title compound 156
89
 (3.65 g, 99%) as a 
clear, colorless oil. 
1
H NMR (300 MHz, CDCl3) δ 5.28 (m, 1H), 5.16 (m, 1H), 1.89 (m, 3H), 1.55 (m, 6H), 1.34 (m, 
6H), 1.00 (m, 6H), 0.90 (t, J = 7.4 Hz, 9H). 
13
C NMR (75 MHz, CDCl3) δ 127.4, 121.4, 111.4, 91.9, 28.7, 26.9, 23.8, 13.6, 11.1. 
IR (KBr) νmax 2956, 2923, 2872, 2853, 2129, 1610, 1464, 1376, 1270, 1073, 965, 891 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 355 (M
+•
, 5%), 299 (100), 269 (10), 243 (30), 185 (50). 
HREIMS Found: (M–Bu•)+, 299.0822. C13H23
120
Sn requires (M−Bu•)+, 299.0822. 
(1S,2R,6S)-4-(3-methylbut-3-en-1-ynyl)-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl 2-
chloroacetate (173) 
 
A magnetically stirred solution of compound 156 (507 mg, 1.54 mmol) and compound 103 
(842 mg, 2.37 mmol) in THF (15 mL) was treated with palladium(II) acetate (20 mg, 89 μmol), 
copper(I) iodide (20 mg, 105 μmol) and triphenylarsine (85 mg, 280 μmol). The ensuing 
mixture was stirred at 20 °C for 1 h, cooled and brine (30mL of a saturated aqueous solution) 
was added. The mixture was extracted with diethyl ether (2 × 30 mL) and the combined organic 
extracts were concentrated under reduced pressure to afford a dark-brown oil. Subjection of this 
material to flash chromatography (silica, 1:4 v/v ethyl acetate/hexane elution) and concentration 
of the appropriate fractions (Rf = 0.3) then gave the title compound 173 (252 mg, 61%) as a 
pale-yellow oil. 
1
H NMR (300 MHz, CDCl3) δ 6.75 (dd, J = 4.8 and 2.4 Hz, 1H), 5.87 (ddd, J = 4.8, 1.2 and 
1.2 Hz, 1H), 5.41 (broad s, 1H), 5.34 (m, 1H), 4.12 (m, 2H), 3.78 (m, 1H), 3.61 (broad d, J = 
3.6 Hz, 1H), 1.91 (broadened s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 189.1, 166.3, 139.1, 125.7, 125.5, 124.5, 97.0, 80.8, 65.8, 54.2, 
52.8, 40.3, 22.9. 
IR (KBr) νmax 1767, 1701, 1163, 991 cm
–1
. 
152 Chapter Four  
Mass spectrum (EI, 70 eV) m/z 268 and 266 (M
+•
, 25 and 60%), 190 (70), 162 (70), 161 (65), 
77 (100). 
HREIMS Found: M
+•
, 266.0346. C13H11
35
ClO4 requires M
+•
, 266.0346. 
Optical rotation [α]D −278.8 (c 2.75, CHCl3). 
Compound 148 [(−)-harveynone] 
 
A magnetically stirred solution of compound 173 (244 mg, 0.915 mmol) in methanol (20 mL) 
was treated with zinc(II) acetate dihydrate (402 mg, 1.83 mmol). The ensuing mixture was 
stirred at 20 °C for 1 h and then diluted with diethyl ether (50 mL) and washed with brine (3 × 
30 mL). The separated organic layer was dried (MgSO4), filtere and concentrated under reduced 
pressure to deliver a brown oil. Subjection of this material to flash chromatography (silica, 1:2 
v/v ethyl acetate/hexane elution) and concentration of the appropriate fractions (Rf = 0.2) then 
gave the title compound 148
90,92
 (133 mg, 76%) as a pale-yellow oil. 
1
H NMR (300 MHz, CDCl3) δ 6.85 (dd, J = 5.4 and 2.7 Hz, 1H), 5.43 (m, 1H), 5.35 (m, 1H), 
4.73 (broad m, 1H), 3.85 (m, 1H), 3.55 (dd, J = 3.6 and 1.2 Hz, 1H), 3.00 (broad d, J = 9.3 Hz, 
1H), 1.93 (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 191.5, 146.1, 125.9, 124.1, 122.7, 95.9, 81.2, 63.2, 57.6, 53.5, 
23.0. 
IR (KBr) νmax 3233, 1689, 1615, 1437, 1235, 1031, 850 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 190 (M
+•
, 100%), 162 (70), 161 (85), 133 (60), 91 (80), 83 
(80). 
HREIMS Found: M
+•
, 190.0630. C11H10O3 requires M
+•
, 190.0630. 
Optical rotation [α]D −204.9 0 (c 0.89, MeOH) {lit.
92
 [α]D −207.4 (c 0.45, MeOH)}. 
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(1S,2R,5S,6R)-5-hydroxy-4-iodo-7-oxabicyclo[4.1.0]hept-3-en-2-yl acetate (188) 
  
A magnetically stirred solution of compound 96 (962 mg, 3.79 mmol) in THF (15 mL) was 
treated with acetic acid (330 µL, 5.77 mmol), ditertbutyl azodicarboxylate (889 mg, 3.86 mmol) 
and triphenylphosphine (997 mg, 3.80 mmol). The ensuing mixture was stirred at 20 °C for 
0.25 h and then concentrated under reduced pressure to give an amber-colored oil. Subjection of 
this material to flash chromatography (silica, 1:2 v/v ethyl acetate/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.3) then gave the title compound 188 (630 mg, 
56%) as a white solid, m.p. = 101-104 °C. 
1
H NMR (300 MHz, CDCl3) δ 6.40 (ddd, J = 4.8, 1.8, 0.9 Hz, 1H), 5.30 (dm, J = 4.8 Hz, 1H), 
4.40 (m, 1H), 3.56 (m, 1H), 3.45 (m, 1H), 3.01 (broad s, 1H), 2.08 (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 169.8, 133.1, 108.0, 68.6, 65.6, 53.7, 53.5, 20.7. 
IR (KBr) νmax 3468, 1727, 1375, 1236, 1064, 1022, 890 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 296 (M
+•
, 9%), 254 (71), 236 (94), 127 (100), 109 (96), 81 
(98), 43 (99). 
HREIMS Found: M
+•
, 295.9541. C8H9
127
IO4 requires M
+•
, 295.9546. 
Optical rotation [α]D −92.2 (c 5.0, CHCl3). 
(1S,2R,6S)-4-iodo-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl acetate (189) 
  
A magnetically stirred solution of compound 188 (587 mg, 1.98 mmol) in DCM (40 mL) was 
treated with acetic acid (140 µL, 2.45 mmol) and pyridinium dichromate (834 mg, 2.22 mmol). 
The ensuing mixture was stirred at 20 °C for 5 h and then diluted with diethyl ether (40 mL) and 
passed through a pad of TLC-grade silica gel. The filtrate was concentrated under reduced 
pressure to a dark-brown oil that was subjected to flash chromatography (silica, 1:3 v/v ethyl 
acetate/hexane elution). Concentration of the appropriate fractions (Rf = 0.3) then gave the title 
compound 189 (445 mg, 76%) as a white solid m.p. = 115-118 °C. 
154 Chapter Four  
1
H NMR (300 MHz, CDCl3) δ 7.36 (dd, J = 5.4 and 2.4 Hz, 1H), 5.62 (ddd, J = 5.4, 1.2, 1.2 Hz, 
1H), 3.77 (m, 1H), 3.65 (dd, J = 3.3 and 1.2 Hz, 1H), 2.13 (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 187.2, 169.4, 147.5, 104.7, 65.7, 55.0, 51.2, 20.5. 
IR (KBr) νmax 2915, 1743, 1695, 1605, 1374, 1334, 1241, 1216, 1031, 908, 872, 805, 780, 588, 
544 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 294 (M
+•
, 25%), 252 (72), 223 (23), 125 (38), 43 (100). 
HREIMS Found M
+•
, 293.9381. C8H7
127
IO4 requires M
+•
, 293.9389. 
Optical rotation [α]D −169.9 (c 5.0, acetone). 
6-methylhepta-1,5-dien-2-yl trifluoromethanesulfonate (193) 
  
A magnetically stirred solution of diisopropylamine (7.50 mL, 53.5 mmol) in THF (45 mL) 
maintained at 0 °C was treated with n-butyllithium (34.0 mL of a 1.6 M solution in hexane, 
54.4 mmol). After 0.25 h the reaction mixture was warmed to 20 °C, kept at this temperature for 
0.25 h then cooled to −78 °C before being treated, dropwise, with ketone 192 (6.1 mL, 41.4 
mmol, ex Aldrich). Stirring was continued for 1 h and then phenyl triflimide (15.5 g, 43.5 
mmol, ex Aldrich) was added to the reaction mixture. This was stirred for a further 20 h during 
which time it was allowed to warm to 20 °C. The reaction mixture was then diluted with hexane 
(100 mL) and washed with water (2 × 100 mL) and brine (1 × 100 mL) before being dried 
(MgSO4), filtered and concentrated under reduced pressure to a yellow oil. Subjection of this 
material to flash chromatography (silica, hexane elution) and concentration of the appropriate 
fractions (Rf = 0.2) gave enol triflate 193
90,101,102
 (7.14 g, 67%) as a pale yellow oil. 
1
H NMR (300 MHz, CDCl3) δ 5.09 (d, J = 3.6 Hz, 1H), 5.06 (dm, J = 7.2 Hz, 1H), 4.93 (broad 
d, J = 3.6 Hz, 1H), 2.39-2.34 (complex m, 2H), 2.27-2.20 (complex m, 2H), 1.70 (s, 3H), 1.62 
(s, 3H), 1.62 (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 156.6, 133.7, 121.58, 118.2 (q, J = 337 Hz), 104.3, 33.9, 25.6, 
24.6, 17.6. 
IR (KBr) νmax 2972, 2920, 2861, 1670, 1419, 1248, 1210, 1145, 933, 899, 848, 705, 612 cm
−1
. 
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trimethyl(7-methyl-3-methyleneoct-6-en-1-ynyl)silane (194) 
 
A magnetically stirred solution of enol triflate 193 (6.82 g, 26.4 mmol) in THF (70 mL) and 
piperidine (30 mL) maintained at 20 °C under a nitrogen atmosphere was treated with cuprous 
iodide (200 mg, 1.05 mmol) and dichlorobis(acetonitrile)palladium (139 mg, 0.540 mmol). The 
ensuing yellow mixture was treated, over a period of 0.3 h, with trimethylsilylacetylene (246) 
(3.90 g, 39.7 mmol, ex Aldrich) then stirred at 20 °C for a further 0.25 h at which point the 
conspicuous formation of palladium black indicated that reaction was complete. Accordingly, 
the reaction mixture was quenched with HCl (150 mL of a 0.5 M aqueous solution) then 
extracted with hexane (2 × 100 mL). The combined organic phases were washed with NaHCO3 
(1 × 100 mL of a saturated aqueous solution) and brine (1× 100 mL) before being dried 
(MgSO4), filtered and concentrated under reduced pressure. The resulting black oil was 
subjected to flash chromatography (silica, hexane elution) and concentration of the relevant 
fractions (Rf = 0.4) furnished dienyne 194
101,102
 (4.48 mg, 82%) as a pale-yellow oil. 
1
H NMR (300 MHz, CDCl3) δ 5.36 (m, 1H), 5.23 (m, 1H), 5.23 (m, 1H), 5.12-5.08 (complex 
m, 1H), 2.20-2.16 (complex m, 4H), 1.69 (s, 3H), 1.62 (s, 3H), 0.19 (s, 9H). 
13
C NMR (75 MHz, CDCl3) δ 132.2, 131.4, 123.3, 122.0, 105.6, 93.9, 37.3, 26.7, 25.7, 17.7, 
0.0. 
IR (KBr) νmax 2963, 2144, 1606, 1448, 1376, 1250, 1105, 975, 942, 883, 842, 759, 698, 633 
cm
−1
. 
Mass spectrum (EI, 70 eV) m/z 206 (M
+•
, 6%), 191 (16), 163 (99), 97 (64), 73 (100), 69 (75), 
59 (23). 
HREIMS Found M
+•
, 206.1490. C13H22Si requires M
+•
, 206.1491. 
tri-n-butyl(7-methyl-3-methyleneoct-6-en-1-ynyl)stannane (190) 
 
A magnetically stirred solution of compound 194 (2.07 mg, 10.0 mmol, ex Aldrich) and bis(tri-
n-butyltin)oxide (2.99 g, 5.00 mmol) in THF (35 mL) maintained under a nitrogen atmosphere 
was treated with tetra-n-butylammonium fluoride (0.50 mL of a 1 M solution in THF, 
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0.50 mmol). The ensuing mixture was heated at reflux for 3 h then concentrated under reduced 
pressure to yield a biphasic oil that consisted of a pale-yellow layer and a denser, dark-brown 
layer. Subjection of this mixture to flash chromatography (silica, hexane elution) and 
concentration of the appropriate fractions (Rf = 0.4) gave the title compound 190
101,102
 (860 mg, 
20%) as a clear, colorless oil. 
1
H NMR (300 MHz, CDCl3) δ 5.31 (m, 1H), 5.16 (m, 1H), 5.11 (m, 1H), 2.23-2.15 (m, 4H), 
1.69 (s, 3H), 1.62 (s, 3H), 1.63-1.51 (complex m, 6H), 1.37-1.30 (complex m, 6H), 1.02-0.97 
(complex m, 6H), 0.90 (t, J = 7.5 Hz, 9H). 
13
C NMR (75 MHz, CDCl3) δ 132.1, 132.0, 123.5, 120.7, 110.5, 92.8, 37.7, 28.9, 27.0, 26.8, 
25.7, 17.7, 13.7, 11.1. 
IR (KBr) νmax 3313, 2958, 2920, 2124, 1609, 1455, 1376, 1270, 1073, 960, 895, 696, 671, 602, 
513 cm
–1
. 
Compound 173 [(−)-tricholomenyn A] (via Route A) 
 
A magnetically stirred solution of compound 103 (138 mg, 0.470 mmol) and compound 156 
(300 mg, 0.710 mmol) in diethyl ether (2 mL) was treated with palladium(II) acetate (10 mg, 
0.045 mmol), copper(I) iodide (10 mg, 0.053 mmol) and triphenylarsine (43 mg, 0.14 mmol). 
The ensuing mixture was stirred at 50 °C for 1 h, cooled and then concentrated under reduced 
pressure to afford a yellow oil. Subjection of this material to flash chromatography (silica, 1:4 
v/v ethyl acetate/hexane elution) and concentration of the appropriate fractions (Rf = 0.25) then 
gave the title compound 173
90-92,101,102,130
 (102 mg, 72%) as a yellow oil. 
1
H NMR (300 MHz, CDCl3) δ 6.75 (ddd, J = 5.4 and 2.4 Hz, 1H), 5.81 (dt, J = 5.4 and 1.2 Hz, 
1H), 5.44 (m, 1H), 5.35 (broad s, 1H), 5.08 (m, 1H), 3.74 (m, 1H), 3.59 (dd, J = 3.6 and 1.2 Hz, 
1H), 2.20 (broad s, 4H), 2.14 (s, 3H), 1.68 (s, 3H), 1.62 (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 189.5, 169.6, 140.3, 132.4, 130.5, 125.0, 123.5, 123.0, 95.9, 81.9, 
64.1, 54.7, 52.9, 36.9, 26.6, 25.7, 20.6, 17.7. 
IR (KBr) νmax 2925, 2205, 1758, 1741, 1702, 1617, 1437, 1372, 1220, 1025, 987, 908 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 300 (M
+•
, 1%), 257 (27), 241 (39), 211 (41), 115 (36), 69 (93), 
43 (100), 41 (85). 
HREIMS Found: M
+•
, 300.1358. C18H20O4 requires M
+•
, 300.1362. 
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Optical rotation [α]D −241.3 (c 1.35, CH2Cl2) {lit.
130
 [α]D −148.1 (c 0.35, CH2Cl2); lit.
90
 
[α]D −237 (c 0.6, CH2Cl2); lit.
92
 [α]D −228 (c 0.1, CH2Cl2)}. 
(1S,2R,5R,6R)-5-hydroxy-4-(7-methyl-3-methyleneoct-6-en-1-ynyl)-7-
oxabicyclo[4.1.0]hept-3-en-2-yl acetate (191) 
  
A magnetically stirred solution of compound 188 (256 mg, 0.860 mmol) and compound 190 
(550 mg, 1.30 mmol) in diethyl ether (2.5 mL) was treated with palladium(II) acetate (20 mg, 
0.089 mmol), copper(I) iodide (16 mg, 0.084 mmol) and triphenylarsine (80 mg, 0.26 mmol). 
The ensuing mixture was stirred at 50 °C for 1 h then cooled and concentrated under reduced 
pressure to afford a brown oil. Subjection of this material to flash chromatography (silica, 1:3, 
v/v ethyl acetate/hexane elution) and concentration of the appropriate fractions (Rf = 0.3) then 
gave the title compound 191 (77 mg, 29%) as a pale-yellow oil. 
1
H NMR (300 MHz, CDCl3) δ 5.96 (m, 1H), 5.55 (broad d, J = 5.4 Hz, 1H), 5.38 (m, 1h), 5.29 
(m, 1H), 5.08 (m, 1H), 4.51 (broad m, 1H), 3.61 (m, 1H), 3.43 (m, 1H), 2.44 (d, J = 8.4 Hz, 
1H), 2.19 (m, 4H), 2.08 (s, 3H), 1.68 (s, 3H), 1.60 (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 169.9, 132.4, 130.6, 127.3, 125.4, 123.0, 122.7, 93.2, 85.6, 65.2, 
64.6, 53.3, 52.8, 37.1, 26.7, 25.7, 20.8, 17.7. 
IR (KBr) νmax 3458, 2926, 1739, 1632, 1443, 1371, 1230, 1059, 1021, 896 cm
–1
. 
Mass spectrum (ESI, 70 eV) m/z 345 (100), 325 [(M+Na)
+
, 81], 283 (5), 265 (14). 
HREIMS Found: (M+Na)
+
, 325.1418. C18H22O4 requires (M+Na)
+
, 325.1416. 
Optical rotation [α]D −85.7 (c 3.6, CHCl3). 
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Compound 174 [(−)-tricholomenyn A] (via Route B) 
 
A magnetically stirred solution of compound 191 (36 mg, 0.12 mmol) in DCM (2.5 mL) was 
treated with acetic acid (10 µL, 0.18 mmol) and pyridinium dichromate (61 mg, 0.16 mmol). 
The ensuing mixture was stirred at 20 °C for 2 h and then treated with silica gel (2 mL) and 
diluted with diethyl ether (2.5 mL). The mixture was filtered and the filtrate was concentrated 
under reduced pressure to a pale-orange oil. Subjection of this material to flash chromatography 
(silica, 1:4 v/v ethyl acetate/hexane elution) and concentration of the appropriate fractions (Rf = 
0.2) then gave the title compound 174
90-92,101,102,130
 (24 mg, 67%) as a pale-yellow oil. The 
spectral data derived from this material matched those obtained from the sample of compound 
174 generated directly via cross-coupling of stannane 156 and iodide 103 as detailed above. 
4.4 EXPERIMENTAL PROCEDURES FOR CHAPTER THREE 
(E)-2-methyl-4-(tri-n-butylstannyl)but-3-en-2-ol (229) 
 
A magnetically stirred solution of propargyl alcohol 232 (3.01 g, 35.8 mmol, ex Aldrich) in 
THF (100 mL) was treated with dichlorobis(triphenylphosphine)palladium(II) (500 mg, 
0.712 mmol) then, dropwise, with tri-n-butyltin hydride (9.5 mL, 35.8 mmol). The ensuing 
mixture was maintained at 20 °C for 1 h and then concentrated under reduced pressure to afford 
a black oil. This material was treated with hexane and the resulting mixture passed through a 
pad of TLC-grade silica gel. Concentration of the filtrate afforded the title compound 229
136
 
(12.6 g, 94%) as a clear, colorless oil. 
1
H NMR (300 MHz, CDCl3) δ 6.10 (m, 2H), 1.60-1.20 (complex m, 18H), 1.29 (s, 6H), 0.88 (t, 
J = 7.2 Hz, 9H) (signal due to hydroxyl group proton not observed). 
13
C NMR (75 MHz, CDCl3) δ 155.5, 122.3[dt, 
1
J(
13
C-
119
Sn) = 752.6 Hz and 
1
J(
13
C-
117
Sn) = 
719.4 Hz], 72.4, 29.4, 29.0 [t, 
3
J(
13
C-
117/119
Sn) = 40.8 Hz], 27.2 [t, 
2
J(
13
C-
117/119
Sn) = 108.6 Hz], 
13.7, 9.4 [dt, 
1
J(
13
C-
119
Sn) = 682.8 Hz and 
1
J(
13
C-
117
Sn) = 652.8 Hz]. 
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IR (KBr) νmax 3364, 2957, 2925, 2871, 2854, 1600, 1463, 1376, 989, 666 cm
–1
. 
Mass spectrum (ESI, 70 eV) m/z 375 [(M−H•)+, 5%], 315 (100), 263 (60), 207 (50), 177 (45), 
137 (40), 59 (40), 41 (40). 
HRESIMS Found: (M−H•)+, 375.1718. C17H36O4
120Sn requires (M−H•)+, 375.1710. 
(1S,2R,6S)-4-((E)-3-hydroxy-3-methylbut-1-enyl)-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl 
2-chloroacetate (230) 
  
A magnetically stirred solution of iodide 100 (398 mg, 1.20 mmol) and stannane 229 (1.37 g, 
3.64 mmol) in acetone (5 mL) was treated with palladium(II) acetate (24 mg, 0.11 mmol), 
copper(I) iodide (20 mg, 0.11 mmol) and triphenylarsine (96 mg, 0.32 mmol). The ensuing 
mixture was stirred in a sealed tube at 50 °C with microwave heating for 0.3 h then cooled and 
concentrated under reduced pressure to afford a dark-brown oil. Subjection of this material to 
flash chromatography (silica, 1:1 v/v ethyl acetate/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.3) then gave the alcoholic precursor to compound 230 (165 mg, 
47%) as a clear, colorless oil. A magnetically stirred solution of this alcohol (156 mg, 
0.54 mmol) in DCM (5 mL) was treated with acetic acid (45 µL, 0.79 mmol) and pyridinium 
dichromate (263 mg, 0.70 mmol). The enxuing mixture was stirred at 20 °C for 1 h and then 
diluted with diethyl ether (5 mL) and the ensuing mixture passed through a pad of TLC-grade 
silica gel. The filtrate was then concentrated under reduced pressure to give a dark-brown oil. 
Subjection of this material to flash chromatography (silica, 2:5 v/v ethyl acetate/hexane elution) 
and concentration of the appropriate fractions (Rf = 0.3) gave the title compound 230 (106 mg, 
68%) as a clear, colorless oil. 
1
H NMR (300 MHz, CDCl3) δ 6.48 (dd, J = 5.4 and 2.4 Hz, 1H), 6.44 (d, J = 16.2 Hz, 1H), 6.29 
(d, J = 16.2 Hz, 1H), 5.86 (dt, J = 5.4 and 1.2 Hz, 1H), 4.10 (ABq, J = 14.0 Hz, 2H), 3.77 (m, 
1H), 3.59 (dd, J = 3.6 and 1.2 Hz, 1H), 1.33 (s, 3H), 1.31 (s, 3H) (signal due to hydroxyl group 
proton not observed). 
13
C NMR (75 MHz, CDCl3) δ 192.7, 166.5, 144.0, 136.3, 131.0, 118.9, 71.0, 66.5, 54.1, 63.5, 
40.4, 29.5(1), 29.4(9). 
IR (KBr) νmax 3447, 2971, 1764, 1689, 1603, 1251, 1166, 984 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 271 ([M − CH3
•
]
+
, 5%), 177 (15), 150 (55), 134 (60), 43 (100). 
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HREIMS Found: (M−CH3
•
)
+
, 271.0381. C13H15
35
ClO5 requires (M−CH3
•
)
+
, 271.0373. 
Optical rotation [α]D −101.5 (c 1.55, Et2O). 
(1S,5R,6S)-5-hydroxy-3-((E)-3-hydroxy-3-methylbut-1-enyl)-7-oxabicyclo[4.1.0]hept-3-en-
2-one (199) 
 
A magnetically stirred solution of compound 230 (40 mg, 0.14 mmol) in methanol (4 mL) was 
treated with zinc(II) acetate dihydrate (15 mg, 0.07 mmol). The ensuing mixture was stirred at 
20 °C for 1 h and then concentrated under reduced pressure to afford a white solid. This 
material was treated with ethyl acetate and the ensuing mixture passed through a pad of TLC-
grade silica gel. Concentration of the filtrate under reduced pressure then gave a pale-yellow oil 
that was subjected to flash chromatography (silica, 1:1 v/v ethyl acetate/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.3) afforded the title compound 199
95
 (24 mg, 
82%) as a clear oil. 
1
H NMR (300 MHz, CDCl3) δ 6.57 (dd, J = 5.1 and 2.7 Hz, 1H), 6.35 (d, J = 16.2 Hz, 1H), 6.22 
(d, J = 16.2 Hz, 1H), 4.71 (broad d, J = 5.1 Hz, 1H), 3.80 (m, 1H), 3.53 (dd, J = 3.9 and 1.2 Hz, 
1H), 1.34 (s, 3H), 1.32 (s, 3H) (signal due to the hydroxyl groups protons not observed). 
13
C NMR (75 MHz, CDCl3) δ 194.5, 143.0, 138.1, 133.8, 119.7, 71.5, 63.6, 57.8, 54.5, 29.7(4), 
29.7(0). 
IR (KBr) νmax 3411, 2925, 1683, 1378, 1259, 1149, 1019 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 195 ([M − CH3
•
]
+
, 10%), 149 (20), 134 (20), 134 (45), 43 
(100). 
HREIMS Found: (M − CH3
•
)
+
, 195.0656. C11H14O4 requires (M − CH3
•
)
+
, 195.0657. 
Optical rotation [α]D −155.0 (c 1.3, acetone). 
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Compound 192 [(+)-panepophenanthrin] 
 
A neat sample of compound 199 (25 mg, 0.12 mmol) was stored at 20 °C for 72 h and thereby 
afforded the title compound 192
95,99,134
 (25 mg, quantitative) as a white, crystalline solid, m.p. = 
140-144 °C [lit.
99
 m.p. = 145-148 °C]. 
1
H NMR (300 MHz, CD3OD) δ 6.77 (dd, J = 4.5 and 2.7 Hz, 1H), 5.96 (d, J = 16.5 Hz, 1H), 
5.64 (d, J = 16.5 Hz, 1H), 4.52 (broad s, 1H), 4.32 (broad s, 1H), 3.80 (t, J = 3.6 Hz, 1H), 3.46 
(t, J = 3.6 Hz, 1H), 3.39 (d, J = 4.2 Hz, 1H), 3.28 – 3.26 (m, 2H), 2.28 (d, J = 9.3 Hz, 1H), 1.99 
(d, J = 9.3 Hz, 1H), 1.41 (s, 3H), 1.31 (s, 3H), 1.16 (s, 3H), 1.13 (s, 3H) (signal due to hydroxyl 
group protons not observed). 
13
C NMR (75 MHz, CD3OD) δ 196.2, 142.9, 10.0, 138.8, 129.3, 102.7, 79.1, 71.8, 69.0, 66.2, 
60.6, 57.4, 57.2, 57.1, 55.6, 55.1, 51.2, 49.9, 32.3, 30.3, 29.5, 26.2. 
IR (KBr) νmax 3422, 2972, 1685, 1599, 1369, 1255, 1148, 1016 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 459 ([M+K]
+
, 25%), 443 [(M+Na)
+
, 50], 332 (100), 330 (75), 
328 (43). 
HREIMS Found: (M+Na)
+
, 443.1672. C22H28O8 requires (M+Na)
+
, 443.1682. 
Optical rotation [α]D +144.0 (c 0.5, methanol) {lit.
99
 [α]D +146 (c 1.0, methanol)}. 
3-methoxy-3-methylbut-1-yne (243) 
 
A magnetically stirred solution of compound 232 (8.40 g, 0.100 mmol) in DMF (100 mL) was 
treated with sodium hydride (6.09 g of 60% w/w dispersion in mineral oil, 0.152 mmol) and the 
resulting mixture stirred at 0 °C for 0.5 h. Dimethyl sulfate (14.5 mL, 0.152 mmol) was then 
added dropwise and then after the addition was complete the reaction mixture was warmed to 
20 °C over 0.75 h. After this time acetic acid (5 mL) was added to the reaction mixture which 
was then distilled to give the title compound 243
142,146
 (8.67 g, 88%) as a clear oil, b.p. = 78-
80 °C @ 760 mm Hg (lit.
142
 b.p. = 78-80 °C @ 760 mm Hg). 
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1
H NMR (300 MHz, CDCl3) δ 3.34 (s, 3H), 2.41 (s, 1H), 1.43 (s, 6H). 
13
C NMR (75 MHz, CDCl3) δ 85.5, 72.0, 70.2, 51.5, 28.1. 
(E)-tri-n-butyl(3-methoxy-3-methylbut-1-enyl)stannane (241) 
 
A magnetically stirred solution of compound 243 (2.00g, 20.4 mmol) in THF (80 mL) was 
treated with dichlorobis(triphenylphosphine)palladium(II) (145 mg, 0.21 mmol) and, dropwise, 
with tri-n-butyltin hydride (5.1 mL, 19.0 mmol). The ensuing mixture was maintained at 20 °C 
for 1 h and then concentrated under reduced pressure to afford a black oil. This material was 
diluted with hexane (50 mL) and passed through a pad of TLC-grade silica gel. Concentration 
of the filtrate under reduced pressure then gave the title compound 241
93
 (6.10 g, 83%) as a 
pale-yellow oil. 
1
H NMR (300 MHz, CDCl3) δ 6.05 (d, J = 19.2 Hz, 1H), 5.89 (d, J = 19.2 Hz, 1H), 3.14 (s, 
3H), 1.48 (m, 6H), 1.30 (m, 6H), 1.25 (s, 6H), 0.88 (m, 15H). 
13
C NMR (75 MHz, CDCl3) δ 153.0, 126.7, 76.6, 50.4, 29.1, 27.2, 25.3, 13.7, 9.4. 
(1S,2R,6S)-4-((E)-3-methoxy-3-methylbut-1-enyl)-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl 
2-chloroacetate (242) 
  
A magnetically stirred solution of iodide 100 (385 mg, 1.16 mmol) and stannane 241 (1.37 g, 
3.51 mmol) in acetone (5 mL) was treated with palladium(II) acetate (24 mg, 0.11 mmol), 
copper(I) iodide (20 mg, 0.11 mmol) and triphenylarsine (96 mg, 0.32 mmol). The ensuing 
mixture was stirred in a sealed tube at 50 °C with microwave heating for 0.3 h, then cooled and 
concentrated under reduced pressure to give a dark-brown oil. Subjection of this material to 
flash chromatography (silica, 1:3 v/v ethyl acetate/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.3) then gave the alcoholic precursor to compound 242 (184 mg, 
52%) as a pale-orange oil. A magnetically stirred solution of this alcohol (184 mg, 0.61 mmol) 
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in DCM (10 mL) was treated with acetic acid (45 μL, 0.79 mmol) and pyridinium dichromate 
(257 mg, 0.68 mmol). The ensuing mixture was stirred at 20 °C for 1 h and then diluted with 
diethyl ether before being passed through a pad of TLC-grade silica gel. The resulting filtrate 
was concentrated under reduced pressure to a dark-brown oil that was subjected to flash 
chromatography (silica, 1:4 v/v ethyl acetate/hexane elution). Concentration of the appropriate 
fractions (Rf = 0.3) then gave the title compound 242 (167 mg, 91%) as a clear, colorless oil. 
1
H NMR (300 MHz, CDCl3) δ 6.48 (dd, J = 5.1 and 2.7 Hz, 1H), 6.26 (d, J = 16.2 Hz, 1H), 6.18 
(d, J = 16.2 Hz, 1H), 5.85 (dt, J = 5.1 and 1.2 Hz, 1H), 4.10 (m, 2H), 3.75 (m, 1H), 3.57 (dd, J = 
3.6 and 1.2 Hz, 1H), 1.33 (s, 3H), 1.31 (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 192.4, 166.4, 141.7, 136.1, 130.8, 121.2, 74.9, 66.5, 54.1, 53.4, 
50.5, 40.4, 25.6, 25.3. 
IR (KBr) νmax 2977, 1766, 1692, 1250, 1167, 1071, 985 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 300 (M
+•
, <1%), 287 and 285 (1 and 40), 207 (20), 191 (35), 
175 (45), 163 (32), 147 (40), 77 (55), 73 (100). 
HREIMS Found: M
+•
, 300.0764. C14H17
35
ClO5 requires M
+•
, 300.0765. 
Optical rotation [α]D −247.5 (c 3.6, CHCl3). 
(1S,5R,6S)-5-hydroxy-3-((E)-3-methoxy-3-methylbut-1-enyl)-7-oxabicyclo[4.1.0]hept-3-en-
2-one (240) 
 
A magnetically stirred solution of compound 242 (70 mg, 0.23 mmol) in methanol (4 mL) was 
treated with zinc(II) acetate dihydrate (7 mg, 0.3 μmol). The ensuing mixture was stirred at 
20 °C for 1 h and then concentrated under reduced pressure to afford a white solid. This 
material was treated with ethyl acetate (5 mL) and passed through a pad of TLC-grade silica gel. 
The filtrate was concentrated under reduced pressure afforded a pale-yellow oil that was 
subjected to flash chromatography (silica, 1:2 v/v ethyl acetate/hexane elution). Concentration 
of the appropriate fractions (Rf = 0.3) then gave the title compound 240
94
 (41 mg, 78%) as a 
clear, colorless oil. 
1
H NMR (300 MHz, CDCl3) δ 6.60 (dd, J = 5.4 and 3.0 Hz, 1H), 6.19 (s, 2H), 4.72 (ddd, J = 
5.4 Hz, 1H), 3.78 (m, 1H), 3.53 (dd, J = 3.6 and 1.2 Hz, 1H), 3.12 (s, 3H), 1.27 (s, 6H) (signal 
due to the hydroxyl group proton not observed). 
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13
C NMR (75 MHz, CDCl3) δ 193.6, 140.2, 137.4, 133.5, 121.8, 75.3, 63.3, 57.5, 54.1, 50.5, 
25.6, 25.4. 
IR (KBr) νmax 3385, 2976, 1687, 1380, 1250, 1170, 1058, 844 cm
–1
. 
Mass spectrum (EI, 70 eV) m/z 224 (M
+•
, <1%), 209 (30), 193 (15), 149 (20), 135 (20), 85 
(80), 83 (100). 
HREIMS Found: M
+•
, 224.1049. C12H16O4 requires M
+•
, 224.1049. 
Optical rotation [α]D −139.9 (c 2.05, CHCl3). 
Compound 236 [(+)-Prehexacyclinol] 
 
A neat sample of compound 240 (121 mg, 0.54 mmol) was stored at 20 °C for 72 h and so 
afforded the title compound 236
93,94
 (121 mg, quantitative) as a clear, colorless oil. 
1
H NMR (300 MHz, CDCl3) δ 6.69 (m, 1H), 5.84 (d, J = 16.8 Hz, 1H), 5.40 (d, J = 16.8 Hz, 
1H), 4.44 (broad s, 1H), 4.21 (m, 1H), 4.07 (d, J = 5.4 Hz, 1H), 3.72 (d, J = 5.4 Hz, 1H), 3.60 
(m, 2H), 3.49 (d, J = 3.6 Hz, 1H), 3.44 (broad s, 1H), 3.35 (d, J = 3.6 Hz, 1H), 3.16 (s, 3H), 3.05 
(s, 3H), 2.67 (m, 1H), 2.57 (s, 1H), 2.52 (broad s, 1H), 1.22 (s, 6H), 1.19 (s, 3H), 1.12 (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 203.4, 194.9, 138.5, 137.9, 134.5, 130.8, 77.1, 75.5, 68.4, 573.5, 
61.3, 59.4, 55.5, 53.6, 53.5, 50.6, 50.3, 48.4, 46.3, 26.0, 25.1, 24.4, 23.1 (signal due to one 
carbon obscured or overlapping). 
IR (KBr) νmax 3424, 2974, 2926, 1699, 1626, 1248, 1059, 842 cm
–1
. 
Mass spectrum (ESI, 70 eV) m/z 919 [(2M + Na)
+
, 100%], 471 [(M + Na)
+
, 78], 318 (60). 
HRESIMS Found: (M + Na)
+
, 471.1997. C24H32O8 requires (M + Na)
+
, 471.1995. 
Optical rotation [α]D +30.8 (c 2.35, MeOH) {lit.
93
 [α]D +29.8 (c 0.40, CH2Cl2)}. 
Experimental procedures associated with work described in Chapters One, Two and Three 165 
Compound 233 [(+)-Hexacyclinol] 
 
A solution of compound 236 (38 mg, 0.085 mmol) in deuterochloroform (1 mL) was stored at 
20 °C for 72 h and then concentrated under reduced pressure to afford the title compound 
233
93,94
 (35 mg, 99%) as a white, crystalline solid, m.p. = 176-178 °C (lit.
94
 m.p. = 179-180 °C). 
1
H NMR (300 MHz, CDCl3) δ 6.72 (dd, J = 6.0 and 2.4 Hz, 1H), 5.47 (d, J = 9.3 Hz, 1H), 5.00 
(m, 1H), 4.82 (d, J = 9.3 Hz, 1H), 3.70-3.54 (complex m, 3H), 3.52 (d, J = 3.6 Hz, 1H), 3.29 (d, 
J = 2.7 Hz, 1H), 3.24 (d, J = 3.6 Hz, 1H), 3.02 (s, 3H), 2.74 (dd, J = 9.9 and 5.1 Hz, 1H), 1.77 
(s, 3H), 1.72 (s, 3H), 1.27 (s, 3H), 1.15 (s, 3H) (signal due to hydroxyl group protons not 
observed). 
13
C NMR (75 MHz, CDCl3) δ 203.1, 193.2, 142.3, 139.6, 132.6, 120.5, 77.3, 75.7, 72.5, 71.4, 
61.0, 60.3, 54.4, 53.2, 53.0, 49.1, 47.6, 40.6, 40.1, 26.6, 26.2, 24.6, 18.4. 
IR (KBr) νmax 3433, 2978, 1711, 1698, 1626, 1448, 1070, 752 cm
–1
. 
Mass spectrum (ESI, 70 eV) m/z 439 [(M+Na)
+
, 100], 417 [(M+H)
+
, 50], 323 (50), 193 (70), 
99 (50), 73 (45). 
HRESIMS Found: (M + Na)
+
, 439.1724. C23H28O7 requires (M+Na)
+
, 439.1733. 
Optical rotation [α]D +129.6 (c 0.36, MeOH) {lit.
94
 [α]D +130.9 (c 0.42, MeOH)}. 
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A.1 APPENDIX ONE 
 
Comparative NMR data recorded for naturally- and synthetically derived 
tambjamines 
Table 5-1: Comparison of the 1H NMR data recorded on naturally- and synthetically-derived tambjamine C (4) , 
isolated as the free base and acetic acid salt, respectively. 
1H NMR Data 1H NMR Data 
Natural 4 
(δH) 
(200 MHz, CDCl3)
6 
Synthetic 4 
(δH) 
(300 MHz, CDCl3) 
10.7 (broad s, 1H) 11.1 (broad s, 2H) 
9.46 (broad s, 1H)  
7.29 (d, J = 15 Hz, 1H) 7.28 (s, 1H) 
7.07 (m, 1H) 7.04 (m, 1H) 
6.73 (m, 1H) 6.70 (m, 1H) 
6.28 (m, 1H) 6.24 (m, 1H) 
5.94 (s, 1H) 5.95 (s, 1H) 
3.93 (s, 3H) 3.90 (s, 3H) 
3.29 (m, 2H) 3.24 (d, J = 6.6 Hz, 1H) 
 2.08 (s, 3H, CH3CO2
−) 
2.03 (m, 1H) 1.98 (m, 1H) 
1.03 (d, J = 6.6 Hz, 6H) 0.99 (d, J = 6.6 Hz, 6H) 
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Table 5-2: Comparison of the 13C and 1H NMR data recorded on naturally- and synthetically-derived 
tambjamine E (2), isolated as the free base and acetic acid salt, respectively. 
13C NMR Data 13C NMR Data 1H NMR Data 1H NMR Data 
Natural 2 
(δC) 
(50 MHz, CDCl3)
145 
Synthetic 2 
(δC) 
(75 MHz, CDCl3) 
Natural 2 
(δH) 
(360 MHz, CDCl3)
145 
Synthetic 2 
(δH) 
(300 MHz, CDCl3) 
 179.2 9.92 (broad s, 1H) 11.1 (broad s, 2H) 
164.6 162.9 9.50 (broad s, 1H)  
142.8 143.6 7.36 (broad m, 1H) 7.30 (s, 1H) 
142.2 140.5 7.07 (broad m, 1H) 6.83 (m, 1H) 
123.8 124.9 6.76 (broad m, 1H) 6.57 (m, 1H) 
123.7 121.8 6.28 (broad m, 1H) 6.19 (m, 1H) 
113.0 114.2 5.97 (s, 1H) 5.94 (s, 1H) 
111.4 110.4 3.93 (s, 3H) 3.85 (s, 3H) 
111.2 109.6 3.56 (broad q, J = 7.3 Hz, 2H) 3.32 (q, J = 7.5 Hz, 2H) 
92.3 91.6  2.10 (s, 3H, CH3CO2
−) 
59.1 68.0 1.41 (t, J = 7.3 Hz, 3H) 1.18 (t, J = 7.5 Hz, 3H) 
45.8 45.6   
 24.7   
15.5 15.7   
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Table 5-3: Comparison of the 13C and 1H NMR data recorded on naturally- and synthetically-derived 
tambjamine F (3), isolated as the free base and acetic acid salt, respectively. 
13C NMR Data 13C NMR Data 1H NMR Data 1H NMR Data 
Natural 3 
(δC) 
(50 MHz, 
CDCl3)
145 
Synthetic 3 
(δC) 
(75 MHz, CDCl3) 
Natural 3 
(δH) 
(360 MHz, CDCl3)
145 
Synthetic 3 
(δH) 
(300 MHz, CDCl3) 
 179.1 9.88 (broad s, 1H) 12.2 (s, 2H) 
164.7 163.5 7.35-7.20 (complex m, 6H) 7.32-7.19 (complex m, 5H) 
143.0 142.8 6.70 (broad m, 1H) 7.08 (s, 1H), 6.68 (m, 1H) 
142.3 140.5 6.27 (broad m, 1H) 6.25 (m, 1H) 
138.7 137.4 5.93 (s, 1H) 5.89 (s, 1H) 
129.8 128.8 3.87 (s, 3H) 3.81 (s, 3H) 
129.3 128.6 3.68 (t, J = 7.2 Hz, 2H) 3.64 (t, J = 7.2 Hz, 2H) 
127.3 126.6 3.03 (t, J = 7.2 Hz, 2H) 3.00 (t, J = 7.2 Hz, 2H) 
123.9 123.5  2.10 (s, 3H, CH3CO2
−) 
123.6 122.9   
113.2 112.5   
113.2 110.8   
113.2 110.0   
92.2 91.1   
59.0 58.0   
52.5 52.3   
36.7 36.6   
 24.6   
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Table 5-4: Comparison of the 13C and 1H NMR data recorded on naturally- and synthetically-derived BE-18591 (5), 
isolated as the free base and acetic acid salt, respectively. 
13C NMR Data 13C NMR Data 1H NMR Data 1H NMR Data 
Natural 5 
(δC) 
(75 MHz, CDCl3)
35 
Synthetic 5 
(δC) 
(75 MHz, CDCl3) 
Natural 5 
(δH) 
(300 MHz, CDCl3)
35 
Synthetic 5 
(δH) 
(300 MHz, CDCl3) 
 179.0 10.8 (broad s, 1H) 11.4 (s, 2H) 
163.6 163.2 9.50 (broad s, 1H)  
142.4 142.6 7.33 (broad d, J = 9.0 Hz, 1H) 7.26 (s, 1H) 
140.0 140.5 7.06 (m, 1H) 7.00 (m, 1H) 
124.1 123.4 6.74 (m, 1H) 6.64 (m, 1H) 
122.3 123.1 6.28 (m, 1H) 6.21 (m, 1H) 
113.2 112.3 5.96 (s, 1H) 5.89 (s, 1H) 
110.6 110.9 3.93 (s, 3H) 3.83 (s, 3H) 
110.6 109.9 3.47 (broad t, J = 7.0 Hz, 2H) 3.37 (t, J = 7.1 Hz, 2H) 
91.9 91.0  2.06 (s, 3H, CH3CO2
−) 
58.4 58.0 1.75 (m, 2H) 1.66 (m, 2H) 
51.0 50.9 1.20-1.45 (m, 18H) 1.22 (m, 18H) 
31.9 31.8 0.88 (t, J = 7.0 Hz, 3H) 0.85 (t, J = 6.8 Hz, 3H) 
30.2 30.3   
29.6    
29.6 29.5   
29.6 29.4   
29.4 29.3   
29.3 29.2   
29.1 29.1   
26.5 26.4   
22.7 24.6   
14.1 22.6   
 14.0   
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Table 5-5: Comparison of the 13C and 1H NMR data recorded on naturally- and synthetically-derived tambjamine 6, 
isolated as the free base and acetic acid salt, respectively. 
13C NMR Data 13C NMR Data 1H NMR Data 1H NMR Data 
Natural 6 
(δC) 
(75 MHz, CDCl3)
2  
Synthetic 6 
(δC) 
(75 MHz, CDCl3) 
Natural 6 
(δH) 
(300 MHz, CDCl3)
2  
Synthetic 6 
(δH) 
(300 MHz, CDCl3) 
 179.0  11.4 (s, 2H) 
163.9 163.5 7.29 (d, J = 14 Hz, 1H) 7.28 (s, 1H) 
143.4 142.9 7.06 (m, 1H) 7.04 (m, 1H) 
141.1 140.6 6.70 (m, 1H) 6.69 (m, 1H) 
134.5 134.1 6.25 (m, 1H) 6.25 (m, 1H) 
124.1 123.9 5.95 (s, 1H) 5.94 (s, 1H) 
124.0 123.7 5.55 (dt, J = 10.8 Hz, 1H) 5.54 (m, 1H) 
123.5 123.1 5.35 (dt, J = 10.8 Hz, 1H) 5.34 (m, 1H) 
113.0 112.5 3.90 (s, 3H) 3.89 (s, 3H) 
111.3 110.9 3.46 (m, 2H) 3.45 (t, J = 6.9 Hz, 2H) 
110.5 110.1 2.46 (m, 2H) 2.45 (m, 2H) 
91.6 91.2  2.09 (s, 3H, CH3CO2
−) 
58.8 58.2 2.01 (m, 2H) 2.02 (m, 2H) 
51.2 50.8 1.70-1.21 (complex m, 12H) 1.22 (m, 12H) 
28.8 31.8 0.86 (t, 3H) 0.85 (t, J = 6.8 Hz, 3H) 
27.8 29.7   
27.7-26.5 (6C) 29.5   
 29.3   
 29.3   
 28.4   
 27.4   
 24.5   
 22.6   
14.5 14.1   
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Table 5-6: Comparison of the 13C and 1H NMR data recorded on naturally- and synthetically-derived 
tambjamine G (8), both isolated as their acetic acid salt 
13C NMR Data 13C NMR Data 1H NMR Data 1H NMR Data 
Natural 8 
(δC) 
(75 MHz, CDCl3)
42  
Synthetic 8 
(δC) 
(75 MHz, CDCl3) 
Natural 8 
(δH) 
(300 MHz, CDCl3)
42  
Synthetic 8 
(δH) 
(300 MHz, CDCl3) 
179.0 179.7 12.85 (broad s, 1H) 11.10 (broad s, 2H) 
164.0 163.6 11.5 (broad s, 1H)  
142.0 141.6 7.30 (broad s, 1H) 7.34 (s, 1H) 
141.4 140.9 6.57 (d, J = 4.2 Hz, 1H) 6.58 (d, J = 3.9 Hz, 1H) 
125.1 124.6 6.18 (d, J = 4.2 Hz, 1H) 6.16 (d, J = 3.9 Hz, 1H) 
114.0 113.8 5.87 (s, 1H) 5.89 (s, 1H) 
112.8 112.5 3.68 (s, 3H) 3.87 (s, 3H) 
111.6 111.2 3.49 (q, J = 8.0 Hz, 2H) 3.50 (t, J = 7.2 Hz, 2H) 
105.6 105.4 2.10 (s, 3H, CH3CO2
−) 2.11 (s, 3H, CH3CO2
−) 
91.4 91.1 1.36 (t, J = 8.0 Hz, 3H) 1.36 (t, J = 7.2 Hz, 3H) 
58.9 58.5   
46.3 45.9   
24.1 24.9   
16.2 15.8   
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Table 5-7: Comparison of the 13C and 1H NMR data recorded on naturally- and synthetically-derived 
tambjamine H (9), both isolated as their acetic acid salt 
13C NMR Data 13C NMR Data 1H NMR Data 1H NMR Data 
Natural 9 
(δC) 
(75 MHz, CDCl3)
42  
Synthetic 9 
(δC) 
(75 MHz, CDCl3) 
Natural 9 
(δH) 
(300 MHz, CDCl3)
42  
Synthetic 9 
(δH) 
(300 MHz, CDCl3) 
179.0 179.1 12.9 (broad s, 1H) 11.30 (broad s, 2H) 
164.1 163.3 11.5 (broad s, 1H)  
142.2 141.3 7.39 (broad s, 1H) 7.29 (s, 1H) 
141.8 141.1 6.63 (d, J = 4.2 Hz, 1H) 6.53 (d, J = 3.6 Hz, 1H) 
125.1 124.4 6.23 (d, J = 4.2 Hz, 1H) 6.14 (d, J = 3.6 Hz, 1H) 
114.1 113.3 5.94 (s, 1H) 5.84 (s, 1H) 
112.9 112.1 3.95 (s, 3H) 3.84 (s, 3H) 
111.6 110.8 3.46 (t, J = 8.0 Hz, 2H) 3.37 (t, J = 7.1 Hz, 2H) 
105.9 104.9 2.10 (s, 3H, CH3CO2
−) 2.08 (s, 3H, CH3CO2
−) 
91.5 91.0 1.78 (m, 2H) 1.71 (m, 2H) 
58.9 58.1 1.04 (t, J = 8.0 Hz, 3H) 0.96 (t, J = 7.1 Hz, 3H) 
53.5 52.6   
30.4 24.5   
24.1 23.6   
11.7 10.9   
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Table 5-8: Comparison of the 13C and 1H NMR data recorded on naturally- and synthetically-derived 
tambjamine I (10), both isolated as their acetic acid salt 
13C NMR Data 13C NMR Data 1H NMR Data 1H NMR Data 
Natural 10 
(δC) 
(75 MHz, CDCl3)
42  
Synthetic 10 
(δC) 
(75 MHz, CDCl3) 
Natural 10 
(δH) 
(300 MHz, CDCl3)
42  
Synthetic 10 
(δH) 
(300 MHz, CDCl3) 
179.0 179.2 12.9 (broad s, 1H) 11.10 (broad s, 2H) 
164.2 163.4 11.5 (broad s, 1H)  
142.2 141.5 7.29 (broad s, 1H) 7.26 (s, 1H) 
142.2 141.3 6.59 (d, J = 4.2 Hz, 1H) 6.55 (d, J = 3.6 Hz, 1H) 
125.1 124.4 6.19 (d, J = 4.2 Hz, 1H) 6.15 (d, J = 3.6 Hz, 1H) 
114.3 113.5 5.89 (s, 1H) 5.86 (s, 1H) 
113.0 112.1 3.89 (s, 3H) 3.86 (s, 3H) 
111.6 110.8 3.28 (d, J = 7.5 Hz, 2H) 3.23 (d, J = 6.9 Hz, 2H) 
106.0 105.2 2.10 (s, 3H, CH3CO2
−) 2.08 (s, 3H, CH3CO2
−) 
91.5 90.7 1.99 (m, 1H) 1.97 (m, 1H) 
59.3 58.6 1.00 (d, J = 7.5 Hz, 6H) 0.97 (d, J = 6.9 Hz, 6H) 
58.9 58.2   
30.2 29.4   
24.1 24.5   
20.4 (2C) 19.7 (2C)   
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Table 5-9: Comparison of the 13C and 1H NMR data recorded on naturally- and synthetically-derived 
tambjamine J (11), both isolated as their acetic acid salt 
13C NMR Data 13C NMR Data 1H NMR Data 1H NMR Data 
Natural 11 
(δC) 
(75 MHz, CDCl3)
42  
Synthetic 11 
(δC) 
(75 MHz, CDCl3) 
Natural 11 
(δH) 
(300 MHz, CDCl3)
42  
Synthetic 11 
(δH) 
(300 MHz, CDCl3) 
179.0 179.3 13.20 (broad s, 1H) 11.10 (broad s, 2H) 
164.3 163.4 11.10 (broad s, 1H)  
142.3 141.5 7.30 (broad s, 1H) 7.26 (s, 1H) 
142.1 141.3 6.63 (d, J = 4.2 Hz, 1H) 6.56 (d, J = 3.9 Hz, 1H) 
125.1 124.4 6.23 (d, J = 4.2 Hz, 1H) 6.15 (d, J = 3.9 Hz, 1H) 
114.3 113.5 5.90 (s, 1H) 5.87 (s, 1H) 
113.0 112.1 3.90 (s, 3H) 3.86 (m, 3H) 
111.7 110.9 3.33 (m, 2H) 3.28 (m, 2H) 
106.0 105.3 2.14 (m, 1H) 2.09 (s, 3H, CH3CO2
−) 
91.5 90.8 2.10 (s, 3H, CH3CO2
−) 1.73 (m, 1H) 
58.9 58.2 1.56 (m, 2H) 1.46 (m, 1H) 
57.8 57.0 1.30 (m, 3H) 1.19 (m, 1H) 
36.6 35.8 0.98 (t, J = 8.0 Hz, 3H) 0.93 (m, 6H) 
27.2 26.5   
24.1 24.6   
17.4 16.7   
11.8 11.1   
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A.2 APPENDIX TWO 
 
X-ray crystal structure report for compound 53 
 
A full X-ray crystallographic report for compound 53 (as compiled by Anthony 
C. Willis of the Australian National University) is provided in PDF-format on 
the compact disc found on the inside back cover of this thesis. 
 
X-ray report 53.pdf 
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A.3 APPENDIX THREE 
 
X-ray crystal structure report for compound 94 
 
A full X-ray crystallographic report for compound 94 (as compiled by Anthony 
C. Willis of the Australian National University) is provided in PDF-format on 
the compact disc found on the inside back cover of this thesis. 
 
X-ray report 94.pdf 
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A.4 APPENDIX FOUR 
 
X-ray crystal structure report for compound 95 
 
A full X-ray crystallographic report for compound 95 (as compiled by Anthony 
C. Willis of the Australian National University) is provided in PDF-format on 
the compact disc found on the inside back cover of this thesis. 
 
X-ray report 95.pdf 
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A.5 APPENDIX FIVE 
 
X-ray crystal structure report for compound 96 
 
A full X-ray crystallographic report for compound 96 (as compiled by Anthony 
C. Willis of the Australian National University) is provided in PDF-format on 
the compact disc found on the inside back cover of this thesis. 
 
X-ray report 96.pdf 
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A.6 APPENDIX SIX 
 
X-ray crystal structure report for compound ent-106 
 
A full X-ray crystallographic report for compound ent-106 (as compiled by 
Anthony C. Willis of the Australian National University) is provided in PDF-
format on the compact disc found on the inside back cover of this thesis. 
 
X-ray report ent-106.pdf 
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A.7 APPENDIX SEVEN 
 
 
X-ray crystal structure report for compound 233 
 
A full X-ray crystallographic report for compound 233 (as compiled by 
Anthony C. Willis of the Australian National University) is provided in PDF-
format on the compact disc found on the inside back cover of this thesis. 
 
X-ray report 233.pdf 
 
  
